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ABSTRACT
Encrustation and the subsequent blockage of indwelling 
urinary catheters is a common problem. For patients in the 
community, the resultant urinary bypassing or painful retention, 
is particularly distressing since professional help is not 
immediately available. Catheter blockage also places increased 
demands on nursing time and resources.
A prospective longitudinal study of 47 community patients 
with long-term catheters was conducted. Demographic, dietary and 
catheter care data were collected. Biochemical and 
microbiological urinalysis were also conducted. Catheters were 
changed on three occasions, after six week intervals, and 
encrustations examined. A model of encrustation in the 
catheterised bladder was developed, and used to evaluate the 
effectiveness of bladder washouts in reducing encrustation.
The results indicated that patients can be classified as 
"blockers" and "non-blockers" (Kunin et al., 1987a). "Blockers" 
produced two or more blocked catheters and were characterised by 
high urinary pH and ammonium concentration, and by infection with 
urease-producing micro-organisms, particularly Proteus mirabilis. 
"Blocker status" was also significantly associated with female 
sex and with poor mobility, but not with fluid intake and urinary 
output. "Blockers" were generally managed by "crisis care" in 
response to leakage or retention, rather than by planned 
recatheterisations prior to catheter blockage. Recognition of
individual patients as "blockers" and the establishment of a 
"pattern of catheter life", would be useful to planning 
individualised care.
The major components of catheter encrustations leading to 
blockage, were struvite and calcium phosphate. Calcium oxalate 
was present on some non-blocked catheters. Acidic bladder washout 
reagents (Suby G and mandelic acid) effectively reduced 
encrustation but saline did not. It is suggested that "mini­
washouts" of 10 - 20ml may reduce encrustation and also minimise 
the potentially detrimental effects of washouts on the bladder 
mucosa.
A number of recommendations for practice are made on the 
basis of these results.
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JL _ URINARY CATHETERS AND THE 
PROBLEM OH ENCRUSTATION
INTRODUCTION
One target identified by the "Strategy for Nursing" 
(Department of Health, 1989) was "the need for clinical 
practice to be founded on up to date information and research 
findings". This report also encouraged practitioners to 
identify needs and opportunities for research presented by 
their work. The study reported here was developed in response 
to the problem of recurrent blockage associated with long­
term, indwelling, urinary catheters. The research focuses on 
catheterised patients living in the community, and includes 
those living in their own homes, or in warden controlled 
housing for the elderly. Control of urinary dysfunction by 
catheterisation is often a lifelong procedure, and recurrent 
blockage is particularly distressing for both patients and 
carers, since help is not immediately available. In addition, 
male patients are frequently referred to hospital with 
catheter-associated problems as many community nurses are 
untrained in male recatheterisation (Kohler-Ockmore, 1992).
The commonest cause of catheter blockage is the occlusion 
of the lumen by hard mineral deposits, or encrustations, which 
are precipitated from the urine. Blockage of the lumen results
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in incontinence due to urinary bypassing of the catheter, or 
in pain and discomfort due to urinary retention (Fig.l). In 
addition, encrustations which are deposited on the external 
catheter surface may cause pain, and physical trauma to the 
urethra when the catheter is removed, increasing the risk of 
infection.
Blockage also places increased demands on nursing time 
and resources, necessitating unscheduled visits, time 
consuming procedures, and replacement of expensive catheters. 
Patients with long term catheters make up approximately four 
per cent of the community nursing caseload (Roe, 1987; 
Getliffe, 1990). However, this figure is likely to increase 
since a large proportion of catheterised patients are elderly, 
and the number of elderly people in the population is rising 
(Meredith Davies, 1991).
FIG. 1 Effects of catheter encrustation and blockage
Catheter Encrustat ion 
and Blockage
Painful ca theter  
removal
Urinary bypassing 
and leakage
Painful urinary 
retention ' Increased demandsDistress to patient
and carers on health services
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Other important complications of catheterisation include 
urinary tract infection, inflammatory reactions to catheter 
materials, and psychological and social difficulties. These 
will be considered in more detail under subsequent sections 
entitled "Patient perspectives", and "Catheter-associated 
complications".
Since urinary tract infection may have a significant 
effect on patient morbidity and mortality, much medical 
research has been focused on this problem, predominantly in 
patients catheterised short-term (Kunin and McCormack, 1966? 
Garibaldi et al, 1974? Platt et al, 1982? Slade and Gillespie, 
1985? Mulhall et al., 1988). By contrast, catheter 
encrustation has received little attention, perhaps because it 
is unlikely to be life-threatening. Nevertheless, 
approximately 50% of long-term catheterised patients suffer 
from persistent encrustation leading to blockage (Cools and 
Van Der Meer, 1986? Roe and Brocklehurst, 1987? Kohler- 
Ockmore, 1990). Recurrent encrustation presents a problem to 
both patients and nursing staff, which is not only difficult 
to resolve, but may have profound psychological and social 
effects on a patient's ability to accept, or cope with the 
catheter. There is a clear need for a thorough understanding 
of the aetiology of encrustation, and the factors which 
contribute to the problem, in order to develop effective care 
procedures.
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THE DEVELOPMENT OF URINARY CATHETERS
Historical Perspectives
Urinary catheters have been used since ancient times to 
relieve the pain of overfilled, obstructed bladders. Indeed 
urinary retention is mentioned in most of the earliest 
recorded histories of civilisation (Herman, 1973). 
Catheterisation has reportedly been accomplished with reeds, 
straws and curled up palm leaves. The thin, hollow leaves of 
the Allium (onion) family were used effectively by the 
Chinese, but breakage and 
difficulties in pushing the dried 
leaves past obstructions limited their 
value. Metal catheters were more 
robust, and tubes of gold, or bronze 
were used by the Egyptians and Greeks 
to relieve obstruction. Similar metal 
catheters were recovered during the 
excavations of Pompeii (Fig.2). Silver 
catheters, although expensive, remained 
popular until the advent of modern 
latex and plastics. The anti-bacterial 
properties of silver are still* employed 
in some modern silver-alloy coated 
catheters (Liedberg and Lundeberg,
1990) .
FIG.2 Hetal catheter discovered 
during excavations at Pompeii. Drawn 
from an illustration in Herman,1973.
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Early records suggest that catheterisation was a painful 
procedure since it was often difficult to obtain the patient's 
consent! (Murphy, 1972). To reduce patients' suffering, 
catheters made of cloth or animal skin were designed. These 
materials were impregnated with wax and moulded on a metal 
former. The catheter was introduced with the help of a metal 
or bone stylet, but rapid softening and collapse often 
occurred following removal of the stylet.
At the end of the seventeenth century, the Dutch surgeon 
Van Solingen constructed a catheter of flat silver wire, wound 
spirally, and designed to accommodate itself to the 
irregularities of the urethra. To avoid damage to the mucosa 
by the metal grooves, it was covered with parchment held in 
place with a silk thread and impregnated with wax to fill in 
any crevices. One patient is known to have used such a
catheter for two years, leaving it in place for four or five
days at a time (Murphy, 1972).
The use of silk, woven catheters, soaked in linseed oil
and then dried, was described by Louis Mercier (1812-1882). 
However, these catheters were difficult to sterilise 
satisfactorily and when old were likely to break during use, 
with resultant tissue trauma and retention of catheter 
fragments. The invention by Mercier of the coude catheter, 
with its curved (elbow) tip designed to help negotiate 
strictures, was of immense value in the treatment of bladder 
neck obstruction.
Early attempts were made to incorporate rubber into 
loosely woven material. However, dramatic advances in catheter
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manufacture became possible after a method of forming and 
shaping rubber, known as vulcanisation, was developed by 
Goodyear in 1844. In less than a decade, Auguste Nelaton of 
Paris was using this method to produce what is still known as 
the Nelaton catheter. Modern plastic catheters of this design, 
with a solid tip and a single eye, are used extensively for 
collection of bladder urine samples and by patients practising 
intermittent self-catheterisation.
When retention of the catheter within the bladder was 
required, most early designs were tied or taped to the penis 
in males and sometimes sewn to the urethral orifice in 
females. Clearly this was unsatisfactory - a catheter which 
could be retained through it's own configuration was needed.
In 1892, Malecot demonstrated his four-winged catheter and 
this was followed shortly by the de Pezzer "mushroom1 (Fig.3), 
however, there was considerable risk of tissue trauma during 
removal of these catheters.
FIG. 3 Halecot catheter
De-Pezzer catheter
Early self-retaining catheters.
Drawn from a medical equipment catalogue illustration (Warne Franklin, 1990).
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Many attempts were made to produce a catheter with an attached 
bag (balloon) which could be inflated within the bladder. In 
some cases the design aimed to relieve strictures by inflation 
of the bag, and in others, to apply pressure to control 
haemorrhage, rather than to facilitate continuous urinary 
drainage. Some early designs incorporated bags made of 
"goldbeaters skin", a submucosal layer of the intestines of 
oxen, tied to the catheter and inflated through a separate 
channel. In the mid-nineteenth century, Reybard designed two 
self-retaining catheters, one held in place by a moveable 
flange and the other fitted with a small inflatable balloon. 
However, most early designs did not prove satisfactory in 
practice. Finally during the 1930's, when latex rubber became 
available, the forerunner of the modern indwelling catheter 
was developed by Frederick Foley of St. Paul, Minnesota. By 
dipping and coagulating latex on metal formers it became 
possible to manufacture a one piece catheter and balloon.
Modern Catheters
The Foley catheter is now the most commonly used of all 
urethral catheters. In its usual form it has a double lumen 
shaft (one lumen for urine drainage, the other for inflation 
and deflation of the retention balloon), a rounded tip and two 
drainage eyes proximal to the balloon (Fig.4). A variety of 
alternative tip designs are available, with either opposed or 
staggered eyes proximal to the balloon? an additional eye 
distal to the balloon to facilitate drainage of residual 
urine? or a terminal opening for maximal drainage of blood
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clots post“operatively. Some catheters have a third channel 
for irrigation or instillation purposes»
FIG, 4 Modern Foley self-retaining catheter
The French were the foremost manufacturers of catheters 
during the nineteenth century and their terminology is still 
used to describe certain catheter features eg. coude and 
jbicoude, (curved or "elbow" tips). Catheter gauge is measured 
as the external diameter of the catheter shaft, and is defined 
in either Charriere units (Ch), (after Joseph Charriere, a 
nineteenth century Parisian instrument maker), or French gauge 
(Fg). Both scales are identical with one unit equivalent to 
l/3mm, eg. an 18Ch or 18Fg catheter has an external diameter 
of 6mm. The diameter of the internal lumen may vary however, 
depending on the catheter material, and the manufacturing 
process. For example, catheters formed by the extrusion of a
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single material usually have relatively thin walls and large 
lumens compared to catheters of the same gauge, produced by 
building up layers through dipping and coating on a former. 
Until relatively recently, the standard male catheter (41- 
45cm) was the only length available to men and women. Now a 
shorter catheter is available for females.
Catheter material
An ideal catheter should be soft for comfort, and yet 
sufficiently firm for easy insertion and maintenance of lumen 
patency in situ. For efficient drainage, the largest possible 
lumen is required for the smallest possible external diameter. 
The material used needs to have elastic recoil, so that an 
inflated balloon can be deflated again to almost its original 
size thus minimising discomfort during catheter removal. The 
aim of current research in catheter design and manufacture is 
to develop a biocompatible material which whilst meeting the 
previous criteria, also:
. causes minimal tissue reaction.
. inhibits colonisation by micro-organisms.
. resists encrustation by mineral deposits.
Modern catheters are usually composed of polyvinyl- 
chloride (PVC or plastic), latex with or without a coating, 
silicone or metal. Plastic catheters are relatively cheap to 
manufacture, and are commonly chosen for short-term use, up to 
14 days. Having a thin wall, they provide the largest lumen,
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and since water absorption by plastic is low, overall 
diameters remain unchanged in situ. Although plastic is soft 
at body temperature, it is rigid at lower temperatures and 
uncomfortable to sit on, and is prone to developing cracks 
with longer term use (Norton, 1987).
Latex catheters are soft and flexible but their high 
surface friction may result in discomfort during insertion or 
removal. Latex may also cause urethral tissue inflammation and 
these catheters are subject to rapid encrustation (Binder and 
Gonick, 1969; Bruce et al., 1974). Furthermore, the absorption 
of water and body fluids by latex may lead to an increase in 
overall diameter, or a reduction in lumen size thus limiting 
the catheter's effectiveness. For these reasons latex 
catheters are restricted to short-term use, and have become 
less common as newer materials are developed. Attempts to 
minimise friction during catheterisation and to reduce tissue 
reactions, led to the impregnation of latex with silicone oil. 
However, the silicone oil was rapidly leached into the urine, 
so that any beneficial effects were short-lived (Ruutu et al., 
1985), and siliconised latex catheters are now rarely used.
Catheters for long-term use have been developed by 
coating latex catheters with a tightly bonded layer of 
material designed to provide a smoother, less irritant surface 
which also minimises the absorption of water. Teflon-coated 
catheters are still in use but silicone elastomer or hydrogel- 
coated catheters are more common (Nacey et al., 1986; Talja et 
al., 1990). Hydrogels are hydrophilic polymers which absorb 
aqueous fluids to produce a soft slippery surface which
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reduces trauma on insertion or withdrawal of the catheter.
They are highly biocompatible, relatively inert and are 
extensively used in other medical applications such as contact 
lenses, synthetic cartilages and drug delivery systems (Nacey 
and Delahunt, 1991).
Catheters made of 100% silicone induce the mildest degree 
of urethral inflammation (Talja et al., 1990) and so minimise 
tissue irritation (Nacey et al., 1986). These catheters are 
manufactured by an extrusion process and provide a larger 
drainage lumen than coated catheters. The small, but potential 
risk of separation or disintegration of a coating material is 
also avoided. However, silicone allows the slow diffusion of 
water, which in time may lead to deflation of the balloon and 
the catheter falling out.
PATIENT PERSPECTIVES
Catheterisation is an essential adjunct to modern nursing 
and medical practice. Indeed 10%-12% of all patients admitted 
to hospital will have an indwelling catheter at some time 
during their stay (Kunin 1987; Crow et al., 1988). The 
commonest indications for short and mid-term use, up to 28 
days (Slade and Gillespie, 1985; Crow et al., 1988), are 
drainage of urine post-operatively, accurate monitoring of 
urine output in acute illness, and management of urinary 
retention.
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Long-term catheterisation is frequently necessary for 
patients with intractable urinary incontinence or urinary 
retention. This procedure is employed in 16%-28% of patients 
in chronic care facilities (Cools and Van Der Meer, 1986? 
Ouslander et al., 1987; Kunin et al., 1987a) and in 4% of 
patients nursed in the community (Roe, 1987; Getliffe, 1990). 
Long-term catheterised patients comprise three main groups:
. patients with neuropathic bladders resulting from major 
neurological disease, or spinal cord injury.
. patients who are unfit for surgical repair of bladder 
outlet obstruction.
. patients who are chronically incontinent often with 
associated debility or confusion.
Recent advances in urodynamics and in the understanding 
of the pathophysiology of voiding dysfunction, dictate that 
management of incontinence by an indwelling catheter should be 
the last resort (Jeter et al., 1990). Careful planning and 
thought can often allow effective management of incontinence 
without catheters. Nordquist et al. (1984), describe the 
removal of long-term catheters from 94% of 124 elderly 
patients admitted to a designated "catheter free" ward. The 
ward staff had been specially trained in the management of 
incontinence without catheters, and in the use of other 
appliances. In a follow up study, 78% of the surviving 
patients were still catheter free. Nevertheless, there are
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some patients for whom alternative treatment is unsuccessful 
or impossible.
The psychological and social effects of long-term 
catheterisation are varied. Whilst the catheter is sometimes 
regarded as a sign of declining independence and a cause for 
embarrassment, many patients are grateful for improved control 
of their urinary dysfunction and the opportunity for social 
activity without fear of incontinence (Roe and Brocklehurst, 
1987). For some patients, a catheter can make the difference 
between coping at home, and the alternative of institutional 
care.
CATHETER-ASSOCIATED COMPLICATIONS
There are three main categories of complications which 
arise during catheterisation: inflammatory reactions, 
infection, and catheter encrustation (Fig.5). The first two 
will be considered briefly before examining the problem of 
encrustation in depth.
Inflammatory Reactions
As a "foreign body" the catheter initiates an 
inflammatory response ranging in severity from mild oedema to 
haemorrhage and destruction of mucosal epithelium (Painter et 
al., 1971; Edwards and Trott, 1973? Nacey et al., 1985; Talja 
et al., 1990? Nacey and Delahunt, 1991). The choice of a 
material which minimises tissue reaction is therefore
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FIG. 5 Catheter-associated coaplications.
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extremely important, particularly during long-term use. 
Leaching of toxic substances from certain materials has been 
implicated in subsequent formation of urethral strictures 
(Talja et al., 1985? Blacklock, 1986), and recognition of this 
problem lead to the enforcement of stricter controls on 
catheter materials and catheter manufacture (British Standard 
1695 part I, 1990).
Adherence of inflammatory products to the catheter 
surface may be an early stage in the development of 
encrustation (Talja et al., 1990). Encrustations may, in turn, 
cause further mucosal irritation thus exacerbating the 
inflammatory reaction. The resulting increased production of
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cellular debris and exudate will contribute to the potential 
blockage initiated by the encrustations.
Infection
A catheter provides a portal of entry for micro-organisms 
into the bladder and, despite modern closed drainage systems, 
bacteriuria is an inevitable consequence of long-term 
catheterisation (Kunin, 1987). Micro-organisms may gain access 
to the catheterised bladder by migration within the catheter 
lumen from the collection bag and/or the catheter-drainage 
tube junction (Kunin, 1987; Schaeffer, 1986; Stamm et al., 
1991). Alternatively the bladder may be reached via the peri­
urethral route between the urethral mucosa and the external 
catheter surface, although infection by this pathway is 
thought to develop more slowly (Garibaldi et al., 1980; 
Schaeffer and Chmiel, 1983; Nickel et al., 1985c; Stamm et 
al., 1989). The comparative importance of these two routes is 
difficult to determine but is probably of more consequence in 
short-term catheterisation where prevention of infection is 
potentially possible. The risk of catheter-associated 
infection increases by five to eight per cent per day (Mulhall 
et al., 1988) and 90% of patients undergoing long-term 
catheterisation develop bacteriuria within four weeks (Cools 
and Van Der Meer, 1986; Slade and Gillespie, 1985; Wyndale et 
al., 1985; Jewes et al., 1988).
A different distribution of micro-organisms, including a 
significantly higher proportion of Gram-negative bacilli, 
occurs in the urine from catheterised, compared to non-
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catheterised patients (Cools and Van Der Meer, 1986). The 
source of these organisms is frequently the bowel (MacLaren 
and Peerblooms, 1986) and micro-organisms identified in the 
urine may often be isolated from the perineum and urethral 
meatus (Ehrenkranz and Alfonso, 1991? Classen et al., 1991). 
Complex mixed communities of micro-organisms, frequently 
unresponsive to antibiotic therapy (MacFarlane, 1985), or 
antiseptic bladder washouts (Stickler et al., 1987), develop 
during longer periods of catheterisation (Jewes et al., 1988). 
Catheter encrustations may protect these organisms from 
therapeutic agents and thus contribute to the persistence of 
infection.
Whilst bacteriuria presents an undoubted risk of upper 
urinary tract infection, renal impairment and bacteraemia, the 
associated risks of morbidity and mortality appear to be 
related to the underlying health of the patient. Although 
increased mortality has been associated with urinary 
catheterisation in acutely ill patients (Platt et al., 1982 
and 1983), no similar relationship was detected for long-term 
catheterised patients in chronic care facilities (Cools and 
Van der Meer, 1986; Kunin et al., 1987a). Furthermore, 
systemic symptoms of infection were commonly absent in the 
latter group. However, for spinally injured patients, who form 
a large proportion of the long-term catheterised population, 
renal failure is a recognised leading cause of death (Stickler 
et al., 1971).
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Catheter Encrustation and Blockage
Catheter leakage and blockage is a major problem for many 
patients. Approximately 50% of patients, whether in hospital, 
long-term care facilities or in the community suffer from this 
complication (Kennedy et al., 1983? Hedelin et al., 1985a? 
Cools and Van Der Meer, 1986? Kunin et al., 1987b? Roe and 
Brocklehurst, 1987? Mobley and Warren, 1987? Getliffe, 1990? 
Kohler-Ockmore, 1990). Whilst kinked tubing, constipation, or 
bladder spasm can sometimes cause catheter blockage, the 
precipitation of encrusting material is the most common and 
persistent cause.
There is considerable variation in the tendency of 
individual patients to develop catheter encrustation, and in 
the quantity of encrustation produced (Bruce et al., 1974? 
Norberg et al., 1983: Kunin et al., 1987a). This variation is 
apparently unrelated to the duration of the catheterisation, 
or to the catheter material. Patients usually retain their 
particular pattern of "catheter life" ie. the characteristic 
length of time a catheter remains in place prior to becoming 
blocked. Ferrie et al. (1979) identified two groups of 
catheterised patients, one of which experienced more problems 
with catheter blockage than the other. These groups required 
different catheter management and were similar to the 
"blockers" and "non-blockers" proposed by Kunin et al. (1987b) 
and Kunin (1989), and defined below?
"BLOCKERS": "those patients who consistently and
repeatedly develop extensive encrustation on their
17
urinary catheters within a few days to several weeks, 
resulting in a shorter catheter life because of 
diminished flow and leakage".
"NON-BLOCKERS": "patients who do not form
encrustations even when the catheter is left in place 
for weeks to months".
Kunin etal. (1987b).
FEATURES OF CATHETER ENCRUSTATION
The development of nursing strategies to prevent or 
minimise catheter blockage, depends on an understanding of the 
factors contributing to the encrustation process. Current 
knowledge of the composition of encrusting material and the 
conditions affecting precipitation, will be examined in the 
following sections. The nursing management of catheter 
encrustation will be discussed in Chapter 2.
The Location of Encrustations
Encrustations form on the surfaces of catheters and 
balloons which are exposed to urine. Deposits on external 
surfaces form at the proximal end of the catheter (Hukins et 
al., 1983? Kunin et al., 1987b), on the tip, around the 
catheter eyes and on the balloon. Within the lumen, the 
distribution of encrustations is usually uniform (Kunin et
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al., 1987a), but greater accumulation occurs at the proximal 
end once the tip becomes obstructed (Norberg et al., 1980).
Encrustations are not found on surfaces in close contact 
with the bladder or urethral mucosa (Kunin et al., 1987a). The 
layer of mucin lining the bladder, which prevents bacterial 
adherence and tissue invasion (Parsons et al., 1975? Sobell, 
1985? Cornish et al., 1988), also acts as a defence against 
adhesion of deposits (Kunin, 1987). However, the mucin layer 
can be disrupted by treatment with dilute acids (Parsons et 
al., 1979). Although recovery of bladder surface anti-adhesion 
properties occurs within 24-48h, the risk of possible tissue 
damage raises considerable implications regarding the use of 
acidic bladder washout preparations, and will be considered in 
the next chapter.
The Composition of Encrustations
The composition of catheter encrustations received 
relatively little attention until Bruce et al. (1974), 
reported the presence of protein, calcium, phosphorus, 
magnesium and uric acid. However, less than 40% of the dry 
constituents were identified by the chemical methods employed. 
Magnesium ammonium phosphate, (which occurs naturally as the 
ore struvite), and calcium phosphates were identified as major 
components, in a study of 95 encrustations from 30 patients, 
by Hedelin et al. (1984). Nearly 75% of the precipitated 
material was identified, including small amounts of oxalate, 
urate, protein and carbonate. In four per cent of the 
encrustations, oxalate was the major constituent. However,
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struvite and calcium phosphates have been confirmed as the 
predominant components of catheter encrustation, by both 
chemical and physical methods (Hukins et al., 1983; Cox et 
al., 1987a? Ohkawa et al., 1990).
A significant positive correlation between the frequency 
of catheter changes due to blockage, and the proportion of the 
encrusting material present as calcium phosphate, has been 
reported (Hedelin et al., 1985a). Examination of encrusted 
material using X-ray diffraction, infra-red spectroscopy and 
extended X-ray absorption fine structure spectroscopy (EXAFS) 
(Cox et al., 1987a), has shown that struvite is present in a 
fully crystalline form, but that calcium phosphate is present 
as poorly crystalline hydroxyapatite. The smaller particles of 
calcium phosphate may have a greater tendency to occlude the 
catheter lumen than larger struvite crystals, and this may 
explain the correlation between calcium phosphate 
concentration and catheter blockage. Thus, potential catheter 
obstruction may depend both upon the composition, and the 
quantity of encrustation precipitated. This is supported by 
the finding that patients receiving allopurinol (an inhibitor 
of uric acid formation) required less frequent catheter 
changes than a control group (Hedelin et al., 1984). The total 
quantity of encrusted material was not significantly reduced 
in patients taking allopurinol, but the composition differed, 
decreased amounts of urate and calcium phosphate being 
present.
With the exception of protein, the organic components of 
encrustations have not been characterised. However, large
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amounts of mucus are voided by patients with long-term 
indwelling catheters (Kunin, 1987) and an increase in urinary 
mucoproteins and mucopolysaccharides is associated with 
infection by some Gram-negative bacteria (Finlayson et al. , 
1961; Griffith, 1978). During conditions of low urine flow or 
high osmolality, this mucus may become inspissated and 
contribute to catheter blockage.
The Formation of Encrustations
Sterile urine is normally acidic, with a pH of 
approximately 6.0 (range 4.5 - 8.5), depending on diet, 
medication and acid/base balance within the body (Watson and 
Royle, 1987). However, the formation of struvite usually 
occurs only when the pH exceeds 7.2 (Elliott et al., 1958). 
Such alkaline urine commonly results during infection with 
urease-producing micro-organisms. These release ammonia from 
urea (Griffith et al., 1976? Griffith, 1978), according to the 
following reaction:
urease
H2N-CO-NH2 ----------   2NH3 + C02
h 2o
Further hydrolysis produces an increase in urine alkalinity by 
the formation of hydroxyl ions:
NH3 + H20 ------ ► NH4+ + OH"
An association between struvite stones in the upper 
urinary tract, (often termed "infection stones"), and the
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presence of urease-producing micro-organisms has long been 
recognised (Brown, 1901; Hellstrom, 1938). Although some 
animal species may form struvite crystals under non-infective 
conditions (Osborne et al., 1985), human "infection stone" 
formation is commonly linked to infection with "urease- 
producers" (Hugosson et al., 1990a). However, there is a large 
inter-individual variation, ranging from the rapid formation 
of large staghorn stones, to simple struvite crystalluria in 
the absence of stone development. It has frequently been 
claimed that the magnitude of the pH increase is the major 
determinant in urease-induced crystallization (Robertson et 
al., 1968; Tiselius and Wall, 1986). The observed clinical 
variation may be due, therefore, to the differing activity of 
ureases from different micro-organisms, or to the severity of 
infection and the quantity of enzyme produced.
Micro-organisms which produce urease
The species most commonly associated with stone formation 
is Proteus mirabilis. Both P.mirabilis and Providentia 
stuartii have been freguently isolated from the urine of 
patients with obstructed catheters (Kunin, 1989; Mobley and 
Warren, 1987). Weaker urease-producers such as Klebsiella 
species and Pseudomonas aeruginosa are also common in urine 
from catheterised patients (Kunin, 1989), but are less often 
associated with catheter blockage. A number of Gram-positive 
micro-organisms are capable of producing urease, but they are 
seldom associated with catheter encrustation. However, all 
urease-producing organisms including Ureaplasma urealyticum,
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are potentially calculogenic (Rosenstein et al., 1980)(Table 
1).
TABLE 1. Micro-organisms which can cause urinary tract infections and which may produce urease
Micro-organism Usually produce urease 
(>90! of isolates)
Occasionally produce urease 
(5-30! of isolates)
Gram-negative bacteria Proteus rettgeri Klebsiella pneumoniae
Proteus vulgaris Klebsiella oxytoca
Proteus mabilis Serratia marcesens
Morganella morganii 
Providencia stuartii
Pseudomonas aeruginosa
Gram-positive bacteria Staphylococcus aureus 
Corynebacterium species
Staphylococcus epidermidis
Mycoplasma Ureaplasma urealyticm
Adapted from Wickham and Buck, 1990, and Kunin, 1987.
It seems likely that catheter encrustations form under 
conditions which are similar to those occurring during 
"infection stone" development. However, micro-organisms, 
capable of producing urease are not always isolated from the 
urine of patients with encrusted catheters (Bruce et al.,
1974; Hedelin et al., 1985a). Urinary pH was not reported in 
these studies, but highly alkaline urine could have been 
indicative of urease activity by undetected micro-organisms.
Scanning electron micrographs of encrusted catheters have 
revealed the presence of micro-organisms underlying mineral 
deposits (Axelsson et al., 1977? Nickel et al., 1985a; Cox et
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al., 1989a). The close association of micro-organisms with the 
catheter surface, or their protection by encrusting material, 
may explain the failure to consistently culture urease- 
producers from the urine of blocked catheters. Indeed, a 
different microbial flora was identified on 11/3 3 catheter 
surfaces compared to that of the bladder urine in a study by 
Ramsey, et al. (1989).
Micro-organisms have a strong tendency to grow on 
available surfaces in preference to free-living in a 
surrounding aqueous environment such as urine (Costerton and 
Lappin-Scott, 1989). Surface colonisation becomes irreversible 
as microbial multiplication occurs and the living layer or 
"biofilm" becomes chemically bound to the surface by 
production of exopolysaccharides and the formation of a 
glycocalyx. Localised urease production from within such a 
biofilm, has been demonstrated in experimentally induced 
bladder stones (Nickel et al., 1987). Furthermore, the pH of 
the urine within blocked catheters is higher than the pH of 
urine flowing from a newly inserted catheter (Norberg et al., 
1980), which suggests a localised production of urease by 
micro-organisms colonising the catheter surface.
The distribution of microbial species in urine fluctuates 
with time (Breitenbucher, 1984; Slade and Gillespie, 1985).
The failure to detect "urease-producers" in the urine might be 
due therefore, to the absence of such micro-organisms at the 
time of sampling. Alternatively, urease production might be 
due to micro-organisms such as Ureaplasma urealyticum or 
Corynebacterium species, which are not detected by
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conventional culture methods (Hedelin et al., 1984; Soriano et 
al., 1985; Digenis et al., 1992). The transfer of urease 
activity from one species of micro-organism to another, by 
bacterial plasmids (Osborne et al., 1985), might also account 
for some instances of catheter encrustation in the absence of 
known urease-producers. An associated high urinary pH would 
support the fact that ureolysis was probably occurring.
In contrast, other investigators report the recovery of 
urease-producing micro-organisms in urine from blocked and 
unblocked catheters with similar frequency (Kunin et al.,
1987a; Mobley and Warren, 1987). This suggests that factors 
inhibiting crystallization are present in the urine of some 
patients. Therefore, although urease plays a critical role in 
crystallization leading to catheter obstruction, other factors 
clearly contribute to the overall effect.
Urine composition and pH
Patients who experience recurrent catheter blockage 
generally excrete a more alkaline urine than patients with 
unobstructed catheters (Kunin et al., 1987a; Hedelin et al., 
1991). In synthetic urine, maximal urease-induced 
crystallization of both calcium phosphates and struvite, 
occurs at a pH of between 7.5 and 8.0 (Hedelin et al., 1985b). 
However, in recent clinical studies, patients with a urinary 
pH as low as 6.8 formed extensive encrustation (Hedelin, et 
al., 1991). Although the sample size was small, this finding 
merits attention since it illustrates the relationship between
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urinary pH and precipitation of struvite in vivo, compared to 
previously reports based on in vitro experiments.
Although struvite precipitation is favoured by alkaline 
conditions because its solubility is decreased, Boistelle et 
al. (1984) have observed in vitro precipitation in both acid 
and alkaline solutions where adequate concentrations of 
magnesium, phosphate and ammonium ions exist. These studies 
suggest that maximal crystallization of calcium phosphate and 
struvite in vivo will take place if the urinary pH is 
elevated, but calcium and magnesium content must also exceed 
critical levels.
The relationship between the formation of catheter 
encrustation and urinary composition has been the subject of a 
number of conflicting studies. In 1974 Bruce et al. found no 
correlation between the concentration of calcium, phosphorus, 
magnesium and uric acid in the urine and that in the encrusted 
material. Later, Kunin et al. (1987a) reported that the urine 
of recurrent "blockers” contained greater quantities of 
calcium, protein and mucin than that of "non-blockers", but 
these results were not confirmed in a subsequent study (Kunin,
1989). Urinary calcium and magnesium concentrations show wide, 
daily, inter and intra-individual variations, which may be 
influenced by diet, fluid intake and output, and patient 
mobility. Therefore, using these criteria to differentiate 
between "blockers" and "non-blockers" may be difficult, or 
unreliable. Urine from different individuals varies markedly 
in its "crystal forming tendency" (Hedelin et al., 1986; 
Hugosson et al., 1990b). However, urines with no precipitate
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despite optimal pH, always exhibit low concentrations of 
calcium and magnesium (Hedelin et al,, 1991). This may be one 
explanation of why certain patients do not experience catheter 
encrustation despite long-standing infection with urease- 
producers and excretion of alkaline urine.
Promoters and Inhibitors of Encrustation 
Promoters
The analogy between "infection stone" formation and the 
development of catheter encrustation is reinforced by the role 
of organic material in the promotion of both processes. The 
production of alkaline urine alone is insufficient to produce 
the rate of crystal aggregation necessary for the formation of 
a macroscopic, clinically significant stone (Rose, 1982; 
Griffith and Klein, 1983). Incorporation of organic material, 
such as urinary mucoproteins (Spector, 1976), is required to 
bind the particulate matter together (Robertson and Peacock, 
1985). However, the specific proteins involved in such binding 
may be unimportant (Robertson and Peacock, 1985), since 
bacterial proteins have been incorporated into experimentally 
induced calculi (Nickel et al,, 1987).
Although normal kidney filtrate contains little protein, 
bladder urine contains more, including mucoproteins, tissue 
exudate and cellular debris. Catheters have been encrusted in 
vitro using synthetic urine supplemented with Jack Bean urease 
(Miller and Opher, 1974? Cox et al,, 1988; Cox and Hukins,
1989). When protein is omitted from this solution, less 
mineral deposition occurs (Cox and Hukins, 1989). In addition,
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the calcium phosphate precipitated is composed of well-defined 
crystals compared to the poorly crystalline form observed in 
clinical samples (Cox and Hukins, 1989).
A number of proteins, including serum, albumin and 
immunoglobulins can promote urease activity in synthetic urine 
(Hugosson et al., 1990c). The mechanism behind this effect is 
not clear, however, albumin has a promotional influence on 
other enzymes, which is thought to be mediated by better 
presentation of substrate to enzyme (Hugosson et al., 1990c). 
In human urine, only high concentrations of serum produce a 
similar effect, possibly because human urine normally contains 
enough protein to ensure maximal stimulation of urease 
activity.
Protein also plays a role in the adherence of both micro­
organisms and crystals to the catheter surface. Fine deposits 
of fibrin have been demonstrated on the surface of catheters 
removed from patients after only three days (Ohkawa et al.,
1990). Since few micro-organisms were demonstrable at this 
stage, the material was probably not bacterial, but may have 
derived from host tissue exudate. Similarly, in vitro studies 
have shown that deposition of non-bacterial organic matter 
precedes the formation of P.mirabilis biofilms, and struvite 
crystallization (McLean et al., 1991). Recent studies suggest 
that lipids may have an aetiological role in the pathogenesis 
of encrustations. Catheter materials dipped in lauric and 
stearic acid were associated with increased encrustation in in 
vitro studies (Whitfield and Holmes, 1991). If urinary lipid 
excretion is sufficiently high (normally 100-150/ig/24h), to
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allow rapid coating of catheter surfaces, lipids may play a 
promotional role in encrustation.
Escherichia coli, the most common urinary tract pathogen 
(Goldstone and Griffith, 1990), very rarely produces urease. 
However, its presence is often associated with "infection 
stones" and encrusted, as well as non-encrusted catheters 
(Hugosson et al., 1990a; Kunin, 1989). There is some in vitro 
evidence, that E.coli influences urease-induced crystal­
lization, in synthetic and human urine, by promoting urease 
activity and the subseguent precipitation of phosphates in a 
way which is currently unknown (Hedelin et al., 1990).
However, these results await clinical confirmation before the 
presence of E.coli, can be considered a factor of etiological 
significance in encrustation formation.
Inhibitors
The presence of urinary inhibitors of crystallization has 
been proposed, to account for differential patient 
susceptibility to catheter encrustation (Bruce et al., 1974; 
Howard et al., 1966). Inhibitors may be implicated also, in 
the lack of a direct relationship between the length of time a 
catheter remains in situ and the extent of encrustation which 
develops (Bruce et al., 1974). However, the evaluation of 
potential inhibitors of crystallization is extremely complex. 
The three main phases in the crystallization process, 
nucleation, crystal aggregation and crystal growth, are 
closely interrelated, and an effect on one phase may influence 
subsequent phases. Potential inhibitors frequently exert
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differential influence at different stages of crystallization, 
and their activity may be subject also to concentration and pH 
effects (Fleisch, 1990; Wilson et al., 1985).
Two major inhibitors of crystal formation have been 
described; low molecular weight materials such as 
pyrophosphate, citrate and magnesium; and macromolecular 
material consisting of glycosaminoglycans, uromucoids and 
polyribonucleotides (Kohri et al., 1989). The role of both 
groups in the pathogenesis of calcium stone formation in the 
upper urinary tract has received considerable attention (Kohri 
et al., 1989), but their potential involvement in "infection 
stone" formation and catheter encrustation is less well known.
Recent studies, using both pooled human and synthetic 
urine, have determined that macromolecules have the greatest 
inhibitory influence on urease-induced, calcium phosphate 
crystallization (Hedelin et al., 1986; 1990; 1991). In similar 
studies, struvite formation was affected by both 
macromolecules, and low molecular weight urinary components 
(Hedelin et al., 1990; Wall and Tiselius, 1990). Both zinc and 
citrate may be potential inhibitors (Hedelin et al., 1989; 
McLean et al., 1990) but further evaluation is necessary.
Human urinary albumin appears to inhibit crystal aggregation, 
particularly under conditions of high urinary magnesium or 
calcium concentration (Hugosson et al., 1990c). This study 
also demonstrated that alkaline conditions are necessary to 
initiate nucleation, but subsequent phases of the crystalliz­
ation process leading to encrustation, are less pH dependent.
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Since whole urine is a highly complex solution, a number 
of criticisms can be made of the techniques used to measure 
inhibitory activity. Most studies of crystallization have used 
synthetic urine containing inorganic components only. The 
effects of proteins and other macromolecules would therefore 
be missed. Where human urine has been used, it was frequently 
diluted. Inhibitory activity is not necessarily linearly 
related to the concentration of the inhibitor, and the 
relative importance of various inhibitors may change with 
dilution. In whole urine, potentiation effects may occur 
between inhibitors or conversely some inhibitors may be 
inactivated by binding to other urinary components.
Surface properties may influence the crystallization 
process and studies of encrustation on glass rods (Hedelin et 
al., 1985b; Hugosson et al., 1990c) may have limited 
application to the process on catheter materials. Furthermore, 
the source of urease in in vitro experiments is commonly Jack 
Bean meal. Ureases from different sources differ in activity, 
inducibility, optimum pH required and susceptibility to 
inhibitors (Rosenstein et al., 1981). Clearly the extent to 
which results from such studies can be extrapolated to the 
clinical situation must be in question.
THE ROLE OF EPIDEMIOLOGICAL AND DIETARY FACTORS
Kennedy and Brocklehurst (1983) reported that the major 
problems of catheterisation experienced by community patients,
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namely; leakage, blockage, offensive smell and urethral 
irritation, were associated with age, female sex and 
immobility. However, this study did not specifically address 
the characteristics of patients experiencing catheter 
encrustation, and the very small number of studies which have 
focused on this problem, have been unable to confirm any 
similar relationship (Kunin, 1989; Getliffe, 1990).
There has been considerable interest in the relationship 
between diet, the excretion of lithogenic or inhibitory 
substances, and the epidemiology of renal "metabolic" or 
calcium stone formation (Coe et al., 1976; Robertson et al., 
1979; Power et al., 1984; Fellstrom et al., 1989). A recent, 
carefully controlled study demonstrated a significant 
association between calcium stone disease and increased 
consumption of dietary protein (Trinchieri et al., 1991). 
Increased dietary protein intake was also significantly 
associated with higher concentrations of urinary calcium, but 
lower concentrations of urinary citrate. Since urinary calcium 
and citrate levels play a role in urease-induced 
crystallization (Hugosson et al., 1990b; Hedelin et al., 1989; 
McLean et al., 1990), it may be postulated that dietary intake 
can influence individual susceptibility to catheter 
encrustation.
Urinary pH, an important parameter in catheter 
encrustation, is also affected by diet. High dietary protein 
intake increases net acid production and excretion, thereby 
promoting a more acid urine and inhibiting renal tubular 
reabsorption of calcium (Lemann et al., 1986). In contrast, a
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predominantly vegetarian diet produces a more alkaline urine 
(Watson and Royle, 1987), which may favour calcium phosphate 
and struvite precipitation. In practice however, where urinary 
infection with urease-producers occurs, active, ureolysis is 
likely to be the major determinant of final urinary pH.
Dietary regimes have been employed in attempts to reduce 
the recurrence of struvite stones. The Shorr regime, developed 
in the 1940's, combined a restriction of dietary phosphates 
with administration of pharmaceutical agents eg. basic 
aluminium gel, to bind intestinal phosphates. This programme, 
when combined with a high fluid intake, diminished the 
recurrence of struvite stones (Goldstone and Griffith, 1990). 
However, the diet was burdensome, induced constipation in a 
high percentage of individuals, and was not considered 
practical for the majority of patients. Such a regime is 
unlikely, therefore, to be of value in the reduction of long­
term catheter encrustation.
The administration of "calculolytic" diets designed to 
reduce the urinary concentration of urea, phosphate, and 
magnesium, have been successful in the dissolution of struvite 
"infection stones" in dogs but not in humans (Osborne et al., 
1985). Furthermore, compliance with stringent dietary controls 
is often poor and long-term dietary restrictions may produce 
alternative unwanted effects, such as vitamin and mineral 
deficiencies, or constipation, particularly in elderly 
patients.
In conclusion, it is increasingly apparent that catheter 
encrustation is a complex procedure which depends on the
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interaction of a number of parameters. Urinary infection by 
micro-organisms producing the enzyme urease, undoubtedly plays 
a key role in the precipitation of struvite and calcium 
phosphate, but urinary composition is also critical. In the 
following chapter, the issues relating to the clinical 
management of catheter encrustation will be discussed.
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2 - CLINICAL MANAGEMENT OE THE
CATHETERISED PATIENT
The twin aims underlying the care of long-term 
catheterised patients are to minimise the risks of secondary 
complications, including catheter encrustation, and to 
maximise patient comfort. In this chapter, the choice of 
equipment and procedures to manage catheter encrustation, will 
be considered.
CATHETER MATERIAL
The selection of a catheter for an individual patient 
requires both a knowledge of the types available and the 
recommendations for their use. However, encrustation can occur 
on all currently available catheter materials, both during 
clinical use or under controlled experimental conditions 
(Bruce et al., 1974? Hukins et al., 1983; Cox et al., 1988). 
Plain latex and teflon-coated latex show the greatest 
susceptibility to encrustation by human and synthetic urine 
(Srinivasan and Clarke, 1972; Bruce et al., 1974). The 
reported superiority of hydrogel surfaces (Miller, 1975) 
remains unconfirmed, and silicone, silicone-elastomer and 
hydrogel appear to resist encrustation equally well (Cox et 
al., 1989c). However, evidence of a correlation between some
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physico-chemical properties of the catheter surface and 
resistance to encrustation has been demonstrated recently 
(Holmes et al., 1992). The incorporation of fluorine- 
containing components into synthetic polymers, conferred 
significant resistance to the formation of encrustation in an 
in vitro system, in which polymer materials were perfused with 
sterile urine. Carbo-fluorinated groups (-CF3), are known to 
reduce the surface energy of polymers and this may influence 
encrustation.
Clinical studies
There are relatively few clinical studies of the 
comparative susceptibility of different catheter materials to 
encrustation. Using the length of time a catheter remains 
patent in situ, as a measure of encrustation, Brocklehurst and 
Brocklehurst (1978) concluded that there was very little 
difference between plain latex and silicone elastomer-coated 
catheters. A recent comparative study of 69 patients over 16 
weeks showed that hydrogel-coated catheters remained in situ 
significantly longer than silicone elastomer-coated catheters 
(Bull et al., 1991). Catheters were assessed for encrustation 
by scanning electron microscopy. However, the authors fail to 
provide evidence for their conclusion that the length of time 
for which the hydrogel-coated catheters remained unencrusted 
was significantly greater than that of the silicone elastomer- 
coated catheters.
The length of time the catheter remains in situ between 
changes is an unreliable parameter of encrustation, if used
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alone. Unless the catheter has been examined specifically for 
blockage by encrustations, other factors such as constipation, 
bladder spasm or twisted tubing may have contributed to lumen 
occlusion leading to removal. The considerable variation in 
patient susceptibility to the formation of encrustations 
implies that either very large numbers of subjects, or cross­
over trials in which patients act as their own controls, are 
required to compare catheter materials. Furthermore, the study 
design should allow patients to be followed for 3-5 "catheter 
lives" for each catheter type, to take into account the 
recognised spontaneous variation in individual "catheter life" 
(Norberg et al., 1983). Where cross-over trials have been 
conducted, and the quantity of encrustation deposited 
examined, latex catheters have consistently shown greater 
susceptibility to encrustation than silicone, silicone-coated 
or hydrogel-coated catheters (Bruce et al., 1974; Kunin et 
al., 1987b). The relative susceptibility of other materials is 
less clearly defined.
There is some evidence to suggest that less encrustation 
occurs on conformable catheters (Brocklehurst et al., 1988;
Cox et al., 1989b). These catheters incorporate a thin walled, 
flexible section which permits the lumen to collapse and 
conform to the "slit" shape of the urethra. Normal micturition 
is simulated when the bladder fills and sufficient pressure is 
exerted to distend the catheter lumen. Although composed of 
plain latex, the pulsatile flow of urine through the catheter 
may dislodge deposits, thus reducing the accumulation of 
encrustations.
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Surface morphology and microbial resistance
A low surface friction is important for ease and comfort 
of catheter insertion. However, less attention has been paid 
to the characteristics of the luminal surface, although this 
is the site of most encrustation, and may provide nidi for the 
crystallization process (Axelsson et al., 1977). Electron 
micrographs of catheter surfaces have shown that internal 
surface topography varies both between catheters composed of 
different materials, and those of similar materials produced 
by different manufacturers (Cox, 1990).
The development of catheter materials which resist 
microbial colonisation is desirable to minimise the clinical 
complications of infection and possibly delay the onset of 
encrustation. However, all catheter materials currently 
investigated support biofilm growth in the clinical situation 
(Ramsey et al., 1989). Micro-organisms adhere to catheter 
surfaces by a number of different mechanisms depending on the 
species, and the surface properties (Gristina et al., 1987; 
Sugarman, 1982; Roberts et al., 1990; Merritt and Chang,
1991). In addition, pre-adherence by one species may enhance 
the adherence of another. The pre-adherence of Staphylococcus 
epidermidis to a range of urinary catheter materials has been 
shown to markedly enhance subsequent adherence by Proteus 
mirabilis (Merritt and Chang, 1991). In contrast, there is 
evidence that lactobacilli competitively exclude adhesion of 
uropathogens to polymer surfaces (Reid et al., 1991). Prior 
application of lactobacilli to catheter surfaces might, there­
fore, reduce subsequent colonisation by uropathogens. The
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investigation of biofilm adherence is however, an emerging 
field and comparison of studies is difficult because of 
differing methodology and conditions.
Hydrophobic forces are influential in the adherence of 
micro-organisms to surface materials (Gristina et al., 1987; 
Jansen and Peters, 1991; Merritt and Chang, 1991). The 
hydrophilic surface of hydrogel-coated catheters may, 
therefore, resist bacterial colonization more effectively than 
other catheter materials. Neither Gram-positive nor Gram- 
negative uropathogens adhered to a hydrophilic catheter 
surface, after overnight incubation (Roberts et al., 1990). 
However, in practice, early deposition of proteinaceous, or 
lipid material (Ohkawa et al., 1990; Whitfield and Holmes,
1991) on catheters in clinical use may rapidly mask 
hydrophilic properties.
Recent reports indicate a reduced risk of urinary tract 
infection in the short-term, when silver-alloy coated 
catheters are used (Schaeffer et al., 1988; Liedberg and 
Lundeberg, 1990; Johnson et al., 1990; Liedberg et al., 1990). 
Whether the potential inhibitory effect extends to a full 
range of micro-organisms including urease-producers is 
unknown, however. Indeed, the potential for longer term 
protection and the ability of the silver coating to maintain 
its integrity is also unknown.
Iontophoresis has been proposed as a method to decrease 
or eliminate bacterial populations (Davis et al., 1989). 
Although the mechanism of action is not clearly understood, 
the generation of metallic or chloride salts by an electric
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current may inhibit bacterial growth. A recent report proposes 
that iontophoresis technology could be incorporated into 
catheters (Davis et al., 1992), and that constant currents of 
200-400/iA may help to prevent catheter-related infections and 
their sequelae.
THE CHOICE OF CATHETER SIZE
Large catheters (20 Charrieres and above), are associated 
with leakage and blockage in elderly, catheterised hospital 
patients (Kennedy et al., 1983). The use of the smallest size 
of catheter compatible with free flow of urine, together with 
a balloon of 5-15 ml, is recommended for long-term 
catheterisation (Thomas, 1979; Blannin and Hobden, 1980; 
Kennedy and Brocklehurst, 1982; Norton, 1987), although these 
recommendations are derived from experience, not from 
controlled experimental trials. Urinary flow rate is 
proportional to the internal diameter of the catheter, 
however, the smallest Charriere size (usually 12, for adults), 
can easily drain normal quantities of urine, including the 
large volumes produced during diuresis (Ebner et al., 1985).
Large catheters and balloons are believed to increase 
bladder irritability, causing spasms and leakage of urine, and 
may occlude urethral glands allowing accumulation of debris 
which contributes to catheter blockage (McGill, 1982; Blandy 
and Moors, 1989). Larger catheters may also exert greater
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pressure against the urethral or bladder wall giving rise to 
ulceration and possible stricture formation.
Catheter balloon size determines the volume of urine 
retained below the catheter drainage eyes. Large balloons 
(30ml) allow a greater volume of urine to collect which may 
result in urinary leakage, and also provides a reservoir for 
infection. However, some patients, prone to bladder spasm, 
readily expel catheters with small balloons. If a larger 
balloon is necessary, a Roberts catheter, which has an 
additional eye below the balloon, will minimise the volume of 
residual urine.
UREASE-INHIBITORS
Inhibition of the urease produced by infecting micro­
organisms would be a logical method to prevent ureolysis and 
the cascade of events leading to struvite stone formation, or 
catheter encrustation. Hydroxamic acids are specific 
inhibitors of urease, their activity depending on their 
stereo-chemical similarity to urea, and their ability to bind 
to nickel atoms in the urea molecule (Fishbein, 1981). Aceto- 
hydroxamic acid (AHA), prevents the formation of struvite in 
vitro and in experimental animals (Kunin, 1987). The efficacy 
of AHA in reducing struvite stone growth has been reported in 
several clinical trials (Goldstone and Griffith, 1990), 
although small sample size and poor control casts doubt on the
41
validity of these results. AHA may also act synergistically 
with antibiotics (Goldstone and Griffith, 1990) and combined 
therapy may provide greater benefit. Although AHA reportedly 
inhibits catheter encrustation (Burns and Gauthier, 1984), its 
long-term use is limited by potential side effects which 
include headaches, change in bowel habits, tremor, haemolytic 
anaemia, deep vein thrombosis and possible mutagenicity 
(Goldstone and Griffith, 1990).
ANTIBIOTICS AND ANTISEPTICS
It is generally recognised that antibiotics will not 
prevent infection in long-term catheterised patients, (Britt 
et al., 1977? Warren et al., 1981? Kennedy and Brocklehurst, 
1982? Kunin, 1987). Whilst systemic antibiotic therapy may be 
effective in eradicating one episode of infection, bacteriuria 
soon recurs and resistant strains may emerge (Dudley and 
Barriere, 1981). Similarly, although irrigation of the bladder 
with antibiotic, or antiseptic solutions has been advocated 
(Thornton et al., 1966), and continues to be used (Stickler et 
al., 1987? Roe, 1989? Getliffe, 1990), eradication of 
infection is rarely achieved and the emergence of resistant 
strains is again favoured (Dudley and Barriere, 1981).
In particular, the benefits of the widespread use of 
chlorhexidine in bladder washouts, lubricating gels and 
antiseptic cleaning solutions, has been disputed (Stickler and 
Chawla, 1987? Davies et al., 1987). Chlorhexidine is
42
ineffectual against a number of commonly occurring urinary 
pathogens, but may remove sensitive bacteria in the normal 
> urethral flora (Stickler and Chawla, 1987), allowing
subsequent colonisation by more resistant organisms, which may 
include urease-producers. A recent study which examined the 
urogenital flora of female patients following antibiotic 
therapy, showed that the indigenous lactobacillus population 
had not been restored in the majority of patients. Rather, 
uropathogenic bacteria were found to dominate! (Reid et al,
1990) .
The biofilm mode of growth
It is now well documented that many chronic infections, 
particularly those involving indwelling devices, such as 
catheters, implants and prostheses, involve bacterial 
populations growing as an adherent biofilm enmeshed within a 
polysaccharide matrix or glycocalyx (Marrie and Costerton, 
1984? Nickel et al., 1986? Gristina et al., 1987). Biofilms 
have been observed on urinary catheters (Nickel et al., 1985a? 
Ramsey et al., 1989), and on urinary drainage bags (Marrie and 
Costerton, 1983).
Biofilm inhabitants are, in general, less susceptible to 
antimicrobial agents than their planktonic counterparts 
(Nickel et al, 1985b? Gristina et al., 1987). Common urinary 
pathogens such as Escherichia coli, although killed in the 
urine by antimicrobial agents, may persist in the biofilm and 
restart the cycle of infection (Stickler et al., 1989). Lack 
of penetration through the biofilm glycocalyx has been
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proposed as a cause of the apparent resistance of biofilm 
inhabitants to anti-microbial therapy and host defences 
(Costerton et al., 1981). Biofilms of mixed micro-organisms 
produce a composite glycocalyx, and this has implications for 
control and elimination of the biofilm, since different 
compositions may be vulnerable to different agents and 
different methods of control.
A physical barrier is not the only mechanism of biofilm 
resistance, since Nichols et al. (1988) have shown that 
antibiotic penetration through the glycocalyx of Pseudomonas 
species is relatively unimpaired. Micro-organisms deep within 
the biofilm are characterised by a slow and variable growth 
rate which is influenced by the availability of nutrients. 
Growth rate is a primary modulator of antibiotic action (Brown 
et al., 1988) and may be, therefore, a major determinant of 
biofilm resistance. The biofilm mode of growth may explain why 
many patients, with heavily colonised urinary catheters, 
experience few overt symptoms of infection (Cools and Van Der 
Meer, 1986; Kunin et al., 1987a). Slow growth rate and 
nutrient deprivation are important factors in reducing 
bacterial pathogenesis (Brown et al., 1988), and may also 
diminish tissue invasion.
In the search for new anti-microbial agents which are 
active against biofilm inhabitants, mandelic acid and mandelic 
acid/lactic acid have proved to be biocidal against some 
biofilms of single, or mixed bacterial species (Stickler and 
Hewitt, 1991). N-acylated amino acids including acyl 
phenylalanine and acyl glycine, also remove biofilm cells from
44
silicone and latex catheter materials (Seo et al., 1990). 
Tissue reaction to these agents in vivo and their efficacy in 
the presence of urinary elements such as mucin and organic 
debris is currently unknown.
CONTROL OF URINARY OSMOLALITY
A high fluid intake of up to two or three litres per day 
is routinely recommended for catheterised patients (Smart and 
Ali, 1980; Slade and Gillespie, 1985; Kunin, 1987). The 
rationale behind this is twofold. Firstly, diuresis will 
assist in voiding micro-organisms from the bladder. When non- 
catheterised patients with urinary tract infections drink 
large volumes of water and empty their bladders at frequent 
intervals, the urinary concentration of micro-organisms 
commonly falls rapidly at first, and then remains almost 
constant (Mackintosh et al., 1975). The initial rapid fall is 
due to the flushing out of planktonic micro-organisms. The 
subsequent, constant inoculum results when micro-organisms 
bound to the uroepithelium shed daughter cells into the urine. 
Secondly, the formation of a dilute urine reduces the 
concentration of encrustation components. In addition, the 
growth rate of infecting micro-organisms, may be depressed by 
the reduced concentration of nutrients in dilute urine.
Despite continuous drainage of urine, the bladders of 
catheterised patients are incompletely emptied, since a 
residual volume of urine remains. Urodynamic mathematical
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models indicate that incomplete emptying of the bladder 
reduces the effective voiding of micro-organisms associated 
with diuresis (Mackintosh et al., 1975). Catheter-associated 
biofilms are unlikely to be removed by the increased urine 
flow caused by diuresis, and therefore provide a continuous 
source of infection. In addition, encrustation products 
embedded within the biofilm have been shown to further enhance 
the stability of the biofilm matrix (McLean et al., 1991).
There is no evidence that catheterised patients who 
develop acute urinary tract infections have a lower mean 
urinary output than similar patients without systemic signs of 
infection (Gibson and Moon, 1978). Nor, does diuresis protect 
experimental animals against the spread of infection from the 
bladder to the renal tissue (Kaye, 1971). However, relatively 
few studies have addressed these issues, and the importance of 
increased fluid intake in minimising the spread of infection 
in long-term catheterised patients, is therefore subject to 
debate.
In the previous chapter it was suggested that if crystal­
lization of calcium phosphate and struvite is to occur, not 
only must the pH be elevated but the urinary content of 
calcium and magnesium must also exceed critical levels. A high 
fluid intake normally results in the production of a dilute 
urine. However, the 24h urinary output necessary to achieve 
undersaturation with magnesium or calcium phosphates, varies 
between individuals, and ranges from 1.9 litres, to up to 10 
litres respectively (Nuseibah and Burr, 1978). In practice, it 
is difficult to achieve a urinary output of greater than four
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litres per day. It would be particularly difficult to maintain 
such a high diuresis and corresponding low urine osmolality 
over a long period of time solely by increasing water intake 
(Nuseibah and Burr, 1978; Hedelin et al., 1985a).
The precise relationship between urinary solute con­
centration and the degree of encrustation formed remains 
unclear (Bruce et al., 1974? Kunin, 1989; Hugosson et al., 
1990b). Kunin (1989) found no difference between the 
osmolality of 24h urine samples collected from patients with 
recurrent catheter encrustation and those with no 
encrustation. By contrast, Hedelin et al. (1985a) reported 
that mean urinary osmolality was low in patients who never 
needed to have their catheters changed due to blockage, but 
was significantly higher in patients requiring very frequent 
changes. However, not all of the patients in the latter group 
had a high urinary osmolality, indicating the influence of 
other factors in the formation of catheter encrustation. The 
collection of a 24h urine sample may mask transient variations 
in the concentration of encrustation components, which occur 
at certain times of the day. Diurnal variation in urinary 
composition may be an important factor in supersaturation 
since urine becomes concentrated overnight when fluid intake 
is lowest. Increased fluid consumption in the late evening to 
reduce overnight concentration may be beneficial for some 
individuals. However, the potential advantages of a dilute 
urine must be weighed against the potential disadvantages, 
since dilution may result in the coincidental reduction in 
naturally occurring inhibitors of crystallization.
47
CONTROL OF URINARY pH
Struvite formation is reversible (Griffith, 1978) and 
exposure to undersaturated urine, or acidification, leads to a 
rapid dissolution of the mineral. A pH change from 7.4 to 6.8 
(only 0.6 units), results in a 75% increase in the solubility 
of struvite (Burns and Finlayson, 1972). Acidification of the 
urine is clearly advantageous to patients prone to catheter 
encrustation, although in practice it may be difficult to 
achieve in the presence of urease production. Oral intakes of 
acidic liquids such as cranberry juice or acidifying agents 
such as ammonium chloride, and ascorbic acid have been 
recommended to increase urinary acidity, (Zinsser et al.,
1968? Burr, 1981; Eddeland and Hedelin, 1983; Kunin, 1987), 
however, their effectiveness in long-term use is unclear.
Historically, crushed cranberries have been used by 
American Indians as a herbal remedy for urinary tract 
infection. Their mechanism of action may relate to lowering 
the urinary pH, or the bacteriostatic effects of the metabolic 
by-product, hippuric acid, which is excreted in the urine 
(Bodel et al., 1959). Most studies to date however, have been 
poorly controlled and although some have demonstrated that 
drinking three glasses of cranberry juice daily reduces the 
symptoms of urinary tract infection (Rogers, 1991), others 
indicate that decreases in urinary pH are only transient (Kahn 
et al., 1967). Drinking cranberry juice is a simple and 
acceptable form of therapy for most patients (Rogers, 1991), 
and well controlled investigations are necessary to confirm or
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refute its potential benefit to catheterised patients. 
Cranberry juice has also been reported to inhibit bacterial 
adherence (Sobata, 1984? Schmidt and Sobata, 1988). This is an 
additional property which could be particularly advantageous 
to catheterised patients with biofilm mediated infections.
Ascorbic acid has been widely employed as a urinary 
acidifier, particularly as an adjunct to the treatment of 
urinary tract infections (Kunin, 1987). However, conflicting 
reports of its efficacy exist (Travis et al., 1965; Murphy et 
al., 1965). Inter-study variations in the daily dose of 
ascorbic acid may have contributed to inconsistent 
conclusions, however, small population size, unclear 
methodology or lack of rigorous statistical analysis also 
undermine the validity of some results. The absorption of 
ascorbic acid is a saturable process (Nahata et al., 1977). 
Large amounts given as a single dose may be only partially 
absorbed therefore, and relatively ineffective at reducing 
urinary pH. In a well-controlled cross-over study of 10 
subjects taking 4g or 6g ascorbic acid daily in divided doses, 
only the 4g regimes were associated with a statistically 
significant decrease in urinary pH (Nahata et al., 1977). The 
maximum drop in overall mean urinary pH for any individual was 
only 0.24 units and the authors state that such a decrease 
would be of little clinical consequence. Nevertheless, it is 
increasingly clear that individual variability in urine 
composition is an important factor in catheter encrustation. 
For some individuals therefore, ascorbic acid or cranberry 
juice therapy may be of value. However, high doses of ascorbic
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acid (>500mg/d) are significantly associated with increased 
intra-renal urinary oxalate concentration and may therefore 
present an increased risk of calcium oxalate renal stone 
formation (Urivetzky et al., 1992) in susceptible patients.
BLADDER IRRIGATION
As discussed above, the maintenance of a low urinary pH 
by oral therapy is difficult, particularly in the presence of 
urease production. Over 200 years ago, John Hunter, an 
eighteenth century surgeon, recommended that catheters prone 
to encrustation should be removed at regular intervals and 
soaked in vinegar to dissolve encrustations prior to re­
insertion (Quist, 1981). Current practices employ intermittent 
irrigation of the catheter and bladder with acidic "bladder 
washout" solutions, to extend "catheter life".
A variety of pre-packed, 100ml, sterile instillations 
(Uro-Tainer, Clini-Med, High Wycombe) are currently used in 
hospital and community settings (Roe, 1989; Getliffe, 1990). 
These products provide a convenient method for nurses or 
patients to perform bladder washouts, and to maintain asepsis. 
However, very few studies have examined the efficacy of 
irrigations in reducing catheter encrustation. In 1943, Suby 
and Albright reported that Solution G, a buffered mixture of 
4% citric acid, magnesium oxide and sodium bicarbonate, was 
effective in dissolving some phosphatic calculi. Hesse et al. 
(1989), demonstrated that catheter encrustation was inhibited,
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or existing mineral deposits largely dissolved, by pumping 
Suby G solution through catheters in an in vitro irrigation 
model. Although clinical conditions were simulated in these 
experiments by using pooled human urine infected with a 
standardised suspension of P.mirabilis, the Suby G solution 
was in contact with the catheter surface for 30min; almost 
twice as long as recommended by the manufacturers of Uro- 
Tainers. Controlled clinical trials are still required to 
confirm the therapeutic value of Suby G, or alternative 
bladder washout solutions, and to establish the most 
appropriate regime for their use. Kennedy (1984), compared the 
instillation of Uro-Tainer Suby G or chlorhexidine solutions, 
on alternate days, with twice weekly saline washouts. 
Catheter-associated problems including leakage of urine, 
catheter blockage and pain, were significantly less with the 
Suby G/chlorhexidine regime. It is unclear, however, whether 
this was a result of the type of solutions used, or the 
increased frequency of washouts.
Many weak organic acids are biocidal, and acetic acid 
solution (0.25%) has been used to reduce infection in 
catheterised patients (Kunin, 1987), and to relieve blockage 
(Hedelin et al., 1984). However, the efficacy of acetic acid 
in dissolving catheter encrustations is unknown. Recent 
reports indicate that mandelic acid (1%) is active against 
some catheter-associated biofilms (Stickler and Hewitt, 1991). 
This reagent may provide dual benefits to catheterised 
patients if the accompanying reduction in urinary pH also 
reduces encrustation. Combined action of this type is of
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particular clinical importance since the biofilm layer confers 
effective protection against dissolution of deeply imbedded 
crystals (McLean et al., 1991). Stronger acidic solutions such 
as Solution R (6% citric acid), have been used successfully to 
dissolve fragments of struvite renal calculi following 
lithotripsy (Holden and Rao, 1991). Dissolution of catheter 
encrustations may be achieved by Solution R also, but the 
benefits may be outweighed by potential inflammatory 
reactions, which limit the freguency with which this solution 
can be used.
Bladder irrigations with saline, and even tap water, have 
also been recommended (Ferrie et al., 1979; Blannin and 
Hobden, 1980; Slade and Gillespie, 1985). These solutions will 
not induce chemical cystitis but the physical force applied to 
wash out encrusting material may damage the bladder mucosa, 
particularly if large volumes are used. Daily washouts with up 
to 1.5 litres of fluid, have been advocated (Slade and 
Gillespie, 1985), as has repeated irrigation until the 
returned fluid is clear (Kennedy, 1984). However, the 
widespread use of pre-packed instillations has imposed a 
standard volume of 100ml.
Elliott et al. (1989) have recently called for a 
reassessment of bladder irrigation methods and indications for 
their use. Having established the validity of measuring uro- 
epithelial cell exfoliation as an indicator of mucosal damage 
(Elliot et al., 1987), these authors demonstrated an increased 
shedding of cells following bladder washouts with 
physiological saline, noxythiolin and chlorhexidine. Dilute
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acid solutions damage the mucus layer lining the bladder 
surface (Parsons et al., 1979; Donmez et al., 1990), thus 
exposing the mucosa to further structural damage, or the 
increased risk of adhesion by micro-organisms. However, the 
mucus layer does reform within 24-48h, and the addition of 
magnesium to washouts reduces the damage caused (Parsons et 
al., 1979? Donmez et al., 1990). Further careful assessment of , 
bladder washout preparations is clearly necessary to determine 
their effectiveness, and to assess the possible detrimental 
effects of long-term use.
CURRENT NURSING PRACTICE
The management of problems associated with long-term 
catheterisation has been characterised by varied and sometimes 
contradictory approaches (Kennedy and Brocklehurst, 1982). 
Current practice remains variable (Roe, 1989), and management 
of catheter encrustation depends largely on the use of bladder 
washouts (Roe, 1989; Getliffe, 1990). However, in a recent 
study, 49% of hospital and community nurses were unable to 
provide a rational, informed reason for their choice of 
bladder washout solution and recommendations for use (Roe,
1989). Furthermore, chlorhexidine bladder washouts are still 
commonly in use (Roe, 1989? Getliffe, 1990; Bailey, 1990) 
despite clear evidence of the lack of efficacy of this agent 
against catheter-associated infection (Stickler et al., 1987).
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It is imperative that nurses understand the potential 
advantages and disadvantages of their choice of bladder 
washout reagent and catheter material, whilst planning patient 
care. Not only will this knowledge contribute to a high 
standard of care, but it will also underpin the economic 
responsibilities accompanying legislation to allow nurses to 
prescribe these items. Frequent bladder washouts may be an 
expensive method of prolonging "catheter life". Alternatively, 
the use of expensive catheters may not be justified if 
frequent replacements are necessary. However, economic costs 
must be weighed against the physical, psychological and social 
needs of the patient. In some localities, patients must attend 
hospital for their catheters to be replaced (Kohler-Ockmore, 
1990). This presents additional psychological and monetary 
pressures on patients, on manpower and on services.
The serious problems associated with urethral catheters 
mandates that alternative strategies should be considered 
wherever possible. A variety of external urinary collecting 
devices are available for both men and women (Jeter et al.,
1990). Incontinence pads to absorb urine, may be appropriate 
for some patients, and bladder retraining exercises and/or 
frequent toiletting may be beneficial to others. For patients 
in whom catheterisation is the most appropriate form of care, 
supra-pubic and intermittent self-catheterisation (ISC), offer 
alternatives to urethral catheterisation. Supra-pubic 
catheters are inserted through the abdominal wall, and many 
patients, particularly those confined to a wheelchair, find 
them more comfortable than the urethral variety. Despite
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spatial separation from potential contamination with faecal 
flora, supra-pubic catheters are susceptible to biofilm 
colonisation (Donovan et al., 1977) and potential encrustation 
(Getliffe, unpublished data). ISC, however, may be a practical 
option for patients who are sufficiently dextrous, since it 
provides greater independence and control over personal 
bladder function. ISC reduces the risk of infection (Kunin, 
1987) and avoids the problem of encrustation since the 
catheter is not retained in the bladder. However, there are 
many patients for whom an indwelling urethral catheter still 
offers the most practical and acceptable method of urinary 
control.
The skills and knowledge necessary to ensure safe and 
effective nursing care of catheterised patients are complex. 
Well informed, planned strategies must take precedence over 
"crisis management” in order that the distressing effects of 
catheter encrustation are minimised. Recurrent encrustation 
causes discomfort and distress to patients and is costly in 
materials, and in increased demands on medical and nursing 
services. The research presented here aims to identify the 
information required for the effective assessment of patients 
vulnerable to catheter encrustation. Such knowledge is 
essential to the provision of planned, individualised care.
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3 - PRELIMINARY STUDIES AND
RESEARCH DESIGN
The current state of knowledge pertaining to catheter 
encrustation has been reviewed in the preceding chapters. 
However, the factors contributing to the problem are complex 
and a number of questions remain. In particular:
. Is the occurrence of catheter blockage a continuum or 
can patients be classified into one of two discrete 
groups ("blockers” or "non-blockers")?
. Why do some patients' catheters block more quickly than 
others?
. Can effective care strategies to relieve or reduce 
catheter blockage be formulated?
PRELIMINARY STUDIES
Previous clinical studies of catheter blockage in long­
term catheterised populations have been based on hospitalised 
patients where possible population biases such as uniformity 
of diet, limited mobility and the potential for cross­
infection exist (Hedelin et al., 1985a? Kunin et al., 1987b;
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Mobley and Warren, 1987). A study population drawn from 
patients living at home minimises these biases. Consequently, 
greater objectivity can be applied to the examination of the 
role of diet, mobility, and frequency of infection with 
particular micro-organisms, in the development of catheter 
encrustation. Preliminary studies were conducted, therefore, 
to examine the magnitude of the catheter encrustation problem 
within the community setting.
Questionnaires (Appendix A), requesting information on 
all patients maintained with an indwelling catheter for more 
than four weeks, were distributed to all district nursing 
teams within one district health authority. A response rate of 
77% was obtained and 81 long-term catheterised patients, 
representing a mean of four per cent of the district 
nurses'case load, were identified. Fifty-four per cent of 
these patients required unscheduled catheter changes, or 
received bladder washouts (at least once weekly) to combat 
recurrent catheter encrustation and obstruction. These results 
confirmed the clear existence of a clinical problem caused by 
catheter encrustation.
A variety of bladder washout preparations were employed 
(Table 2) and regimes varied between:
. a policy of "no bladder washouts".
. use of washouts only in the event of catheter blockage.
. regular prophylactic use of one reagent, at a frequency 
ranging from alternate days to once a month.
. a combination of reagents used on alternate occasions.
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TABLE 2 Bladder washout reagents received by patients
BWO Reagent Patients 1
Suby G 13 30.0
Suby G + Chlorhexidine* 3 7.0
Suby G + Saline* 1 2.3
Suby G + Mandelic acid* 1 2.3
Chlorhexidine 8 18.0
Saline 7 16.0
Solution R 2 4.5
Unspecified 9 20.0
* Reagents used on alternate occasions
Whilst these results may indicate individualised patient 
assessment and planned care in some cases, they also reflect 
confusion amongst nurses regarding the freguency and use of 
bladder washouts (Roe, 1989). The widespread use of 
chlorhexidine, which has been shown to be ineffective against 
catheter-associated bacteriuria (Stickler and Chawla, 1987; 
Davies et al., 1987), also emphasizes the gap between 
research and practice. Clear presentation of the scientific 
knowledge required by nurses, on which to base their practice 
and the advice given to patients and carers, is essential.
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RESEARCH DESIGN
On the basis of the preliminary survey it was concluded 
that catheter encrustation was a problem for many community 
patients, and that sufficient numbers were available for 
recruitment into the study. Several key objectives were 
identified which would provide the necessary knowledge base 
for accurate, reliable nursing care. These objectives were:
OBJECTIVES
1. to determine whether patients can be classified as either 
"blockers" or "non-blockers" (Kunin et al., 1987a).
2. to determine the composition of catheter encrustations
3. to determine the factors which contribute to encrustation
4. to determine the potential value of bladder washouts
The research design comprised three main approaches, as 
illustrated in Fig.6. An overview of each approach is 
presented here whilst full details of the methods employed are 
given in the chapters which follow.
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FIG. 6 Research Design. An outline of the study.
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DEFINITION OF KEY TERMS
CATHETER BLOCKAGE
A "blocked catheter" was defined as having at least one 
score of +3 or +4 on the "extent of encrustation" scale, 
where:
+4 = catheter lumen completely occluded 
+3 = narrow patent channel
(Table 15, Chapter 5).
BLOCKER STATUS
Patients were defined as "blockers" if two or more of 
their catheters became blocked during the study-
I. A PROSPECTIVE LONGITUDINAL STUDY OF PATIENTS WITH 
LONG-TERM CATHETERS
This section of the research was a comparative study of 
the characteristics and usual catheter management, of a cohort 
of community patients. The classification of patients as 
"blockers" and "non-blockers" (definition above), was 
dependent upon analysis of clinical specimens, and will be
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discussed further in Chapter 5. "Blocker" status was compared 
with all other parameters measured.
The limited population of long-term catheterised 
patients, and the frailness of many elderly patients (who were 
therefore unwilling or unable to be recruited) precluded the 
selection of a randomised population sample. A convenience 
sample was therefore enroled. Data were collected during semi­
structured interviews with patients, who also provided a four- 
day dietary record and 24h urine specimen. Three catheters 
were collected at six week intervals, or earlier if the 
catheter became blocked. These used catheters provided the 
clinical material for the study of encrusted catheters 
(section II and Chap.5).
The validity of classifying patients into groups of 
"blockers" and "non-blockers", on the basis of the recurrent 
extent of encrustation observed on their catheters, was 
accepted as a working hypothesis. Acceptance was based on the 
literature review and data from the preliminary studies. These 
studies indicated that patients with recurrent problems 
associated with catheter blockage usually required catheter 
changes in less than six weeks. Patients with infrequent, or 
no problems usually retained their catheters for up to 12 
weeks. Several reported studies have suggested that patients 
tend to retain a characteristic "pattern" of "catheter life", 
which can be identified by observations of a series of 
catheters (Norberg et al., 1983; Kunin et al., 1987a).
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II- AN INVESTIGATIVE STUDY OF ENCRUSTED CATHETERS USING
CLINICAL SPECIMENS
Three used catheters from each patient were examined to 
identify their particular pattern of "catheter life” and to 
distinguish between catheter blockage caused by encrustation, 
from blockage by any other cause eg. involuntary muscular 
spasm, twisted drainage tubing or constipation. Each catheter 
was analysed for the presence of adherent micro-organisms, and 
for the recurrent extent and composition of encrustations. 
Encrustations were examined by chemical analysis, and by 
electron microscopy and X-ray analysis.
Two samples were collected at each recatheterisation 
episode, one of urine passing through the old catheter, and 
one of urine passing through the newly inserted catheter. 
Comparison of the two samples allowed the effect of micro­
organisms colonising the catheter luminal surface to be 
evaluated.
Inter-relationships between data collected in both 
sections I and II were investigated.
III. AN EXPERIMENTAL STUDY OF BLADDER WASHOUT PROCEDURES 
USING AN IN VITRO MODEL
A model of the catheterised bladder was developed and 
conditions required for the precipitation of catheter 
encrustation were established. The model was used to evaluate
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the effectiveness of bladder washout reagents in reducing 
catheter encrustation in vitro. Whilst controlled clinical 
trials of bladder washout solutions would provide direct 
evidence of their efficacy in vivo, such a study was beyond 
the limitations of the current research. Furthermore, 
community based clinical trials would be difficult to control 
and could also raise ethical questions related to potential 
detrimental effects of bladder washout reagents on the bladder 
mucosa (Elliott et al., 1989).
DATA ANALYSIS
Data files were created using WordPerfect 5, and Lotus 
123 release 2.2, software. The data was double entered for 
verification of patient identity and records. The consistency 
of the data was checked using logical and range checks. Any 
inconsistencies were corrected by reference to the original 
data collection forms. Statistical analyses were performed 
using EPIINFO version 3 (Centres for Disease Control,
Atlanta), and SPSS/PC+ (Statistical Package for Social 
Sciences) software.
Non-parametric techniques (Siegel and Castellan, 1988) 
such as Chi-squared tests (X2), Mann Whitney-U and Spearman's 
correlation were used to examine whether the differences 
observed were statistically significant. Yates correction was 
applied if the frequency count within any cell of the 
contingency table for the X2 test was less than five.
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Parametric techniques included both paired and pooled t-tests. 
The tests used are indicated in the appropriate chapters with 
reference to the data to which they were applied.
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4. A PROSPECTIVE LONGITUDINAL
STUDY OF PATIENTS WITH TL. OISTG—
TERM CATHETERS
METHODS AND MATERIALS
Study Population
Patients who were expected to remain catheterised for at 
least four months were eligible for inclusion, providing that 
continuing care would be maintained by district nurses. 
Patients were not eligible if they were less than 16 years 
old, were being treated by long term antibiotic therapy or 
were severely mentally confused. Preliminary studies 
identified a minimum of 81 long-term catheterised patients in 
one District Health Authority (DHA), however, when recruitment 
for the main study commenced a number of patients, being 
elderly or severely disabled, had died or been transferred to 
nursing homes. Others had had their catheters removed eg. 
after prostatectomy, or were unwilling to conform to the study 
protocol. Therefore, ethical committee approval was obtained 
to conduct the study within three DHAs. This multi-centred 
approach introduced a number of advantages. These included a 
sample population drawn from a greater proportion of the whole 
population, and a reduction of locality-based bias eg. choice 
of equipment, bladder washout policies. However,
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communication, and co-ordination of sample collection 
presented some difficulties.
It was not feasible to select a random sample since the 
limited target population of long-term catheterised patients 
in the community, and the severe disability and/or advanced 
age and frailty of many of those patients, restricts the 
numbers available. Similarly, it was impossible to take a case 
controlled approach where "blockers" and "non-blockers" were 
pre-matched for variables such as age, sex, medical condition 
etc. A preliminary selection also operated as district nurses 
and general practitioners (GPs) excluded those patients whose 
medical and/or social history rendered them unsuitable for 
enrolment. The extent of sampling bias was limited by 
approaching all patients who were identified by the district 
nursing services within the three DHAs. Less than 8% of 
patients who were asked to take part in the study were 
unwilling to do so.
The sample size required to detect differences between 
patient groups experiencing recurrent catheter blockage and 
those unaffected, was calculated from the magnitude of 
differences observed in the early stages of the study. The 
projected sample size varied depending on the parameter under 
study, and was also based on the assumption that patients 
could be classified unequivocally into two groups of 
"blockers" and "non-blockers". In practice, sample size was 
limited by the availability of patients, and the target was 
set at 50.
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Bladder washouts were withheld during the period of the 
study, and all patients were requested to use silicone 
elastomer-coated, or hydrogel-coated catheters. These 
materials, together with all-silicone, are recommended for 
long-term use (Nacey et al., 1986? Talja et al., 1990), and 
are reported to resist encrustation equally well (Cox et al., 
1989c). Most patients in the preliminary studies were already 
using one of these two catheter types. The choice of catheter 
was restricted to avoid complications of data analysis 
presented by an additional parameter.
Recruitment Procedure
Letters were sent to all district nurse managers and 
general practices in each DHA, outlining the research protocol 
and requesting co-operation. In addition, presentations were 
made to groups of district nurses and primary health care 
teams. All patients identified as a result of these contacts 
were initially approached by their district nurse, and 
subsequently visited by the researcher, with approval of the 
patient's GP. Written informed consent (Appendix B) was 
obtained and anonymity was preserved by the assignation of an 
individual code number.
Patients entered the study when a new catheter was 
inserted. Three used catheters, replaced at six weekly 
intervals, or before if blockage occurred, were collected from 
each patient. The quantity of encrustation produced during a 
known period of time could thus be compared. Six weeks was 
chosen because preliminary studies and previous research
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indicated that patients with recurrent catheter blockage 
usually produce considerable encrustation within that period 
(Kunin et al., 1987a; Hedelin et al., 1991). In addition, more 
frequent changes may have reduced patient and medical staff 
compliance, whilst longer intervals might have resulted in 
losses of clinical specimens. The data collection protocol is 
illustrated Fig.7.
Patient characteristics and catheter management
Data relating to patient characteristics and usual 
catheter management, were collected during a semi-structured 
interview with the patient. The interview was based on a 
questionnaire (Appendix B), completed by the researcher. The 
key areas addressed are summarised below.
FORM A
Demographic variables and data relating to 
patients' life-style 
FORM B
Catheter management 
FORM C
Patients' attitudes to catheterisation
The majority of information was coded at the time of 
collection, but answers to open ended questions on Form C were 
also recorded verbatim.
Blood pressure and mobility were both measured since they 
may affect urinary composition, and calcium excretion iN
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FIG. 7 Summary of the Data Collection Protocol
Patient enters study 
when a new catheter is inserted
W EEK
Semi-structured interview 
First blood pressure recording
DURING 
W EEKS 1-6
Four day dietary record 
24h urine collection
W EEK 6
First catheter and urine specimens 
collected a t 6 weeks (earlier if blocked) 
Second blood pressure recording
W EEK 12
Second catheter and urine specimens 
collected a t 12 weeks 
(earlier if blocked)
W EEK 18
Third catheter and urine specimens 
collected a t 18 weeks 
(earlier if blocked)
Patient leaves study
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particular (Cappuccio et al., 1990; Watson and Royle, 1987). 
Systolic and diastolic (phase V) blood pressure was recorded 
during the first and second visits. Measurements were made 
with an anaeroid sphygmomanometer (Accoson, England), with the 
arm well supported and after the patient had been resting 
comfortably for at least 10 minutes. Two readings were taken, 
two minutes apart and the first discarded. Patients were 
classified as hypertensive if they had a systolic pressure > 
160mm mercury, or a diastolic pressure > 95mm mercury on 
either occasion, or if they were receiving pharmacological 
treatment for high blood pressure (Cappuccio et al., 1990).
Patient mobility was assessed on a scale of 1-4:
1. Bed/chair bound
2. Walks with an aid
3. Walks unaided at home only
4. Fully mobile
Assessment was made by discussion and where appropriate, by 
observation of the patient walking from one room to another.
Bowel habits were recorded since constipation can 
interfere with urinary flow through the catheter, and may also 
exert an effect on blood pressure. "Difficulty" with bowel 
evacuation was defined as "irregular elimination of small 
hard, dry stools which are difficult to expel" (Watson and 
Royle, 1987).
Items 14-15 on Form A, "at home" and "main carer", were 
designed to collect information with potential relevance to
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the patient's attitude and ability to cope with a catheter, 
and the support required from nursing services. The main carer 
was considered to be the person responsible for getting the 
patient up and washed each day and for emptying the urine 
drainage bag on a regular basis. Data on Form B, pertaining to 
catheter management practices, was confirmed with District 
Nurses where necessary.
Items on Form C, which addressed patients' attitudes to 
catheterisation, were not intended to form part of an in depth 
study on attitudes. They were designed to explore the possible 
relationship between catheter blockage and attitudes, and to 
provide preliminary information about the consequences of 
blockage and implications for nursing. Items were initially 
presented to the patient as open ended questions. Answers were 
recorded verbatim. The questions were then repeated and the 
answer scored on a Likert scale.
A pilot study to test the questionnaire and the interview 
technique, was carried out on five patients prior to the main 
study. A number of revisions to the method of coding 
information were made. Initial attempts to employ an analogue 
scale for measurement of perceived pain (Form D) were 
abandoned during the main study when it became clear that a 
large number of patients had little or no sensation in the 
bladder and peri-urethral region.
Dietary analysis
Dietary intake was determined by a four day, weighed 
dietary record. The validity and reliability of this method
72
has been shown previously (Fellstrom et al., 1989). Patients 
(or their carers) were provided with a set of flat-topped, 
digital readout scales (Hanson,UK), and instructed to record 
the weight of the plate on which the food was to be served and 
to record the total weight as each portion of food was added 
separately. Fluids such as tea, coffee and soft drinks were 
weighed in the first instance and subsequently served in the 
same container without weighing. Portions of food which were 
not consumed were weighed at the end of the meal.
The dietary study was carried out during two week-days 
and two weekend days to allow for possible differences. Lists 
of ingredients from ready-prepared cartons of food were 
retained to assist dietary analysis. "Superdiet11 software,
(R.Gentry, University of Surrey) was used, in conjunction with 
food tables (McCance, 1991; Holland, 1988? 1989? 1991), to 
analyse data for biochemical and mineral components (Table 3). 
The analysis included both the average daily weight (ADW) of 
components and the percentage of reference nutrient intakes 
(PRN), where these values have been established.
TABLE 3. Dietary components analysed
Fluid volume Vitamin A Riboflavin Calcium Copper
Energy Vitamin B6 Thiamine Magnesium Zinc
Protein Vitamin B12 Niacin Sodium Phosphate
Carbohydrate Vitamin C Folate Potassium Chloride
Fat Vitamin D Iron Iodide
Cholesterol Selenium
Fibre
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Urinary composition
All urine produced during one 24h period was collected 
for analysis of calcium, magnesium, phosphate, oxalate, urate, 
ammonia, citrate and protein concentrations. All these 
components have been cited in encrusting material (Bruce et 
al., 1974; Hedelin et al., 1984? Cox et al., 1987a). In 
addition, magnesium, phosphate and citrate may inhibit 
crystallization (Kohri et al., 1989). Urinary creatinine 
concentrations were measured to screen for abnormal renal 
function (Montgomery et al., 1980). Urine collection took 
place during the four day dietary study to allow comparisons 
between dietary intake and urinary output compositions. 
Collection start and finish times were carefully monitored by 
the researcher or district nurse since precise timing of ,24hrs 
is crucial to the accurate measurement of urinary componentX 
concentrations. If, when questioned, patients reported that \ 
leakage or spillage of urine had occurred during the previous 
24h, collections were repeated. Urinary osmolality was 
measured using a vapour pressure osmometer (5100C Westcor 
Inc., USA). Urinary pH was measured using a digital pH meter 
(PTI-55, Courtcloud Ltd. England). Aliquots for calcium 
measurement were acidified with concentrated hydrochloric acid 
prior to storage. Samples awaiting analysis were stored at - 
40°C. All chemical analyses were undertaken by the DHA 
Pathology Service (Frimley Park Hospital, Surrey).
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RESULTS
STUDY POPULATION
Forty seven patients were enroled, over 20 months. The 
data analysis is based on information collected from 42 
patients (Table 4), who provided a minimum of two catheter 
samples. Patients excluded were: two who did not provide 
catheters, and three who provided only one.
TABLE 4. Study population
Males Females
Sex 18 24
Median age (years) 77.5 70.0
Range (years) 58 - 90 27 - 90
Reason for catheterisation:
Incontinence 9 22
Retention 9 1
Other 0 1
More patients were catheterised for incontinence (31/42; 
73.8%), than for recurrent retention of urine (10/42; 23.8%) 
(X2=21.01; p<0.0001). One patient, although not incontinent, 
was catheterised to provide relief from diurnal and nocturnal 
urinary frequency.
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The major medical conditions within the study population 
(Table 5), were multiple sclerosis (MS) in 28.6% of patients 
and enlargement of the prostate gland in 21.4%. The latter 
condition occurred in 50% of the male patients.
TABLE 5. Medical conditions
Condition Frequency ( * )
prostate enlargement 9 (21.4)
multiple sclerosis 12 (28.6)
spinal lesion 5 (11.9)
CVA* 10 (23.8)
malignant neoplasm 0 ( 0.0)
diabetes 5 (11.9)
Parkinsons disease 1 ( 2.4)
arthropathy 4 ( 9.5)
other conditions 6 (14.3)
CVA* cerebral vascular accident
Patients' medication was extremely varied and for 
statistical purposes was broadly grouped into therapeutic 
categories (MIMMS, 1991)(Table 6), whilst recognising that 
mode of action, and metabolic by-products were diverse even 
within these groups. Diuretics were the most commonly used 
medication, followed by analgesics and then muscle relaxants.
More patients lived at home with their spouse only 
(20/42; 47.6%), than alone or with others, and for 17/42 
(40.5%) of patients the spouse was the main carer (Fig.8). One
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patient employed a private carer and for one patient the 
community nursing service was the main carer.
Items 8 and 9 on Form A, which relate to diet and fluid 
intake, are considered in more detail in the section on 
dietary analysis.
TABLE 6. Patient medication
Medication Frequency ( % )
anti-coagulants(including aspirin) 8 (19.0)
diuretics 18 (42.9)
muscle relaxants 11 (26.2)
anti-hypertensives 6 (14.3)
anti-anginal/cardiac arrhythmia 7 (16.7)
analgesics (including NSAID*) 14 (33.3)
anti-depressants 9 (21.4)
anxiolytics 9 (21.4)
hypnotics 7 (16.7)
vitamin/other dietary supplements 8 (19.0)
*NSAID : non-steroidal anti-inflammatory drugs
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FIG. 8 Patients' home situation and main carer
Home si tuat ion
With relatives 11.9%
Alone 23.8%
Other 4.8%
Spouse + family 4.8%
With spouse 47.6% 
20
Main carer
Relative 9.5%
Other 4.8%
S.services 2.4%
Spouse 40.5%
17
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COMPARISON OF BLOCKERS AND NON-BLOCKERS
Eighteen patients (42.9%) were classed as "blockers".
Twenty-four patients (57.1%) were classed as 
"non-blockers".
Patient characteristics
Significantly more females (14/18? 77.8%) than males 
(4/18; 22.2%) were "blockers" (X2=4.10; p=0.043), but "blocker 
status" was not associated with age.
Catheterisation for incontinence was significantly 
correlated with being a "blocker" (two-tailed Fisher's exact 
test, p=0.028). However, more females (22/24? 91.7%) were 
catheterised for incontinence than males (9/18? 50%)(two- 
tailed Fisher's exact test, p=0.001) and therefore it is 
unclear whether incontinence and female sex were independently 
related to "blocker" status.
Patients' range of mobility is shown in Fig.9. "Blockers" 
were significantly less mobile than "non-blockers" (Mann- 
Whitney U= 141.5? p=0.04).
None of the remaining items on Form A: age; medical 
condition; blood pressure; medication; alcohol consumption; 
bowel habits? smoking; were correlated with "blocker" status.
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FIG. 9 Patient Mobility
15
10
5
0
Mobility scale: 1 bed/chair bound, 2 walks with an aid,
3 walks unaided at home, 4 fully mobile.
Catheter history
All patients, except one, used catheters composed of the 
same material throughout the study (Table 7).
TABLE 7. Catheter material
Material Blockers ( * ) Non-blockers ( * )
Silicone-elastomer 12 (66.7) 11 (45.8)
Hydrogel 5 (27.8) 10 (41.7)
Silicone 0 ( 0.0) 2 ( 8.3)
Teflon-coated 1 ( 5.5) 1 ( 4.2)
Non
blockersBlockers
Patients
1 2  3 4
Mobility scale
8 0
Two patients used supra-pubic catheters, and one was 
managed with a supra-pubic and a urethral catheter (to reduce 
concurrent urethral leakage of urine). Five of 15 (33.3%) 
patients who used hydrogel-coated catheters and 12/23 (52.2%) 
who used silicone elastomer-coated catheters were "blockers", 
but these differences were not statistically significant.
Charriere size ranged from 12-22, with 50% of patients 
using size 14 (Table 8). There was no relationship between 
"blocker" status and Charriere size, but "catheter blockage" 
(+3 or +4 encrustation on any individual catheter) often 
occurred even in larger catheters.
TABLE 8. Catheter size (Charriere)
Charriere Blockers ( * ) Non-blockers (% )
12 1 ( 2.4) 2 ( 4-8)
14 7 (16.7) 14 (33.3)
16 6 (14.3) 5 (11.9)
18 2 ( 4.8) 2 ( 4.8)
20 1 ( 2.4) 1 ( 2.4)
22 1 ( 2.4) 0 ( 0.0)
The majority of patients 32/42 (76.2%) experienced at 
least one recurrent problem with their catheter (Fig.10). Of 
these problems, both leakage and urinary retention were sig­
nificantly associated with being a "blocker" (X2=4.58; p=0.032
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and X2=5.35? p=0.021 respectively). All four "non-blockers11 who 
experienced recurrent retention had "neurogenic" bladders 
resulting from multiple sclerosis or spinal injury, and were 
subject to bladder muscle spasms.
"Blocker" status was positively correlated with the need 
for recatheterisation in less than six weeks (X2=19.07? 
p=0.0007) (Fig.11), and also with a catheter change policy of 
"replacement only when the catheter becomes blocked" (X2=8.40; 
p=0.0038). Whilst the catheters of "non-blockers" were usually 
changed according to a pre-defined schedule, no similar 
planned schedule existed for the majority of "blockers".
Patients had been catheterised for varying lengths of 
time ranging from four weeks to >20 years, with over 45% 
catheterised for more than two years. Five of nine (55.6%) 
patients catheterised for less than six months were 
"blockers", including one catheterised for just one month. 
However, the length of time patients had been catheterised was 
not associated with "blocker" status, nor was the place of 
recatheterisation, or the qualifications of the practitioner 
who undertook the procedure.
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FIG. 10 Recurrent problems in 32/42 patients
Blockers
Leakage Retention Falls out
Catheter problems
FIG. 11 Frequency of recatheterisation prior to the study
P at ien ts
< 6  weeks
Blockers
Non
blockers
6 -  <12weeks 
R e ca th e te r is a t io n
12 weeks or more
8 3
Use of bladder washouts
Bladder washouts were used by 15/42 (35.7%) patients 
(Fig.12) prior to the commencement of the study and their 
regular use was closely related to "blocker1 status (Mann- 
Whitney U= 121.0; p=0.0045). All washouts were Uro-Tainer 
instillations (Clini-Med, High Wycombe). Suby G was the 
reagent used most commonly, and some patients used 
combinations of reagents on alternate occasions. However, the 
frequencies with which each reagent was used were too small to 
allow statistical analysis (Table 9). In patients who were 
"blockers", bladder washouts were retained within the bladder 
for a longer period (Mann-Whitney U= 110.0; p=0.0016).
Fig. 12 Dse of bladder washouts
1 -  3/week 21.4%
If blocked 11.9% 
5
> 3/week 2.4% 
1
No BWO 64.3% 
27
8 4
TABLE 9. Bladder washout reagents used by 15/42 patients
Reagent All patients ( % ) Blockers ( % ) Non-blockers ( % )
Chlorhexidine 7 (46.7) 5 (27.8) 2 ( 8.3)
Suby G 10 (66.7) 6 (33.3) 4 (16.7)
Saline 4 (26.7) 3 (16.7) 1 ( 4.2)
Solution R 1 ( 6.7) 1 ( 5.6) 0 ( 0.0)
Four patients used Suby G and chlorhexidine alternately
Two patients used Suby G and saline alternately
One patient used chlorhexidine and Solution R alternately
Drainage bag care
A number of different drainage systems were in use. Nine 
patients (21.4%) used either a day bag or a night bag only, 
(usually a night bag). Seventeen patients (40.5%) used a "link 
system" which allowed their day bag to remain in place and a 
night bag to be attached to the drainage outlet, and 16/42 
patients (38.1%) removed their day bag from the catheter in 
order to attach a night bag. None of these practices was 
correlated with "blocker" status.
Care of the drainage bag varied considerably (Table 10). 
Of 32/42 (76.2%) patients who re-used bags, 19 (59.4%) washed 
their bags between use, and 13 (40.6%) did not. Bags were 
washed either with water (with or without a small quantity of 
detergent) or with antiseptic agents including chlorhexidine 
or a mild hypochlorite solution. "Blocker" status was not
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associated with any particular procedure.
The duration of drainage bag use varied from 1 - >14 
days. Ten patients (23.8%) used their bags for <7days, and 
7/42 patients (16.7%) used them for >14 days. The length of 
time for which bags were in use was not correlated with 
"blocker11 status, nor was there any significant relationship 
between patient hygiene (Item 6, Form B) and being a 
"blocker".
TABLE 10. Drainage bag care
Care procedure Frequency ( % )
Not re-used* 9 (21.4)
Washed with water 14 (33.3)
Washed with antiseptic 5 (11.9)
Not washed 13 (30.9)
Other# 1 ( 2.4)
* Not re-used: Patient used one bag (day or night bag) continuously 
for more than 24h.
# Other: Patient discarded both day and night bag daily.
Patient attitudes to catheterisation
Thirty-four patients (80.9%) responded to the 
questionnaire (Form C) concerning their attitudes to 
catheterisation. Reasons for non-respondence included 
dysphasia following a CVA, or mild dementia and general 
frailness. When patients were asked "how they felt about
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having a catheter" (Question 1), responses varied from 
positive enthusiasm from two patients (one a "blocker"), who 
felt their quality of life had improved, to extreme resentment 
by three others, two of whom were "blockers". The remaining 
patients expressed acceptance of the catheter and acknowledged 
beneficial effects in comparison to previous alternative 
management of their urinary dysfunction. Responses to 
Questions 2-5 were recorded on a Likert scale and are shown in 
Table 11.
"Feeling embarrassed" about having a catheter was not 
significantly associated with being a "blocker", but patients 
were particularly concerned about the intimacy of the 
recatheterisation procedure, and the need for other carers to 
be involved if they were unable to cope alone. Older patients 
were significantly less embarrassed than younger ones 
(Spearman correlation coefficients.285; p=0.048), but 
embarrassment was not related to the sex of the patient, or to 
how long they had had a catheter.
Patients who were frequently worried about the catheter 
"working properly" (Question 3), were significantly more often 
"blockers" (7/10) than "non-blockers" (Mann-Whitney U= 66.0; 
p=0.0056). However, most patients (70%) were rarely concerned, 
including 50% of the "blockers". Patients who had been 
catheterised for a longer time were less worried than those 
who had been catheterised more recently (Spearman correlation 
coefficients.35; pS.019). All patients felt that the 
catheter was a help to them (Question 4) but 4/34 (11.8%)
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frequently felt they could manage without a catheter (Question 
5). Three of these four patients were "blockers".
TABLE 11. Patients' attitudes to catheterisation
Patients' responses
Question Always Often Seldom Never
Freq. ( 1 ) Freq. ( % ) Freq. ( % ) Freq. ( % )
2 7 (20.1) 3 ( 8.8) 11 (32.3) 13 (38.2)
3 5 (14.7) 5 (14.7) 9 (26.5) 15 (44.1)
4 32 (94.1) 2 ( 5.9) 0 ( 0.0) 0 ( 0.0)
5 1 ( 2.9) 3 ( 8.8) 6 (17.6) 24 (70.6)
Key: Q2. Do you ever feel embarrassed about having a catheter?
Q3. Do you ever feel worried about the catheter working properly? 
Q4. Do you feel that having a catheter is a help to you?
Q5. Do you ever feel you could manage without a catheter?
Physical awareness of impending blockage was apparent to 
13/18 "blockers" (72%). Ten of 18 (55%) felt either abdominal 
swelling or abdominal pain, whilst the remaining 3/18 (17%) 
felt slight leakage of urine only. Three patients did not 
answer this question and two were unaware of blockage.
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DIETARY ANALYSIS AND URINARY COMPOSITION
Dietary analysis
Thirty-two patients, 12 of whom were "blockers" (37.5%), 
completed the four day dietary record. Two further patients 
completed records but were rejected because of unreliable data 
or subsequent loss to the study due to hospitalisation. 
Patients not participating were either elderly and infirm, or 
severely disabled.
For the majority of dietary components measured (Table 
3), the mean percentage of reference nutrient intake (PRN) 
consumed was close to 100%. However, the PRN was less than 
75%, for folate, magnesium, potassium, zinc, iodine and 
selenium. Patients diets provided a mean of 70.1 ± 17.76% of 
the recommended energy supply for their ages and lifestyle. 
However, patients with severely restricted mobility, ie. 
"bed/chair bound", may have lower energy requirements than 
predicted by the "sedentary lifestyle" category in the 
software package used (Superdiet II).
Comparisons between "blockers" and "non-blockers" 
revealed no significant differences in the average daily 
weight (ADW) of any dietary component measured, (Appendix C). 
Similarly, there was no significant relationship between 
dietary variables and the occurrence of blockage in the 
catheter in situ during the dietary study (first catheter 
episode). The greatest dietary difference between "blockers" 
and "non-blockers" was in the ADW of fibre. "Blockers" 
consumed 18.44 ± 34.17g fibre, compared to "non-blockers" 7.80
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± 3.56g, but variations within the "blocker" group were too 
large to allow a significant difference to be reached.
The average daily fluid intake (ADV) for "blockers" and 
"non-blockers" was 1606.6 ± 608.9ml and 1429.1 ± 416.8ml 
respectively.
There was no significant difference in average 
daily fluid intake between "blockers" and "non-blockers".
Urinary analysis
Twenty-four hour urine collections were obtained from all 
patients. Urinary creatinine concentrations decline with age 
as muscle mass decreases but all values were within the 
expected range for age, and for normal kidney function (males 
8.8-17.0 mM/24h; females 7.0-16.0 mM/24h (Montgomery et al., 
1980).
ADV was positively correlated with urinary volume (Mann- 
Whitney U= 0.48; p=0.002), and negatively correlated with 
urinary magnesium and urinary phosphate (Mann-Whitney U=
-0.44; p=0.006 and -0.31; p=0.042 respectively). High ADV was 
also associated with greater mobility (Mann-Whitney U= -0.32; 
p=0.035).
Mean twenty-four hour urinary compositions are shown in 
Table 12, and values for individual patients are given in 
Appendix D. "Blocker" status was significantly associated with 
high urinary pH and high urinary ammonia (two-tailed Mann- 
Whitney U= 63.5; p<0.0001 and 112.0;p=0.0082 respectively), 
but not with urinary volume, osmolality or any other urinary 
component.
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Cross correlations between urinary components yielded 
significant positive relationships between urinary osmolality 
and the following parameters: urine volume (correlation coef­
ficient -0.37? p=0.005); oxalate (correlation coefficient
0.27; p=0.032)? phosphate (correlation coefficient 0.46; 
p=0.001); magnesium (correlation coefficient 0.29; p=0.024) 
and calcium (correlation coefficient 0.34; p=0.012).
Table 12. Hean 24h urinary composition for "blockers and "non-blockers"
Component
Blockers 
Mean t SD
Non-blockers 
Mean + SD
Volume 1728 + 549.1 1549 + 670.9
Osmolality 277.5 + 165.6 310.5 + 125.4
pH 7.39 + 1.07 6.11 + 0.665
Calcium 2.47 + 1.64 2.19 i 1.58
Magnesium 1.84 + 1.54 1.91 + 0.867
Phosphate 9.75 + 4.36 11.8 t 6.72
Oxalate 189.4 + 84.4 160.5 + 75.4
Orate 0.867 + 0.516 1.31 + 0.905
Ammonia 67.9 + 76.42 23.26 + 19.89
Citrate 0.747 + 1.13 0.991 + 1.17
Creatinine 4.22 + 2.42 5.17 + 3.05
Protein 0.201 + 0.168 0.24 t 0.905
Dnits: volume, ml? osmolality, mosmol/L; protein, g/L; oxalate, pol/L; all other components, 
mH/L.
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DISCUSSION
STUDY POPULATION
Almost 43% of patients suffered from recurrent catheter 
blockage and were classed as "blockers”. This percentage was 
slightly lower than the figure reported in several other 
studies (Table 13), with the exception of Ouslander et al., 
1987.
Table 13. Studies of catheterised patients
Reference Year No. patients % Female % Recurrent 
blockage
Cools and Vander Heer 1986 69 75 54
Roe and Brocklehurst 1987 36 44 64
Ouslander et a 1. 1987 54 0 35
Kunin et al. 1987a 46 82 56
Kunin 1989 32 100 53
This study 1992 42 57 43
The definitions of catheter blockage and "blockers" used 
in the current study were based strictly on the guantity of 
encrustation deposited on catheters within a specified period. 
Such precise definitions of catheter blockage were not
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provided in the first three reports in Table 13, and the 
percentage of patients with "recurrent blockage" may have 
included those with problems of catheter occlusion caused by 
other factors, such as constipation, muscle spasm or twisted 
drainage tubing, in addition to encrustation. Furthermore, 
most studies in Table 13 were subject to population biases 
caused by patients' residence in institutionalised care. 
Potential biases such as risk of cross-infection and 
restricted mobility have been discussed previously (Chapter 
3). Of the studies cited, only Roe and Brocklehurst (1987), 
studied patients living in the community, however, their 
identification of recurrent blockage was dependent on 
patients' reports, which may account for the relatively high 
percentage quoted.
PATIENT CHARACTERISTICS
Although no particular underlying medical condition was 
associated with "blocker" status, the diseases suffered by 
patients indicated a high level of disability within the 
sample population. The range and frequency of conditions was 
similar to those identified in other community-based studies 
of catheterised patients (Bull et al., 1991; Roe and 
Brocklehurst, 1987). Less than 36% of patients were self­
caring, and whilst the views of carers were not sought in this 
study, recurrent catheter blockage undoubtedly adds to the 
burden of care.
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Significantly more females (77.8%) than males were 
classed as "blockers". This has not been reported previously, 
but the majority of investigations have been restricted to 
patients who were predominantly of one sex (Table 13).
However, it has been suggested that females are at greater 
risk of catheter-associated infection than males (Kennedy and 
Brocklehurst, 1983; Kunin, 1987). Since micro-organisms 
responsible for bacteriuria in catheterised patients are 
frequently present in the patient's own bowel flora, the 
shorter female urethra may allow more rapid colonisation. It 
is also interesting to note that the lowest percentage of 
patients suffering from recurrent blockage (Table 13) was 
recorded in the "all male" study by Ouslander et al. (1987).
Reason for catheterisation
Nearly 75% of "blockers" were catheterised for 
incontinence (p<0.05). However, it is difficult to predict how 
this may increase the risk of catheter blockage since both 
incontinence and urinary retention are relieved when a 
catheter is inserted. The loss of muscle tone associated with 
incontinence may facilitate urinary tract infection via the 
peri-urethral space and there is some evidence that 
incontinent patients are more likely to become infected 
(Mulhall et al., 1988). However, this seems of limited 
importance since all long-term catheterised patients are 
likely to have bacteriuria within four weeks (Slade and 
Gillespie, 1985). Alternatively "incontinence" may simply be 
co-varying with female sex as 71% of patients catheterised for
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incontinence were female, and 90% of patients catheterised for 
urinary retention were male.
Patient mobility
A high level of disability was present within the sample 
population, but "blockers" were significantly less mobile than 
"non-blockers" (p<0.05). Greater mobility may enhance 
unimpeded urine flow, reducing the risk of static reservoirs 
of infected urine within the drainage tubing, and increasing 
the potential for flushing out precipitated salts as they 
form. However, there was no correspondingly significant 
relationship between "non-blockers" and high average daily 
fluid intake, high 24h urinary volume or administration of 
diuretic medication, all variables which might be expected to 
produce increased urinary flow.
Kennedy and Brocklehurst (1983) also reported that lack 
of mobility in community patients was a significant factor 
related to "catheter problems", which included blockage, 
leakage and offensive smell. Such patients may be alone for 
long periods, with limited access to drinks and unable to 
alter their position to improve urinary flow. In addition, 
poor mobility is associated with de-mineralisation of bone and 
resultant excretion of increased urinary calcium 
concentrations (Watson and Royle, 1987). The relationship 
between urinary composition and catheter encrustation will be 
discussed in detail in the following chapter, but although 
calcium is a known component of catheter encrustations 
(Hedelin et al., 1985a; Cox et al., 1987a), there was no
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association between "blocker" status and higher urinary 
calcium in this study.
CATHETER MANAGEMENT
Recurrent problems and "crisis care"
At least 76% of all patients experienced one or more 
recurrent problems associated with catheterisation, with 
almost half (47%) complaining of urinary leakage, and nearly a 
third (32%) suffering from retention. Whilst both leakage and 
urinary retention were significantly associated with being a 
"blocker", clearly catheterisation is rarely trouble-free and 
nurses have an important role, not only in educating patients 
and carers in catheter care, but also in providing on-going 
support.
A prevailing tendency towards "crisis care" appeared to 
exist for patients classed as "blockers", as indicated by the 
practice of replacing the catheter "only when it blocks". 
Although there may be some merit in not interfering whilst the 
catheter is still patent, this policy fails to meet the needs 
of patients who urgently require help when the catheter 
suddenly becomes blocked. "Blockers" had a significantly 
shorter time between recatheterisations than "non-blockers" 
(p<0.0001), with 89% of "blockers" usually recatheterised in 
less than six weeks, compared to 21% of "non-blockers". 
However, individual patients usually exhibit a characteristic 
pattern of "catheter life" (Norberg et al., 1983; Kunin et 
al., 1987a)(see also Chapter 5). If recatheterisation is
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planned to precede the predicted development of blockage, the 
distress suffered when blockage occurs, could be reduced. A 
policy of planned recatheterisation would also reduce the 
pressures on community and hospital services when urgent 
unscheduled visits are required, or patients are sent to 
hospital outpatient/emergency departments for catheter 
changes. The majority of "blockers” (72%) experienced early 
warning symptoms of impending blockage and where possible, a 
defined course of action should be planned with nursing staff 
and initiated by the patient when those symptoms occur.
Following a recent study of community patients, it was 
reported that established catheter users were more likely to 
suffer from catheter blockage than new users, catheterised for 
less than two months (Roe, 1990). In the present study there 
was no significant relationship between "blockers" and the 
period for which they had used a catheter. However, more than 
55% of patients catheterised for less than six months were 
"blockers", including one who had been catheterised for just 
four weeks.
Reducing the risks of infection
Catheter care practices directed towards reducing the 
risk of infection eg. drainage bag care and personal hygiene, 
were unrelated to "blocker" status, despite a recognised 
association between encrustation and infection with urease- 
producers (Mobley and Warren, 1987; Kunin, 1989; Hedelin et 
al., 1991). Long-term catheterised patients are subject to 
chronic urinary infection and micro-organisms colonising the
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catheter surface as a biofilm provide a constant source of 
infection regardless of the frequency of bag changes or 
personal hygiene. Similarly, micro-organisms growing as a 
biofilm on the surface of drainage bags are unlikely to be 
eradicated by any method of cleaning the bag. Nevertheless, 
infecting species fluctuate over time (Breitenbucher, 1984) 
and patients are at risk of cross infection from carers. 
Therefore, it is important that clean catheter care procedures 
are performed by patients and aseptic procedures carried out 
by carers to reduce the risk of infection by potential 
pathogens.
Bladder washouts and catheter material
The percentage of patients using regular bladder washouts 
prior to the commencement of the study (36%), was lower than 
observed during the preliminary study (54%) and the 44% quoted 
by Roe (1990). The decision to use bladder washouts and the 
choice of reagent is usually the responsibility of the 
district nurse. The reduction in their use may be in response 
to recent publications highlighting potentially detrimental 
effects on the bladder mucosa (Elliott et al., 1989), and the 
resistance of catheter-associated infections to chlorhexidine 
(Stickler et al., 1987). However, the present dearth of 
research to support, or refute the value of bladder washout 
procedures to diminish encrustation, results in a potential 
imbalance of information available to nurses. Suby G,
which is recommended by the manufacturers to reduce 
encrustation, was the reagent most commonly used (60% of
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patients using washouts). However, the use of Suby G by 17% of 
all "non-blockers" was clearly inappropriate and unnecessary. 
Furthermore, chlorhexidine was used by 47% of patients using 
washouts, despite published reports of ineffectiveness against 
catheter-associated infection (Stickler et al., 1987).
Although the frequencies with which each reagent was used were 
too small for statistical analysis, these results suggest that 
some nurses are still unclear about which, if any bladder 
washout is appropriate for a particular patient.
Patients classed as "blockers" used both silicone 
elastomer-coated and hydrogel-coated catheters. The study 
design did not permit analysis of the relative 
susceptibilities of these two materials to clinical 
encrustation, but during in vitro studies they appear to 
resist encrustation equally well (Cox et al., 1989c). The role 
of catheter material in encrustation will be considered 
further in the following chapters.
Patients' attitudes to catheterisation
Current trends within the health service include a 
greater focus on community care and on responding to consumer 
needs (Government white papers? "Promoting better health", 
1987; "Working for patients", 1989; "Caring for people",
1989). The section on patients7 attitudes to catheterisation 
and blockage, was designed to elicit preliminary consumer 
feedback information. It was not intended to be a major part 
of this study nor an in depth investigation of attitudes, and 
therefore patients were not screened for variables which might
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have influenced their answers, such as their general "sense of 
well-being" or traits of personality disorder.
Nearly 30% of patients were frequently worried about 
their catheter working properly and significantly more of 
these (70%) were "blockers". This information underlines the 
need for a planned care policy which the patient also 
understands. The intimacy of the recatheterisation procedure 
and the need for other carers to be involved in catheter care 
were particular sources of embarrassment for many patients. 
Although being a "blocker" was not significantly associated 
with embarrassment, recurrent blockage is not only a cause of 
more frequent recatheterisations, but accompanying leakage 
often places an additional burden on carers. With the 
implementation of a planned care policy, including scheduled 
recatheterisation, the patient is more likely to be 
recatheterised by a nurse or GP who is already known to them 
and the problems such as leakage may occur less frequently.
DIETARY ANALYSIS AND URINE COMPOSITION
Detailed analysis of patients7 diets and 24h urinary 
composition revealed that "blockers" were characterised by 
high urinary pH and ammonia concentrations compared to "non­
blockers", as previously reported by others (Norberg et al., 
1980; Kunin et al., 1987a; Kunin, 1989). High ammonia 
concentrations and alkaline conditions are produced when urea 
is catalytically decomposed by urease, synthesised by
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infecting micro-organisms. The frequency of such urease- 
producers in the present study will be discussed in Chapter 5.
No further relationships between "blockers" and dietary 
or urinary components were detected, however, wide variations 
in both intake and output may mask more subtle differences 
which exist on an individual level. Although not statistically 
significant, "blockers" consumed more fibre than "non­
blockers". This practice may have been encouraged by nurses 
and GPs, to avoid constipation as a possible cause of catheter 
blockage.
Patients with poor mobility scores had lower average 
daily fluid intakes than more mobile patients, which may 
reflect difficulties experienced by relatively immobile 
patients in preparing or obtaining fluids. However? "blocker" 
status was not associated with average daily fluid intake, 24h 
urinary volume or osmolality. Therefore, it is unlikely that 
"urging patients to drink plenty" will reduce catheter 
encrustation. Similarly, drinking water which has been 
filtered to remove inorganic salts is unlikely to be 
beneficial in terms of diminishing encrustation.
Earlier studies reported that patients with blocked 
catheters excreted more calcium, protein and mucin than 
patients whose catheters did not block (Kunin et al., 1987a). 
Such results were not confirmed in the present study, but are 
in agreement with those of Bruce et al. (1974), and do not 
support the concept of a metabolic difference between 
"blockers" and "non-blockers".
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A summary of the main points identified in this chapter 
is presented below.
KEY POINTS
1. More females than males were "blockers".
2. "Blockers" were more often catheterised for 
incontinence than for any other reason.
3. "Blockers" were less mobile than "non-blockers".
4. "Blockers" had higher urinary pH and ammonium 
concentrations than "non-blockers".
5. Being a "blocker" was NOT associated with low 24h 
fluid intake or urinary volume, or with high urinary 
osmolality.
6. Being a "blocker" was NOT associated with particular 
catheter care or personal hygiene practices.
7. "Blockers" were managed by "crisis care" rather than 
planned recatheterisations.
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3 . AN INVESTIGATION OF
ENCRUSTED CATHETERS USING 
CLINICAL SPECIMENS
METHODS AND MATERIALS
Sample collection
Three used catheters were collected from each patient 
recruited as described in Chapter 4. Catheters were replaced 
at intervals of six weeks, unless blockage necessitated an 
earlier change. Recatheterisation was undertaken by the 
practitioner who normally performed the procedure for that 
patient, usually the district nurse.
A "catheter episode" was defined as the period 
during which a catheter remained in the bladder.
Two urine samples were collected at each 
recatheterisation. "First" samples were collected aseptically 
through the sample port on the drainage tubing prior to 
removal of the old catheter. "Second" samples were either 
collected directly from the end of the newly inserted 
catheter, before attaching a new drainage bag, or through the 
sample port. Both samples were deemed to belong to the
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preceding catheter episode. Used catheters were placed in a 
sealed specimen bag. All samples were maintained at 4°C and 
transported to the laboratory, on ice, within four hours of 
collection. Microbiological culture of urine, and pH measure­
ments were carried out immediately on arrival. Each catheter 
was examined for adherent micro-organisms, and for the 
presence, quantity and composition of encrustations.
Microbiological analysis and urinary pH
Ten microlitres of urine were cultured on cysteine 
lactose electrolyte deficient (CLED) agar at 37°C for 24-3Oh. 
Colony forming units (cfu's) were counted and representative 
colony types were identified by conventional techniques (Cowan 
and Steel, 1977), and the API identification system (API-bio- 
Merieux, Basingstoke). All organisms were stored at -70°C in 
16% glycerol broth (Protect Bacterial Preservers, Technical 
Service Consultants Ltd., Bury) for further testing as 
required. Enterococcus faecalis was identified by growth on 
aesculin slopes (Cowan and Steel, 1977), but further 
identification of other streptococcal species was not 
undertaken because urease production by these micro-organisms 
was considered highly unlikely (Table 1, Chapter 1). Standard 
techniques were available, if required, for isolation of 
mycoplasmas in urinary samples with high pH, in the absence of 
recognised urease producers.
Urinary pH was measured using a digital pH meter (PTI-55, 
Courtcloud Ltd., England), after samples for culture had been 
removed and the urine had stabilised at room temperature.
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Where small sample size precluded the use of the meter, the pH 
was recorded using narrow range reagent strips (pH 5.0-10.0, 
BDH Ltd., Dagenham).
Micro-organisms colonising the catheter luminal surface 
were identified by a semi-quantitative culture method. A small 
section of catheter, 5mm in length, was excised aseptically 
from the area behind the balloon, which was protected from 
external contamination. The section was rinsed briefly in 
peptone water, and washed with vortex agitation for 60s in a 
further 3ml peptone water to dislodge adherent micro­
organisms. This procedure was repeated three times. Each 3ml 
peptone water wash was cultured quantitatively on CLED agar, 
and micro-organisms identified as described above.
Morphology, quantity and location of encrustation
Catheters were drained on filter paper and allowed to 
dry, in a protected place for seven days. The external 
appearance was recorded (Table 14). The internal appearance 
was recorded, using the same scale, after opening the catheter 
by a longitudinal incision. The quantity of encrustation per , 
20mm of catheter length was visually estimated using the scale 
of Kunin et al., (1987a) (Table 15). The maximum extent of 
encrustation observed in any 20mm section was the unit of the 
scale recorded.
Catheter blockage was defined as a score +3 or +4
for at least one 20mm section.
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Observations were made by a single observer to avoid 
inter-observer bias. Reliability was tested by the test-retest 
method. Ten catheters were re-assessed blind after a minimum 
period of 10 days. This procedure was repeated on three 
different occasions using different groups of catheters. The 
mean encrustation score (mean score of all catheter sections) 
was calculated in order to examine relationships between the 
distribution of deposits along the length of the catheter and 
other variables.
TABLE 14. Encrustation morphology
Code External/internal encrustation
0 None/ powdery film
1 Powdery deposit
2 Gritty particles
An observational method of measuring quantity of encrust­
ation was adopted because it could be readily incorporated 
into a patient assessment procedure used by nurses. Two 
additional methods were tested in attempts to correlate 
results using different methodology, and thus provide greater 
validity and reliability. One method based on the weight of 
encrustation (Hedelin et al., 1985a; 1991) was subject to
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error due to the variable absorption of water by the latex 
component of the catheter (Cox et al., 1988). The second 
method described by Kunin et al. (1987a) was dependent on the 
increased time taken for 50ml water to flow through an 
encrusted catheter compared to a new catheter. However, loose 
encrustations were washed out during this procedure, thus 
reducing the accuracy of subsequent observational assessment. 
Both of these methods were, therefore, rejected.
TABLE 15. Quantity of encrustation
Code Description
0 None
+1 Rough surface
+2 Wide channel
+3 Narrow channel
+4 Total occlusion
Composition of encrustations
Small samples of encrusting material were scraped from 
the surface of all catheters with sufficient quantity of 
deposit. Samples were dried in a desiccator at room 
temperature (17-20°C), for a minimum of two days to remove
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adsorbed water but not crystal water (Larsson et al., 1984). 
Five milligrams of the dried material was dissolved in 1ml 
concentrated nitric acid. Samples were stored at -40°C prior to 
analysis of calcium, magnesium, phosphate, oxalate, urate, and 
protein using a wet chemical procedure for analysis of urinary 
calculi (Larsson et al., 1984). This method permits analysis 
of as little as lmg of material, however, larger quantities 
allow greater accuracy and 5mg was analysed for all samples 
except two. Samples were assayed in triplicate, and all assays 
for a given analyte were completed in one batch.
Calcium and magnesium were measured by flame atomic 
absorption spectrometry (L353, Thermo Electron Ltd.,
Warrington). Specimens were diluted in a solution of lanthanum 
chloride. Lanthanum "competes" with calcium for phosphate and 
therefore effectively removes interference from phosphate and 
protein. Calcium and magnesium were measured at wavelengths of 
422.7nm and 285nm respectively. Standard solutions of known 
concentrations were measured at the beginning and end of each 
series of measurements. Internal control samples were measured 
after every five encrustation samples to monitor internal 
reliability. The concentration of calcium and magnesium in the 
encrustation samples was calculated from standard curves.
Inorganic phosphate and protein were measured spectro- 
photometrically (Uvicon 860, Kontron instruments). Phosphate 
was measured at 640nm by the reaction with acid molybdate 
(Lawrence, 1974). Protein was measured by a method based on 
the "xanthoprotein reaction" with nitric acid. This reaction 
involves the introduction of nitro groups in the tyrosine and
108
tryptophan residues of the protein (Herring, 1962), producing 
a yellow product which is changed to orange under alkaline 
conditions. Absorption was measured at 410nm and corrected for 
interfering compounds as A410 - (A350 + A470)/2 . The protein 
concentration was read from a standard curve prepared with 
fibrin (Sigma, Poole) concentrations 0-5g/l.
Oxalate and urate were measured by fluorometry (LS-5, 
Perkin Elmer, Beaconsfield). The method for oxalate was based 
on quenching the fluorescence of a zirconium-flavonol complex 
by oxalate (Britton and Guyon, 1969). The method for urate was 
based on the oxidation of uric acid to alloxan and ammonium 
ions by nitric acid. The alloxan was determined fluoro- 
metrically as the quinoxaline derivative obtained with 1,2- 
phenylenediamine (Bilic and Felber, 1969).
The composition of the encrustations was computed from 
the molar concentrations of each analyte in the sample 
solutions. Calculations for components consisting of more than 
one analyte were based on the concentration of the analyte 
present in the smallest amount. It was assumed that oxalate 
was present as the monohydrate (CaC204. H20), uric acid either as 
the free acid and/or the ammonium salt, magnesium as struvite 
(Mg(H4N)P04.6H20) and phosphate either as struvite, brushite 
(CaHP04.2H20), or hydroxyapatite (Ca10(PO4)6(OH)2) (Larsson et 
al., 1984; Hedelin et al., 1985a; Cox et al., 1987a). Calcium 
oxalate and struvite concentrations were determined first. The 
ratio of the remaining excess calcium to the remaining excess 
phosphate was then computed. Calcium phosphate was assumed to 
be in the form of brushite if the ratio was close to 1, or
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hydroxyapatite if the ratio was close to 1.67 or greater. (The 
derivation of the formulae for computation of apatite and 
brushite reported by Larsson et al. (1984) was obscure and 
after extensive discussion with inorganic chemists, it was 
rejected). No attempt was made to determine the liklihood of 
mixed calcium phosphates occurring together.
Scanning Electron Microscopy
Scanning electron microscopy of the internal catheter 
surface was used to examine the morphology of encrustations. 
Preliminary studies of both used and unused catheter sections 
showed that simple air-drying produced fewer artefacts than 
other methods of fixing and drying and this approach was 
adopted. Longitudinal sections of catheter (10mm), were 
excised 100mm distal to the catheter tip, and dried in a 
desiccator for seven days. Loose encrusting material was 
shaken from the catheter surface prior to mounting on 
aluminium stubs with adhesive (Bostik, Leicester). Good 
electrical and thermal contact between sample and stub was 
ensured by the application of a small quantity of silver paint 
to each end of the sample. Gold sputtering was carried out 
using an Edwards S150 sputterer (Crawley), at a low current 
with specimen cooling to prevent artifacts caused by 
overheating. Specimens were examined in a Cambridge Stereoscan 
S250 (Cambridge), at an accelerating voltage of lOkV. Heavily 
encrusted samples sometimes produced poor images, due to local 
accumulations of electrical charge. In those circumstances,
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lightly encrusted samples chosen from alternative sites on the 
catheter were observed.
A qualitative X-ray analysis of encrustation components 
was performed on a random selection of samples. These samples 
were prepared by lightly touching the encrusted surface with 
double-sided adhesive tape, which was then mounted on 
aluminium stubs. Samples were carbon coated (Edwards,
Crawley), and scanned in a Jeol JXA 8600 Superprobe (Welwyn 
Garden City), at an accelerating voltage of 15.5kV.
Observation of micro-organisms closely adherent to the 
catheter surface required a more rapid procedure of fixing and 
drying to prevent their loss. Catheter sections, approximately 
5mm in length and located behind the catheter balloon, were 
removed aseptically using a sterile scalpel. Sections were 
excised longitudinally and fixed in 2.5% glutaraldehyde in 
0.2M sterile cacodylate buffer, pH 7.4 for 2h or overnight. 
Samples were washed twice for lOmin each in buffer, then held 
in 2% osmium tetroxide in 0.2M buffer for lh. After two 
further washes in buffer for lOmin each, samples were 
dehydrated through an ethanol series, washed twice in 50% 
ethanol/50% acetone and washed twice in 100% acetone. Finally, 
after critical point drying (Critical Point Drier, Bio-Rad, 
Hemel Hempstead), the samples were mounted, gold-coated and 
examined as described above.
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RESULTS
One hundred and twenty four catheter episodes for 45/47 
patients were studied, (two patients left the study before 
their first catheter change, see Chapter 4). Thirty-seven 
patients provided three catheters, five provided two catheters 
and three provided one catheter only.
Fifty-five catheters were classed as blocked, (having at 
least one score of +3 or +4, Table 15). First urine samples 
were not obtainable during seven catheter episodes, due to 
complete occlusion of the catheter lumen. Statistical analysis 
included data from 124 catheters, except for correlations with 
"blocker" status when data from 121 catheters were used, (see 
section on "blockers and "non-blockers" below).
MICROBIOLOGICAL ANALYSIS AND URINARY pH
Microbial analysis
The micro-organisms isolated from urines and/or catheters 
are shown in Table 16. Cultures from almost all patients were 
polymicrobial with a up to five different species present, and 
a mean of 3.2 species. Only one patient was infected by a 
single species, which was Escherichia coli. The most prevalent 
species were E.coli, and Proteus mirabilis which were isolated
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Table 16. Frequencies with which micro-organisms were isolated from 124 catheter episodes by 
urine and/or catheter culture.
Micro-organism Drease Activity* Catheter blocked (56)
Frequency %
Escherichia coli - 21 37.5 35 51.4
Proteus mirabilis ++ 34 60.7 0 0.0
Enterococcus faecalis - 15 26.8 24 32.3
Other Streptococcus species - 13 23.2 12 17.6
Klebsiella pneumoniae + 10 17.9 11 16.2
Pseudomonas aeruginosa + 7 12.5 13 19.1
Horganella lorganil ++ 9 16.1 4 5.9
Other Pseudomonas species - 5 8.9 8 11.8
Citrobacter species - 2 3.6 7 10.3
Staphylococcus aureus ++ 5 8.9 1 1.5
Klebsiella oxytoca + 0 0.0 5 7.3
Enterobacter cloacae - 0 0.0 4 5.9
Acinetobacter species - 2 3.6 2 2.9
Lactobacillus species - 3 5.4 0 0.0
Staphylococcus epidermidis + 1 1.8 2 2.9
Serratia marcescans + 0 0.0 3 4.4
Providencia stuartii ++ 2 3.6 0 0.0
Others# . 0 0.0 6 8.8
++ urease produced by >901 of isolates 
+ urease produced by 5-301 of isolates (Wickham and Buck, 1990).
# six other organisms were isolated from one catheter episode each.
Not blocked (68) 
Frequency %
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from 56/124 (45.2%), and 34/124 (27.4%) catheter episodes, 
respectively.
Thirty-seven per cent of isolates were potential urease- 
producers (Table 1, Chapter 1). Positive API tests for urease 
were produced by all P.mirabilis, Morganella morganii and 
Klebsiella pneumoniae isolates, and by 16/20 (80%) of 
Pseudomonas aeruginosa and 5/6 (83.3%) Staphylococcus aureus 
isolates. Urease-producers were isolated from urine and/or 
catheter samples from all blocked catheters except for one 
episode. Additional techniques for isolation of mycoplasmas 
were not, therefore, employed.
Urease-producers were significantly associated with 
catheter blockage (Table 16) (X2=16.24; p<0.0001).
The only species of micro-organism significantly 
associated with catheter blockage was P.mirabilis, 
which was isolated from 34/56 (60.7%) blocked catheters 
but 0% of unblocked catheters (X2=29.88; p<0.0001).
Although the difference was not significant, M.morganii was 
isolated from cultures obtained from 9/56 (16.1%) blocked 
catheters compared to 4/68 (5.88%) non-blocked catheters. 
However, P•mirabilis was also associated with three of the 
blocked catheters, therefore the direct effect of M.morganii 
alone was difficult to determine. Other micro-organisms were 
isolated with similar frequency from both blocked and non-
blocked catheters, or occurred too infrequently to detect any 
relationships (Table 16).
Variations in microbial flora
The distribution of microbial species in urine fluctuated 
with time, and variations in microbial flora from one episode 
to another occurred between 35/121 (29%) catheter episodes. 
Antibiotics were in use during 13/121 episodes but were being 
administered in only 7/35 (20%) where changes in microbial 
flora occurred.
Different micro-organisms were sometimes isolated from 
first urine samples compared to second samples from the same 
episode, or from catheter cultures compared to urine cultures. 
In 22/117 episodes (18.8%), micro-organisms present in the 
first urine sample were not detected in the second. In 10/124 
episodes (8.1%), micro-organisms isolated from catheter 
sections were not detected in urine cultures. The new species 
isolated was frequently P.mirabilis (50% of all occasions).
For one "blocker" P.mirabilis was isolated from catheter 
cultures only, never from urine cultures.
Urinary pH
The pH of urine samples from blocked catheters was 
significantly higher than the pH of samples from catheters 
which were not blocked (two-tailed Mann-Whitney U =168.5; 
p<0.0001). The difference in pH between the first and second 
urine samples of any catheter episode was greater in blocked
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catheters than in non-blocked catheters (paired t-test =14.80; 
df= 107; p<0.005) (Table 17).
TABLE 17. pH differences between paired urine samples
First urine sample* Catheter blocked (49) Catheter not blocked (68)
mean pH 7.81+ 0.78 5.87 + 0.59
pH range 5.85 - 9.03 4.36 - 7.34
Second urine sample
mean pH 6.73 + 0.71 5.87 + 0.51
pH range 4.49 - 8.13 4.52 - 7.00
* First urine samples were not obtainable from 7 blocked catheters
"Blockers" and "non-blockers"
The data which follow were obtained from 121 catheters 
provided by patients classed as "blockers" (18/42) or "non­
blockers" (24/42)(Chapter 4). The definition of "blocker" 
requires a minimum of two blocked catheters per patient.
Urine samples from "blockers" were significantly more 
alkaline than samples from "non-blockers" (two-tailed Mann- 
Whitney U =63.5; p=0.0001)(see also Chapter 4). Urease- 
producers were isolated from all "blockers" (Table 18).
P.mirabilis was isolated from 13/18 "blockers" (72.2%) and
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only 3/24 (12.5%) "non-blockers", and was significantly 
associated with "blocker" status (X2=13.13; p=0.0003).
Urine samples from which Providentia stuartii was 
isolated, in the absence of P.mirabilis, had a high pH (>7.5) 
but the pH was lower (6.5-7.5) in samples from which the only 
urease-producer isolated was K .pneumoniae. Of the two 
"blockers" from whom Pseudomonas aeruginosa and Staph.aureus 
were the only urease-producers cultured, one was characterised 
by particularly high urinary concentrations of calcium, 
magnesium and phosphate. The second developed catheter 
encrustations composed of a large percentage of oxalate 
(21.6%)(see section on composition of encrustations below).
TABLE 18. Urease-producers isolated frou "blockers"
Urease-producer "Blockers" (18)
Frequency i
P.mrabilis 13 72.2
K.pnemoniae* 2 11.1
Ps.aeruginosa* 2 11.1
Providencia stuartii* 1 5.6
Staphylococcus aureus* 1 5.6
* Urease producers isolated in the absence of P.mrabilis.
Pseudomonas aeruginosa and Staph.aureus were isolated together from one "blocker"
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Urease producers were absent from 3/4 (75%) episodes 
during which a patient classed as a "blocker" produced a non­
blocked catheter. Seven patients, classed as "non-blockers", 
produced one blocked catheter during the study. Urease- 
producers were isolated from five of these patients during the 
blocked catheter episode only, and the mean urinary pH for 
these patients during the blocked catheter episode was 7.36 ± 
0.18 compared to 5.96 ± 0.53 during non-blocked episodes.
K .pneumoniae, was isolated from all catheter episodes for a 
further 2/7 patients, whose urinary pH remained similar during 
both blocked and non-blocked catheter episodes. An eighth 
patient produced one blocked catheter obstructed by bright 
yellow granules which also stained the urine drainage bag.
This material, deposited in a pH environment of 4.39, was 
different in appearance from other encrustations, and may have 
been a metabolic by-product of the patient's medication 
(frusemide, sinemet and tylex), and/or diet.
CATHETER ENCRUSTATION
One blocked catheter was excluded from the following data 
because of the unknown composition of the bright yellow 
encrustation (see above).
Encrustation morphology
Catheter encrustations, characterised by both "powdery 
deposits" and "gritty particles" (Table 14), were positively 
correlated with "blocker" status (two-tailed Fisher's exact
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test, p=Q.0063 and p=0 . 0001 respectively). Comparison of the 
two morphological forms with 98blocker8 status confirmed a 
stronger correlation with 8lgritty particles98 (two-tailed 
Fishery’s exact test, p=0e019).
Quantity and location of encrustation
The reliability of the observational method of assessing 
the quantity of encrustation (Fig,13) was 96,3% with the same 
encrustation score being recorded during the test and re-test 
for 607/630 catheter sections. When scores differed on the re­
test it was never by more than one point on the encrustation 
scale, and the differences were never critical to the 
classification of "blockers" and ”non-blockerst9. In all 
encrusted catheters there was a trend towards greater 
encrustation in the sections close to the tip,
FIG, 13 Grades of encrustation
Blocked catheters
The maximum encrustation score of +4 was recorded on 
44/55 (80.0%) blocked catheters. Maximum scores occurred 
within the first 100mm of catheter proximal to the tip in 
39/55 (70.9%) of catheters (Fig.14). However, extensive 
encrustation (+3 and +4) was deposited along the whole length 
of the catheter in 11/55 (20.0%) blocked catheters. Scores of 
+3 or +4 were recorded within the last 60mm, most distal to 
the tip in 15/55 (27.2%) blocked catheters. This location may 
be prone to blockage due to slight narrowing of the lumen at 
the bifurcation of the inflation channel. However, the pattern 
of distribution of encrustations along the length of the 
catheter was not significantly associated with time in situ.
FIG. 14 Distribution of encrustation scores in blocked catheters
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Non-blocked catheters
Some encrustation was deposited on catheters classed as 
non-blocked. In 50/68 (73.5%) non-blocked catheters the 
maximum score for any section was +1, and only one non-blocked 
catheter exhibited +2 encrustations in more than half of its 
sections. In 34/68 (50%) of non-blocked catheters there was no 
visible encrustation at all.
Mean encrustation score
Catheters remained in the bladder ("time in situ") for a 
significantly shorter period when their mean encrustation 
score was high (Mann-Whitney U =420.5; p=0.0001). The mean 
encrustation score per catheter episode was positively 
correlated with the pH of the first urine sample for that 
episode (Spearman's correlation =0.625? p=0.0001), and also 
with encrustation in the form of "gritty particles" (Mann- 
Whitney U =328.5; p<0.0001). These particles were large in 
comparison to the powdery deposit observed in other catheters, 
and may have occluded the lumen more quickly. Alternatively, a 
greater quantity of encrustation may have been deposited under 
the highly alkaline conditions associated with the formation 
of "gritty particles", thus leading to more rapid blockage. 
However, there was no significant relationship between mean 
encrustation score for the whole catheter, or mean 
encrustation score for any of three sub-sections (0-100mm; 
101-200mm and 201mm to 440mm, from the catheter tip), and 
average daily fluid intake? 24h urine volume? 24h urinary 
osmolality? catheter size or catheter material.
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The length of time catheters remained in situ prior to 
removal for blockage was variable both between patients who 
were "blockers" (range 5 - 4 1  days)(Table 19), and between 
catheter episodes for the same patient. In 5/7 (71.4%) 
patients who had catheters in situ for a mean time of <19 
days, 24h urinary concentrations of calcium and magnesium 
(Chapter 4) were higher than mean concentrations for 
"blockers" as a group. Although the differences were not 
statistically significant, this may be indicative of a 
relationship between urinary composition and encrustation, 
which is commonly masked by the wide variations which occur 
normally. Intra-individual variation in time in situ appeared 
to be least in patients infected with urease producers other 
than P.mirabilis, and no patient with a mean time in situ >30 
days was infected with P.mirabilis.
Table 19. Mean length of tine catheters from "blockers" remained in situ
Mean time catheter in situ
<19days 19-30 days >30days
"Blockers (18) 7 (391) 8 (44.41) 3 (16.61)
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Composition of encrustations
Standard curves for all assays except oxalate, were 
linear within the concentration range used. Under the standard 
conditions established for the oxalate assay, a reproducible 
curve was obtained (Fig.15).
FIG. 15 Oxalate assay standard curve
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Sufficient material for analysis was obtained from 48 
encrusted catheters. Thirty-nine samples were obtained from 
the catheters of "blockers", six samples were from blocked 
catheters produced by patients classed as "non-blockers" and 
the remaining samples were from non-blocked catheters.
Catheter encrustations were composed principally of 
calcium, magnesium and inorganic phosphate (Appendix E). 
Oxalate was present in seven samples (17.95%) but 
concentrations were very small in four of these. Protein and 
urate were detected in 6/39 (15.38%) and 5/39 (12.82%) samples 
respectively, but concentrations of these components were
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close to the detection limit for each assay, and therefore 
they are not included as percentages of the total sample 
composition (Appendix E).
The mean percentage recovery was 70.61 ± 14.94%, range 
50.6% - 99.6%. However, samples fell into two distinct groups. 
The mean percentage recovery for samples collected early in 
the study (29 samples from 12 patients), was 60.75 ± 8.33%, 
but for those collected in the latter period (19 samples from 
14 patients), the mean percentage recovery was much higher; 
85.32 ± 9.99%. In addition, the molar ratios of calcium and 
phosphate in samples from the early group were more indicative 
of calcium phosphate in the form of apatite. In later samples, 
the molar ratios were more consistent with calcium phosphate 
in the form of brushite. Although storage conditions were 
identical for both groups of samples, the extended storage 
time imposed on the early samples to allow subseguent chemical 
analyses to be undertaken in one batch, may have influenced 
compositions.
Each component was calculated as a percentage of the 
total mass recovered (Appendix E). The percentage composition 
for encrustations from blocked and non-blocked catheters was 
very variable (Table 20). The percentage of struvite in any 
encrustation sample increased with increasing pH (pH of the 
first urine sample collected during the same catheter 
episode)(Spearman correlation =0.405? p=0.004). Conversely the 
percentage of oxalate was correlated with low urinary pH 
(Spearman correlation =-0.295? p=0.029). There was no 
significant relationship between encrustation composition and
124
TABLE 20. Composition of encrustations from blocked and non-blocked catheters
Component Mean percentage composition
Blocked catheters Non-blocked catheters
Struvite 55.90 + 24.36 23.53 t 25.13
Calcium phosphate 43.06 + 22.08 37.16 i 37.20
macroscopic morphology ie. gritty particles or powdery 
deposits. Both struvite crystals and amorphous aggregates of 
calcium phosphate were observed on scanning electron 
micrographs of the two morphological types of deposit.
Scanning electron microscopy
Catheter samples from 37/45 patients were scanned by 
electron microscopy. Surfaces of samples from "blockers" were 
characterised by relatively large struvite crystals, readily 
identified by the Y-shaped cracks on their faces (Fig.16a) 
(Medina et al.r 1990). These crystals were typically 
orthorhombic, often "coffin-shaped", and ranged in size from 
approximately 8/zm-450jum in length. They were found to occur 
either singly, or in clusters (Fig.16b), and were irregularly 
and sometimes sparsely distributed over the catheter surface. 
In some cases the edges of the crystals were rounded or broken 
(Fig.16c), but in others they exhibited very sharp angular
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lines (Fig.16b), which may reflect the conditions under which 
they were formed. Although some struvite crystals occurred in 
isolation, they were more frequently surrounded by amorphous 
aggregates of calcium phosphate. Calcium phosphate particles 
were typically 0.5/m-3jum in diameter (Figs.16a and 16c). 
Encrustations which appeared as gritty particles under visual 
observation (Table 14) were shown to contain large numbers of 
struvite crystals embedded in a crust of calcium phosphate, 
which together formed a discrete fragment (Fig.l6d). It was 
not possible to distinguish crystals of brushite within the 
aggregations of calcium phosphate.
Calcium oxalate dihydrate crystals had a very character­
istic bipyramidal tetragonal form (Fig.17a)(Medina et al., 
1990) and isolated crystals were readily recognised in a 
number of catheter samples. Calcium oxalate occurred alone or 
in combination with struvite and calcium phosphate. One small 
oxalate crystal is visible amongst the calcium phosphate 
particles in the top right section of Fig.16a. Oxalate 
crystals were usually sparsely distributed, however, a notable 
exception was presented by one patient, a "non-blocker". 
Although this patient's catheter encrustation score was no 
more than +1 for any section, the catheter surface was densely 
covered with oxalate crystals (Fig.l7b).
The composition of crystals and other particles was 
confirmed by x-ray analysis of representative samples.
Elements of atomic number less than 10 are not detected by the 
procedure employed. The magnesium and phosphorus peaks 
produced by a 10/im spot scan of a struvite crystal (Fig. 16a)
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are shown in Fig.18a. A 1mm spot scan of the same sample is 
shown in Fig.18b, showing the additional presence of calcium 
phosphate. Scans of calcium oxalate crystals produced calcium 
peaks alone (Fig.18c), since oxygen cannot be detected by this 
methodology.
Non-encrusted catheter surfaces were characterised by a 
flaking appearance (Fig.19a). At low magnification, this could 
have been interpreted as de-lamination of the catheter 
surface, but at higher magnifications, this flaking crust was 
clearly composed of a thick layer of micro-organisms forming a 
biofilm. The thickness of the crust, and the ability of the 
biofilm to spread and to engulf crystals, is illustrated in 
Fig.17a. At even higher magnification, individual bacteria 
could be seen intimately associated with encrustations 
(Fig.19b). Specific sample preparation techniques, for 
observation of micro-organisms adherent to the catheter 
surface, resulted in loss of the inorganic encrusting 
material, and the organic glycocalyx. However, mixed colonies 
of micro-organisms were clearly visible. Fig.20 shows colonies 
of P.mirabilis, Enterococcus faecalis and Lactobacillus 
species.
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FIG. 16a SEH of large struvite crystal embedded in calciui phosphate deposits
FIG. 16b SEH of sharply angular struvite crystals
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FIG. 16c SEK of rounded and broken struvite crystals eibedded in calciui phosphate deposits
100HM 10KV
FIG. 16d SEM of "gritty particle" of encrustation
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FIG. 17a SEH of crystal of calciui oxalate dihydrate engulfed in a thick biofili
FIG. 17b SEH of masses of calcium oxalate dihydrate crystals coating a catheter surface
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FIG. 18a Qualitative X-ray analysis of struvite crystal (10/m spot size)
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FIG. 18b Qualitative X-ray analysis of calciui phosphate deposits (In spot size)
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FIG. 18c Qualitative X-ray analysis of calcium oxalate crystal (10 ja spot size)
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FIG. 19a SEH of non-encrusted catheter showing thick biofili
FIG. 19b SEH showing bacteria closely associated with catheter encrustation
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FIG. 20 SEH showing nicro-organisis (Proteus nirabilis, Enterococcus faecalis, and Lactobacillus 
species), colonising a catheter surface.
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DISCUSSION
"BLOCKERS AND "NON-BLOCKERS"
Using the criterion for this study, it is possible to 
reliably, and usefully, classify patients as "blockers" and 
"non-blockers". Almost 75% of patients, thus classified, 
produced three catheters which were either all blocked or all 
non-blocked. Where the pattern of catheter blockage was less 
consistent, the absence or sudden appearance of urease- 
producers in urinary or catheter culture, occurred in the 
predominant proportion of cases and was often associated with 
antibiotic therapy. "Blockers" were characterised by infection 
with urease-producers and with P.mirabilis in particular, 
whilst this organism was rarely isolated from "non-blockers", 
and never from a non-blocked catheter.
Catheter changes due to lumen occlusion, were necessary 
for almost all "blockers" in less than six weeks, whilst "non­
blockers" rarely required recatheterisation prior to the 
scheduled change. Time alone is not a controlling factor in 
the accumulation of catheter encrustation, and indeed, in half 
the non-blocked catheters there was a complete absence of any 
visible encrustation after six weeks. However, the quantity of 
encrustation deposited does determine the time a catheter can 
remain functional. Recognition of a patient's characteristic
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pattern of "catheter life" is therefore, a valuable tool in 
planning individualised patient care, and early identification 
of patients as "blockers" will be instrumental in identifying 
that pattern. The implications for patient care raised by this 
study will be considered further in Chapter 7.
MICROBIAL ANALYSIS AND THE ROLE OF UREASE
Bacteriuria is an almost inevitable consequence of long 
term catheterisation (Warren et al., 1982? Cools and Van Der 
Meer, 1986? Jewes et al., 1988; Kunin, 1989), and was present 
in 100% of catheter episodes. Polymicrobic communities are 
common in catheterised patients and up to five different 
species (mean 3.2 species), existed in over 97% of catheter 
episodes. In an earlier study, Clayton et al. (1982) found up 
to seven different species present in the urine of their 
catheterised patients, however the mean number of 3.6 was 
similar.
In the present study, certain micro-organisms including 
E.coli; P.mirabilis; Enterococcus faecalis and K.pneumoniae 
were stable inhabitants of urine, and were recovered from 
almost all catheter episodes from infected patients. However, 
the persistence of other microbes fluctuated with time. Such 
"dynamic" variation in infecting species has frequently been 
observed (Clayton et al., 1982; Tenney and Warren, 1987), and 
presents particular difficulties in determining which
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antibiotic to prescribe and the benefits of repeated 
bacteriological surveillance.
Micro-organisms which are normal inhabitants of the 
bowel, are common sources of catheter-associated urinary 
infection (MacLaren and Peerblooms, 1986; Jewes et al., 1988; 
Kunin, 1989). However, Proteus, Providentia and Morganella 
species are distinguished from E.coli and other common bowel 
organisms by the production of urease (Jones and Mobley, 
1987). The hydrolytic cleavage of urea catalysed by urease 
results in the release of ammonium ions, which not only 
increase the urinary pH but may be combined with urinary 
magnesium and phosphate to form struvite. Urine may be 
alkaline under normal physiological conditions, however, the 
concentrations of ammonium ions are usually too low to 
precipitate struvite (MacLaren and Peerblooms, 1986)
Although more often isolated from patients with blocked 
catheters, several studies have reported the isolation of 
P.mirabilis from patients with both blocked and unblocked 
catheters (Kunin et al., 1987a; Mobley and Warren, 1987; 
Kunin, 1989). However, catheter blockage was not rigorously 
defined in the study by Mobley and Warren (1987), and during 
the studies by Kunin and his colleagues, (1987a); and (1989), 
blockage was assessed after a maximum of 26 and 14 days 
respectively. In the present study, P.mirabilis was isolated 
only from blocked catheters, however, catheters were retained 
in situ up to 42 days allowing more time for encrustation and 
blockage to develop.
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Other strongly urease positive species, including 
Providentia stuartii and M.morganii were comparatively 
uncommon in this study. Since M.morganii was only isolated 
from blocked catheter episodes together with P.mirabilis, its 
association with catheter encrustation could not be clearly 
determined. However, M.morganii was also isolated from some 
non-blocked catheter episodes.
Although urease production is a common feature of 
uropathogens, one micro-organism - P.mirabilis, is more often 
associated with encrustation than others (Hedelin et al., 
1985a? Jones and Mobley, 1987? Kunin, 1989). This may be due 
to the ability of the urease from P.mirabilis to hydrolyse 
urea at faster rates than enzymes from other species (Jones 
and Mobley, 1987). P.mirabilis urease is also inducible (ie. 
more enzyme is synthesised in response to high urea 
concentrations), whilst ureases from some other species eg. 
M.morganii, are not (Rosenstein et al., 1981). In addition, 
there is some evidence to suggest that P.mirabilis may be more 
adherent to catheter surfaces than other Gram-negative 
bacteria (Roberts et al., 1990). In this respect it is 
pertinent to note that 50% of species isolated from the 
catheter cultures, but absent from corresponding urine 
cultures, were P.mirabilis. The close association of this 
micro-organism with the catheter surface may also explain some 
reports of failure to detect urease-producers in urine from 
patients with blocked catheters (Bruce et al., 1974? Hedelin 
et al., 1985a). Indeed, for one patient in this study,
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P.mirabilis was isolated from catheter cultures, but never 
from the urine.
K.pneumoniae and Ps.aeruginosa, which are common in 
hospital-acquired cross infections, occasionally produce 
urease (5 - 30% of isolates; Wickham and Buck, 1990). In some 
blocked catheter episodes these were the only urease producers 
isolated. Much less is known about the urease enzymes from 
these species, although K.pneumoniae has been associated with 
calculous pylonephritis (MacLaren and Peerblooms, 1986).
The significant difference in pH between paired first and 
second urine samples from blocked catheters suggests a 
localised production of urease by micro-organisms colonising 
the catheter surface as a biofilm. The association of crystals 
with the biofilm is depicted by scanning electron microscopy 
(Figs.16a and 18b). McLean et al. (1991) provided experimental 
evidence that struvite crystals trapped within such a biofilm 
can resist increased flow rates and mild acidification 
therapy, far better than crystals not associated with 
biofilms. Presumably such resistance is due to the maintenance 
of an alkaline micro-environment within the biofilm. 
Furthermore, the biofilm itself was stabilised by the presence 
of mineral deposits. These results imply that efforts to 
reduce encrustation should focus concurrently on the 
eradication of biofilm inhabitants and the dissolution of 
encrustation components.
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THE COMPOSITION AND MORPHOLOGY OF ENCRUSTATIONS
Nearly three quarters of the encrustation material was 
identified by chemical analysis (mean 71%), a comparable yield 
to that reported by Hedelin et al. (1984), using similar 
methodology. The principal components were calcium phosphate 
and struvite with smaller amounts of oxalate, protein and 
urate also detected. Unidentified portions probably included 
carbonate, in the form of carbonate apatite and crystal water 
(Hedelin et al., 1984; Cox et al., 1987a), and possibly other 
components in samples where low percentage recoveries were 
achieved.
Whilst most analyses of catheter encrustation have 
identified struvite and calcium phosphate as the major 
components (Hukins et al., 1983; Hedelin et al., 1985a; Cox et 
al., 1987a), the form of calcium phosphate present has been 
more difficult to determine. In this study, and that of 
Hedelin et al. (1985a), stoichiometric relationships based on 
chemical analyses have suggested that much of the calcium 
phosphate is present as brushite. However, analysis of 
catheter encrustations by physical methods, including X-ray 
diffraction, infra-red spectroscopy and extended X-ray 
absorption fine structure spectra (EXAFS) indicate that 
calcium phosphate is present as poorly crystalline 
hydroxyapatite (Cox et al., 1987a; Hukins et al., 1989).
The mean pH of first urine samples from blocked catheter 
episodes was 7.81, and since brushite is normally precipitated 
from urine when the pH is less than 6.6, while struvite is
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formed above a pH of 7.2 (Elliot et al., 1958), calcium 
phosphate would be expected to co-precipitate with struvite as 
hydroxyapatite at this pH. However, the pH of first urine 
samples from some blocked catheters, was much lower (range 
5.85-9.03) and Hedelin et al. (1991) have suggested that the 
critical pH for struvite formation in vivo may be as low as 
6.8. Crystallization processes are complex and in depth 
analyses were beyond the bounds of this study, however, the 
required calcium/phosphate ratio of 1.67 for formation of 
hydroxyapatite from supersaturated solutions is not always 
met, at least during the initial phases of precipitation 
(Nancollas, 1990). This may explain apparent differences in 
the interpretation of analytical results obtained from 
chemical and physical analyses. In addition, stoichiometric 
relationships may be complicated further by the potential 
presence of mixed calcium phosphates.
Oxalate was identified as the major encrustation 
component from three catheter episodes but in none of these 
episodes was the catheter blocked. Hedelin et al. (1984), also 
found oxalate to be the main component of a small number of 
encrustations. Calcium oxalate monohydrate is more commonly 
associated with renal calculi than the dihydrate form (Larsson 
et al., 1984). However, monohydrate crystal morphology is less 
distinctive and therefore more difficult to distinguish from 
aggregates of amorphous of calcium phosphate, by scanning 
electron microscopy. It is perhaps surprising that calcium 
oxalate which is a major component of renal stones, is not 
more commonly associated with catheter encrustation. However,
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calcium stone formation usually results from a metabolic 
imbalance producing increased urinary concentrations of stone 
forming constituents (Kohri et al., 1991; Fleisch, 1991). A 
similar relationship between urinary components and catheter 
encrustation has not been established.
The proportions of struvite and calcium phosphate in the 
encrustations showed wide inter-individual variation, however, 
encrustations from the same individual were of more consistent 
composition. A significantly higher percentage of struvite 
occurred in encrustations from blocked catheters compared to 
non-blocked catheters (p<0.005), contrasting with reports by 
Hedelin et al. (1985a). These authors described positive 
correlations between the frequency of catheter changes due to 
blockage and the proportion of calcium phosphate in the 
encrustation, and between catheter blockage and high urinary 
osmolality. However, numbers of patients were small and no 
similar association between catheter blockage and urinary 
osmolality was found in the present study, nor in that of 
Kunin et al. (1987a) and Kunin (1989).
Encrustation morphology ie. "gritty particles" and 
"powdery deposits", was not characteristic of underlying 
composition and may reflect rather, the pH environment or 
other conditions under which encrustations are formed.
However, morphological differences may be useful in planning 
patient care since "gritty particles" were significantly 
associated with shorter functional "catheter lives". Further 
studies are required to determine if these hard particles are 
less susceptible to dissolution by bladder washout reagents 
than powdery encrustations.
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KEY POINTS
1. Catheter blockage was significantly associated 
with:
the isolation of urease producers and with 
P.mirabilis in particular, 
high urinary pH.
encrustation composed of a higher 
proportion of struvite.
2. The length of time a catheter could remain in 
situ was significantly associated with:
mean encrustation score.
pH of the first urine sample per catheter 
episode.
encrustation deposited as "gritty 
particles".
3. Catheter time in situ was not related to:
24h fluid intake, urinary volume or 
composition.
catheter material or size, 
species of urease producer.
4. The major components of catheter encrustations 
were struvite and calcium phosphate.
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6. A EXPERIMENTAL STUDY OF
BLADDER WASHOUT PROCEDURES 
USING AN J O N  V J T ' T N O MODEL
MATERIALS AND METHODS
The model of the catheterised bladder
A model of the catheterised bladder was used to produce 
catheter encrustation in vitro, and to evaluate the 
effectiveness of bladder washouts in reducing encrustation.
The bladder model (Figs.21 and 22) consisted of a glass 
"bladder" composed of a specially converted 5 port, jacketed, 
glass reaction vessel with "quickfit" ground glass 
connections. A catheter (18 Charriere) was inserted into the 
base of the bladder through a glass "urethra". The bladder was 
supplied with synthetic urine from a 10 litre nalgene 
reservoir through marprene manifold tubing, 2.79mm bore 
(Watson-Marlow Ltd., Falmouth). The flow of urine into the 
bladder simulated the rate of secretion of ureteric urine. The 
rate of flow was maintained at 1.0 ± O.lml/min, using a 502AA 
4-channel peristaltic cassette pumphead connected to a 502S 
Drive (Watson-Marlow Ltd., Falmouth). Residual urine collected 
below the catheter eyes, and excess urine drained through the
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catheter into a 10 litre glass vessel. Urine flowed from the 
reservoir to this vessel within a sealed system thus 
minimising the risk of microbial contamination. The bladder 
temperature was maintained at 37°C± 1°C by circulating water 
through the outer jacket from a thermostatically controlled 
bath (Grants Instruments Ltd., Cambridge) using a pumphead
FIG. 21 The model of the catheterised bladder
driven by a Capex 30 electric motor 220/240 volts/50 Hz 
(Charles Austen Pumps Ltd., Byfleet). All air entering the 
model system, reservoir and collecting vessel passed through 
Millex-FG 50 (0.2/im pore size, 50mm diameter) filter units 
(Millipore, Molsheim, France). Experiments utilised two or
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three models simultaneously. This design allowed one bladder 
system to act as the control whilst the others were used as 
experimental systems. Bladder systems were numbered I, II and 
III, and the particular set of apparatus used as the control 
or the experimental system was changed for each series of 
experiments according to a pre-defined schedule. This 
procedure minimised any bias caused by a particular bladder 
system, such as differences in residual urine volume produced 
by slight differences in bladder shape. All experiments were 
conducted a minimum of four times.
Catheterisation
Each bladder was catheterised aseptically. The catheter 
was retained within the bladder by inflating the balloon with 
10ml distilled water. A water tight seal at the base of the 
bladder was obtained by holding the catheter firmly in place 
while tightening a nut and silicone washer at the lower end of 
the "urethra". Care was required to avoid applying a downward 
tension on the catheter causing deformation of the balloon and 
a subsequent variability in residual urine volume.
Silicone catheters were chosen since their balloons 
inflated more evenly than other types, allowing the catheter 
tip to become situated centrally and upright within the 
bladder. This was important in the production of consistent 
residual urine volumes in all experiments. Preliminary 
experiments, with silicone catheters enabled the quantity of 
encrustation produced in each bladder system to be measured by 
the difference in catheter weight before and after the
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experiment. Measurements based on weight could not be used 
with coated-latex catheters because of the differential uptake 
of water by latex (Cox et al., 1988). All catheters were 
supplied by Bard Ltd, Clacton.
Synthetic urine
Synthetic urine was chosen in preference to human urine 
to provide a consistent, known composition thus eliminating 
inter-experimental variation in either components, or 
concentrations. The use of synthetic urine also excluded the 
presence of unknown urinary inhibitors, or promoters of 
encrustation crystallization (Hedelin et al., 1985b). The 
synthetic urine used (Table 21) was a modified version of that 
proposed by Griffith (1976), and was shown to support 
bacterial growth in preliminary experiments. The addition of 
0.5% protein (gelatin, Sigma Chemicals,Poole) to the urine was 
associated with increased deposition of encrusting material, 
confirming reports by others (Cox et al., 1987b). Although the 
excretion of >150mg/L of urinary protein is usually associated 
with disease states (Montgomery et al., 1980), proteinaceous 
material may be present in urine as cell debris or mucin which 
would normally be removed during urine filtration or 
centrifugation.
A fresh concentrated stock solution of artificial urine 
was prepared for each experiment. Sodium sulphate was 
dissolved separately to minimise precipitation. Calcium 
chloride was dissolved separately from oxalate and phosphate 
to avoid precipitation of their calcium salts. Gelatin was
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dissolved in hot water. Solutions were mixed immediately prior 
to use and diluted to provide the required concentration and 
volume. The pH of the final solution was adjusted to 5.8 with 
1M sodium hydroxide. Approximately 8.5 litres of urine was 
supplied to each bladder during a standard experiment lasting 
138h.
TABLE 21. Coiposition of synthetic urine
Compound g/litre Concentration/litre
CaCl2.H20 0.65 Ca, 4.3 mM
MgCl2.6H20 0.651 Hg, 3.2 iH
NaCl 4.6
Ha2S04 2.3 S04, 16 mM
Na2citrate.2H20 0.65 Citrate, 2.3 iH
Na2oxalate 0.02 Oxalate, 0.149 mM
k h2po4 2.8 P04, 20.5 mM
KC1 1.6
HH4C1 1.0 HH4, 19 mM
Urea 25.0
Protein (gelatin) 5.0
Total Na 118 mM 
Total K 42 mM
Final pH adjusted to 5.8 with 1H NaOH
Experimental Conditions
The apparatus was allowed to equilibrate at 37°C for lh 
following commencement of the urine flow. A 1ml inoculum of an
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overnight culture of Proteus mirabilis, containing 
approximately 109 cfu/ml, was then added to the residual urine 
through one of the ports at the top of the bladder. A 
sufficient volume of culture for the whole experimental series 
was prepared from a single batch culture and stored at -40°C. 
Aliquots were grown overnight in 10ml nutrient broth as 
required. A standard experiment continued for 138h after which 
the apparatus was dismantled and the volume of residual urine 
in each bladder recorded.
Decontamination of equipment
Initial attempts to prevent the retrograde spread of 
P.mirabilis throughout the apparatus, by inserting a bulk 
filter (Sartobran II, Sartorius Ltd., Epsom) between the 
peristaltic pump and the bladder, were abandoned when the 
filter recurrently blocked prior to the end of the experiment. 
On completion of each experiment and following removal of the 
catheter, the apparatus was flushed with a solution containing 
dilute hydrochloric acid pH 2.0, followed by distilled water, 
to remove deposits within the tubing. The urine reservoir, 
bladder and collecting vessel were soaked in a 1% solution of 
Hycolin (William Pearson Ltd., Hull) for a minimum of 4h or 
overnight before washing. All equipment was sterilised by 
autoclaving prior to the next experiment.
Monitoring of pH and bacterial contamination
During experiments the urine was monitored at 24h 
intervals for bacterial contamination and pH. Extraneous
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contamination could affect the pH of the urine directly, or 
might exert a promotional or inhibitory effect on the growth 
of P.mirabilis and/or encrustation formation. Samples were 
withdrawn by sterile syringe through the sample port on the 
drainage tubing and cultured on cysteine lactose electrolyte 
deficient (CLED) agar. The pH was measured using a digital pH 
meter (PTI-55, Courtcloud Ltd., England).
DEVELOPMENT OF THE MODEL
Preliminary experiments were conducted to identify the 
optimal experimental conditions to produce catheter 
encrustation, and to ensure that the quantities produced were 
not significantly different between model systems. The 
quantity of encrustation formed was measured by recording the 
difference in catheter weight before and after the experiment. 
At the end of each experiment the catheter was drained on to a 
pre-weighed filter paper so that dislodged fragments of 
encrustation were retained for weighing. The catheter was cut 
longitudinally and allowed to dry at room temperature in a 
protected place for 10 days prior to re-weighing. This method 
was not employed during the main series of experiments which 
included measurements of encrustation formed on hydrogel 
coated-latex catheters, since this material is known to absorb 
water.
The quantity and distribution of encrustations, along the 
catheter, was estimated visually for each 20mm of catheter
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length. The scale of 0-4 used previously was employed (Chapter 
5).
0 None 
+1 Rough surface 
+2 Wide channel 
+3 Narrow channel
+4 Total occlusion
An alternative measure of catheter encrustation, based on 
the time taken for 50ml water to flow through the catheter 
(Kunin et al., 1987b) was also investigated. However, this 
method was considered to be unreliable as the water flushes 
out some encrusting material.
The standard experimental time adopted was 138h, since 
catheter blockage frequently occurred after this time. Early 
experiments included continued production of encrustation for 
periods of 120-240h, however, catheters were often blocked 
within 144h.
In order to compare catheter encrustations produced in 
vitro with clinical encrustations, four random samples were 
analysed by scanning electron microscopy and by chemical 
methods as described in Chapter 5.
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EXPERIMENTS TO INVESTIGATE ENCRUSTATION ON DIFFERENT CATHETER 
MATERIALS AND THE EFFECTS OF BLADDER WASHOUTS ON CATHETER 
ENCRUSTATION
CATHETER MATERIAL
The formation of encrustation on silicone and hydrogel 
coated-catheters was examined in the absence of bladder 
washouts. Six catheters of each type were compared during a 
series of four experiments.
BLADDER WASHOUTS
Administration of bladder washouts
The effect of bladder washout reagents on encrustation 
formation was investigated using 100ml sterile pre-packed Uro- 
Tainer solutions (Clini-Med, High Wycombe). The reagents 
tested were Saline 0.9%, Suby G, and Mandelic acid 1%.
Washouts were administered aseptically after 114h, or in some 
additional experiments with Suby G, after 18h, 66h and 114h to 
simulate prophylactic use on alternate days (Table 22). The 
experimental schedule included more washouts with Suby G than 
other reagents, to allow comparisons between Suby G and 
mandelic acid, or saline, during the same experiment.
Washouts were instilled gently via the catheter, over a 
period of 90s, to avoid dislodging encrustations. The tubing 
was then clamped and the solution retained in the bladder and
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catheter for 15min. When the clamp was released, the bladder 
was allowed to drain.
Table 22. The effects of bladder washouts on catheter encrustation:
experimental protocol.
Reagent Time administered No. of expts
Suby G (1) 114 h 8*
Suby G (3) 18, 66, 114 h 4
Mandelic acid 114 h 4
Saline 114 h 4
* 10 expts with Suby G (1) were perforied but equipment failure 
precluded results from 2 of these.
Urine collection and analysis
A 10ml sample of the "returned" bladder washout solution 
was collected, with further aliquots removed at 30min 
intervals. The pH of each sample was recorded immediately, 
prior to storage at -40°C for subsequent chemical analysis of 
calcium and magnesium concentration by atomic absorption flame 
photometry (Chapter 5). Bladder washouts with reagents able to 
promote the dissolution of encrustations would be expected to 
result in increased concentrations of calcium and magnesium in 
the "returned" washout solution. None of the reagents used 
contained calcium but Suby G contained 0.38% magnesium oxide. 
Therefore, it was necessary to measure the concentration of
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magnesium, in the "returned" bladder washout solution, which 
was attributable to Suby G. This was done by measuring 
magnesium concentrations following bladder washouts with Suby 
G, using water in place of urine, and in the absence of 
P.mirabilis.
Measurement of catheter encrustation and lumen patency 
The effectiveness of a bladder washout solution is 
ultimately determined by its efficacy in preventing catheter 
blockage. In view of this, a method of directly measuring 
catheter lumen patency at the end of each experiment was 
developed. Five 2mm long cross sections of catheter were cut 
at standard locations? 20mm, 40mm, 100mm, 200mm and 300mm 
distal to the catheter tip. A further four 2mm sections were 
cut from the area of catheter behind the balloon. All sections 
were placed on a rectangular piece of filter paper and allowed 
to dry at room temperature for 72h in a protected place. All 
catheter sections obtained during one experiment were 
photographed together, with a mm scale. A 6-fold photographic 
enlargement of the catheter sections was computer digitized 
(Image III frame grabber, Eltime Systems Ltd.). Grey scale 
enhancement of the selected scan was performed to highlight 
both the edge of the catheter lumen and the surface of the 
encrustation. A software package (Rameses II, Eltime Systems 
Ltd.) was used to measure the cross-sectional area of lumen 
which was still patent. Each catheter section was measured 
three times and the mean area recorded.
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Cross-sections of unused catheters were also photographed 
and measured to investigate manufacturing tolerances for the 
mean lumen area of catheters composed of the same or different 
materials. Comparisons were made between the mean lumen area 
per catheter and between areas at defined locations along the 
length of the catheter, 20, 40, 100, 200, 300mm distal to the 
catheter tip.
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RESULTS
A total of 29 experiments were performed with the model 
of the catheterised bladder.
DEVELOPMENT OF THE MODEL
Initial development and difficulties
The development of standard conditions for bladder model 
experiments, under which reliable and valid results were 
obtained, took approximately three months. In the initial 
stages only two models were available, and frequent leakage 
around the "urethra” or blockage of tubing caused 
difficulties. When a third model was added, there appeared to 
be differences in the quantity of encrustation produced 
between models. However, differences were not significant 
following cleaning of all glassware with chromic acid. 
Equipment failure such as breakage of pump cassettes, or 
deflation of the catheter balloon on two occasions also 
presented problems.
Early experiments conducted without the addition of 
protein to the urine, produced relatively little encrustation. 
When the effects of ovalbumin and gelatin (0.05% - 1%)(Sigma
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Chemicals, Poole) were measured by weighing encrusted 
catheters, the lowest concentration promoting sufficient 
encrustation for future comparative experiments was 0.5%. 
Gelatin was chosen as there was no apparent difference between 
the effects of the two proteins tested, but gelatin was easier 
to dissolve.
Determination of standard conditions
During a standard experiment lasting 138h the pH of the 
urine collected through the catheter rose from 5.8 to a mean 
of 7.86 ± 0.38 (Fig.23). As the pH increased the bladder urine 
became progressively more opaque and precipitation was visible 
on the catheter balloon and drainage tubing within 96h.
FIG. 23 Changes in pH during a standard experisent lasting 138h.
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Contamination by other micro-organisms occurred during two 
preliminary experiments, but in each case the number of 
contaminating micro-organisms was <105 cfu/ml and there was no 
significant change in pH. Experiments conducted in the absence 
of a source of urease (no inoculation of P.mirabilis) did not 
produce any visible catheter encrustation.
The mean weight of encrustation produced in the absence 
of bladder washouts was 0.727 ± 0.168g. There was no 
significant difference between the quantities of encrustation 
produced in bladder systems I, II or III during any particular 
experiment. However, the quantity of encrustation formed 
during different experiments was more variable. Encrustations 
were distributed along the whole length of the catheter lumen, 
but scores of +3 were not observed beyond the first 100mm 
distal to the catheter tip.
Samples from four experiments were chemically analysed 
(Table 23). More than 77% of the encrusting material was 
identified from all samples (mean % recovery = 83.15 ± 5.7). 
Approximately 30% of the identified material was struvite 
(mean 30.05 ± 0.02%) and approximately 53% (mean 53.05 ±
0.04%) was calcium phosphate. The molar ratios of calcium and 
phosphate were more consistent with the presence of calcium 
phosphate in the form of brushite than as apatite.
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TABLE 23. Composition of encrustations formed in vitro
Sample Ca Hg P Struvite CAP* Mass recover}
mM/L mM/L mH/1 mg/ml t mg/ml 1 mg/ml 1
1 18.17 8.87 31.48 1.46 29.2 2.83 56.6 4.49 86.0
2 15.14 9.12 28.97 1.50 30.0 2.36 47.2 3.86 77.0
3 16.65 8.51 24.72 1.40 28.0 2.59 51.8 3.99 80.0
4 18.16 10.01 34.74 1.65 33.0 2.83 56.6 4.48 89.6
Mean 17.03 9.13 29.98 1.50 30.05 2.65 53.05 4.21 83.1*
+ SD 1.45 0.64 4.23 0.11 2.13 0,23 4.51 0.33 5.7(
* CAP - calcium phosphate
Scanning electron microscopy of encrusted catheter 
sections (Fig.24) showed the presence of large struvite 
crystals and amorphous calcium phosphate, similar to 
encrustations observed from clinical samples (Chapter 5). 
However, in vitro deposits were white in comparison to the 
creamy/beige colouration of most clinical encrustations.
Manufacturing tolerances of unused catheters
Comparisons were made between the mean cross-sectional 
area of patent lumen per catheter, measured from 6-fold 
photographic enlargements of five 2mm catheter cross sections. 
Five silicone and five hydrogel-coated catheters were 
measured. The luminal area of individual catheters did not 
differ significantly along their length, although there was a 
tendency for the lumen to be smaller in the region behind the
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balloon (20mm from the tip) in hydrogel-coated catheters. 
Catheters of the same material were not significantly 
different from each other at any of the defined locations 
(Table 24). However, the cross sectional lumen area of 
hydrogel-coated catheters was significantly smaller than that 
of silicone catheters (two sample t-test, t=21.16? p<0.005).
TABLE 24. Mean cross-sectional area of linen : unused catheters
Distance from Mean cross-sectional lumen area (mm2)
catheter tip (m m ) Silicone Hydrogel
20 8.94 + 0.19 5.95 + 0.22
40 8.87 + 0.12 6.52 + 0.08
100 9.14 + 0.25 6.44 + 0.07
200 9.14 + 0.15 6.35 + 0.13
300 9.09 t 0.12 6.23 ± 0.10
Whole catheter 9.04 + 0.12 6.30 + 0.22
Five silicone and five hydrogel-coated catheters were Measured
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Fig. 24 SEM of catheter encrustation formed in vitro.
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RESULTS OF EXPERIMENTS TO INVESTIGATE ENCRUSTATION ON 
DIFFERENT CATHETER MATERIALS AND THE EFFECTS OF BLADDER 
WASHOUTS
A series of 17 experiments was conducted, to compare the 
formation of catheter encrustation on silicone catheters and 
hydrogel-coated catheters and to examine the effect of bladder 
washouts on encrustation. Silicone catheter balloons deflated 
during two experiments and the results of these were excluded. 
The mean residual urine was 26.6 ± 1.72ml. Contaminating 
micro-organisms were not isolated during any experiment.
There was no significant difference between the area of 
patent lumen on catheters encrusted in bladder system I, II or 
III when all catheters were composed of the same material and 
no bladder washouts were used.
CATHETER MATERIAL
There was no significant difference in the area of patent 
lumen for encrusted hydrogel-coated catheters compared to 
encrusted silicone catheters. Since the original luminal area 
of unused hydrogel-coated catheters is significantly smaller, 
than in silicone catheters, these results indicate that less 
encrustation occurs on the former type.
164
BLADDER WASHOUTS AND CATHETER ENCRUSTATION
Mean patent lumen area
Occlusion of the catheter lumen by encrustations is shown 
in Fig.25. Both Suby G washout regimes, (once after 114h or on 
alternate days) and mandelic acid washouts resulted in 
significantly less catheter encrustation, compared to control 
systems with no washouts (two sample t-test, Suby G regimes 
t=3.60; p<0.005 and t=3.73? p<0.005; mandelic acid t=2.56? 
p<0.05)(Table 25). There was no significant difference between 
the effects of Suby G, used once, and mandelic acid washouts. 
Comparisons between Suby G regimes were less conclusive. 
Although encrustation was less following washouts on alternate 
days compared to one washout after 114h, the difference was 
not significant.
The opacity of the bladder urine was visibly reduced 
during the time these washouts were retained in the bladder. 
Small white particles were visible in the returned washout 
solutions of Suby G and mandelic acid. The smallest of these 
dislodged particles of encrustation, dissolved within 3-4h, 
but larger particles were still present after 24h at room 
temperature.
Saline washouts did not significantly reduce encrustation 
compared to controls with no washouts. The saline washouts 
dislodged encrustation particles which could be seen in the 
returned washout solution. These particles had not dissolved 
after 24h at room temperature.
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TABLE 25. Patent lumen area following bladder washouts
Bladder washout Mean patent lumen area (mm2)
None (control) 4.61 1 1.45
Suby G (8) 6.51 + 0.36
Suby G, alt. days (4) 6.81 + 0.75
Mandelic acid (4) 6.52 ± 0.27
Saline (4) 4.77 t 1.35
Numbers in parentheses refer to the number of experiments conducted 
with each bladder washout reagent. More experiments were conducted with 
Suby G than other reagents, to enable direct comparisons with Suby G and 
mandelic acid or saline during the same experiment.
FIG. 25 Catheter lumen occlusion
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Urinary calcium and magnesium concentration
The maximum "expected” urinary calcium and magnesium 
concentrations, assuming no encrustation dissolution, were 
compared to the actual concentrations measured in the 
"returned” washout solution (Table 26).
TABLE 26. Coiparison between expected and actual urinary calciui and magnesium 
concentrations immediately after bladder washouts.
Mean calcium concentration (mM/L)
Bladder washout Suby G Mandelic acid Saline
Expected 3.24 + 0.26 3.04 ± 0.09 3.21 ± 0.28
Measured 13.82 + 3.74 11.25 + 2.32 3.40 + 1.15
Significance p<0.05 p<0.05 NS
Mean magnesium concentration (mM/L)
Bladder washout Suby G Mandelic acid Saline
Expected 2.75 + 0.31 2.73 t 0.32 2.78 ± 0.38
Measured 15.68 + 2.67 12.31 + 3.53 2.94 + 0.92
Significance p<0.05 p<0.05 NS
NS no significant difference between expected and measured concentrations
Significant increases in urinary calcium and magnesium 
occurred after bladder washouts with both Suby G and mandelic 
acid (p<0.05), but there was no significant increase in these
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urinary components following bladder washouts with saline. 
There was however, no significant difference between the 
effects of Suby G and mandelic acid. Variations in urinary 
calcium and magnesium concentrations closely followed changes 
in urinary pH subsequent to bladder washouts (Fig.26).
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FIG. 26 Drinary pH, calciun and nagnesiun changes following bladder washouts
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Calculations of expected urinary calcium and magnesium 
concentrations
With the exception of magnesium present in Suby G, the 
only non encrustation sources of calcium and magnesium were 
the fresh urine supplied from the reservoir and the residual 
urine in the bladder. The expected concentrations of calcium 
and magnesium were the sum of:
i) mmoles Ca/Mg in the residual urine volume (26.6ml).
ii) mmoles Ca/Mg in fresh urine supplied during the
15min the bladder washout was retained in the bladder 
(15ml).
Measured concentrations were corrected for dilution with 100ml 
of bladder washout reagent. After washouts with Suby G, a 
further correction was required to allow for the magnesium 
contained in this product. This was determined experimentally 
as 89.4 mM/L magnesium.
Assumptions made during calculations
Certain assumptions were made during calculations:
i) the concentration of calcium and magnesium in the
"fresh" urine was the same as at the beginning of the 
experiment.
This assumption could have been false if the retrograde spread 
of P,mirabilis through the apparatus had reached the reservoir
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of urine and promoted precipitation of these components. 
However, the statistical significance of the experimental 
results would not be affected. Indeed, lower concentrations in 
the "fresh" urine would have made significant differences 
easier to attain.
ii) complete mixing of solutions occurred within the 
bladder.
If this assumption was false and mixing was incomplete, the 
"returned" solution would contain a greater proportion of the 
bladder washout reagent. Actual concentrations of calcium and 
magnesium would therefore be lower than the calculated 
expected value.
iii) concentrations of calcium and magnesium in the 
residual urine were the same as concentrations 
measured in urine immediately prior to the washout.
The actual concentrations of calcium and magnesium in the 
residual urine may have been higher than assumed, if depletion 
occurred during the flow of urine through the catheter.
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DISCUSSION
USING A MODEL TO SIMULATE CLINICAL CONDITIONS
In order to simulate the effects of bladder washout 
reagents as they are used clinically, a model using the whole 
catheter was developed. This unique design incorporated the 
hydrodynamic effects of urine, and bladder washout flow on 
catheter encrustation, in a way which is not possible with 
sections of catheter. Previous in vitro studies have mainly 
investigated factors affecting the encrustation process 
(Hedelin et al., 1989 and 1990; Hugosson et al., 1990b and 
1990c) and the susceptibility of different materials to 
encrustation (Cox et al., 1988 and 1989b? Gleeson et al.,
1989). In most of these studies small sections of catheter 
material or even glass rods have been used, frequently with 
Jack Bean urease in preference to a microbial source.
The model system developed for the present study utilised 
synthetic in preference to human urine to provide a consistent 
known urinary composition and to avoid variables, such as 
potential urinary inhibitors, or promoters of encrustation, 
which might affect the rate or quantity of encrustation 
deposited.
P,mirabilis, the micro-organism most frequently 
associated with catheter encrustation in vivo, was the source 
of urease. This was an important choice for two reasons.
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Firstly, bladder washouts may affect the adherence of 
P,mirabilis or other urease-producers which colonise the 
catheter surface. The removal of such a biofilm, and the 
alkaline micro-environment which it creates is a major 
objective of catheter care in vivo. Secondly, the biochemical 
characteristics of P.mirabilis urease differ from other 
microbial ureases and from Jack Bean urease (Rosenstein et 
al., 1981? Jones and Mobley, 1987)(Chapter 5).
The model differed from the human bladder in a number of 
known respects, including the rigid nature of the glass 
bladder. This may have allowed a larger residual volume of 
urine to be retained below the catheter eye. Residual urine is 
a reservoir for infection, and P.mirabilis may have reached 
higher concentrations than normally occur in vivo. In 
addition, bladder washouts given in vivo result in distention 
of the bladder. Subsequent emptying of the bladder may be 
accompanied by muscular contraction which could potentiate the 
effects of the bladder washout by flushing additional 
particles of encrustation from the catheter surface. This 
effect could not be simulated in vitro.
Catheter encrustation
Encrustations produced in the model were similar to those 
observed in clinical practice (Chapter 5), both in composition 
and morphology. However, encrustations formed in vivo were 
usually creamy coloured rather than the pure white of bladder 
model encrustation. Presumably the additional colour produced
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in the clinical situation, is due to the incorporation of 
organic material or other human urinary components.
The addition of protein to synthetic urine resulted 
in increased encrustation, as observed by others (Cox et al., 
1987b), although relatively little protein was identified in 
clinical encrustations (Chapter 5). However, organic material 
may play a role in the adherence of micro-organisms and 
crystals to the catheter surface, and fibrin has been detected 
on catheter surfaces shortly after insertion (Ohkawa et al.,
1990).
Encrustations formed in vitro contained a larger 
proportion of calcium phosphate to struvite (53%:30%) than 
encrustations deposited on blocked catheters from patients 
(43%:56%)(Chapter 5). However, clinical encrustations varied 
considerably in the relative proportions of these two 
components. During encrustation experiments lasting 138h, the 
urinary pH rose gradually from pH 5.8 to approximately 7.8. 
Since calcium phosphate precipitation begins at a lower pH 
than struvite, conditions conducive to precipitation of the 
former, were present for longer than the more alkaline 
conditions associated with struvite formation.
Despite the lengthy nature of experiments and the 
difficulties experienced during the early stages of 
development, the model provided a reliable technique to 
produce catheter encrustation within an acceptable period of 
time. Controlled conditions avoided confounding factors 
present in the clinical environment such as polymicrobic 
infection, variable urine composition and differences in
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patient mobility. The effects of bladder washouts were 
examined under conditions which simulated the clinical 
situation. Such results have not been reported previously.
ENCRUSTATION ON DIFFERENT CATHETER MATERIALS
Silicone catheters are manufactured by an extrusion 
process, which results in a larger catheter lumen than 
hydrogel-coated catheters, which are formed by successive 
build up of layers on a "former". Although a similar degree of 
catheter lumen occlusion was seen for both types of catheter, 
these experimental results imply that less encrustation 
occurred on hydrogel surfaces, since the luminal area was 
smaller initially. A similar trend was reported in a recent 
clinical study (Bull et al., 1991), in which hydrogel-coated 
catheters remained in situ for significantly longer than 
silicone elastomer-coated catheters. Cox et al. (1988) 
reported that both materials encrust at a similar rate. 
However, Jack Bean meal was the source of urease in their 
experiments and differential adherence of microbial urease- 
producers to varied catheter materials may be an important 
parameter.
THE EFFECTS OF BLADDER WASHOUTS ON CATHETER ENCRUSTATION
Both Suby G and mandelic bladder washouts were effective 
in reducing catheter encrustation but saline washouts had no
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significant effect. In all experiments the results obtained 
from measurement of patent catheter lumen areas were confirmed 
by measurements of urinary calcium and magnesium 
concentrations. It is suggested that acidic reagents are 
effective in reducing encrustation because at low pH the 
equilibrium between P043-, HP042"and H2P041_ is displaced towards 
the dihydrogen phosphates which are readily soluble. The net 
effect is the dissolution of both calcium phosphates and 
struvite (magnesium ammonium phosphate). Complexing of calcium 
with citrate may also be favoured by the high citrate 
concentration in Suby G.
Although there was slightly less encrustation following 
washouts with Suby G on alternate days compared to a single 
washout, the difference was not statistically significant. The 
regular prophylactic use of Suby G washouts on alternate days 
cannot be supported by these results. However, the urinary pH 
was relatively low during the early stages of each experiment 
and the rate of encrustation formation may have been 
correspondingly low. The experimental design did not allow a 
more in depth study of optimum frequencies for bladder washout 
use, since "control" catheters not receiving bladder washouts, 
blocked rapidly after 144h.
Hesse et al. (1989), also reported that catheter 
encrustations were prevented or largely dissolved by 
irrigation with Suby G, but that saline was ineffective. Hesse 
et al. claim that it is possible to prevent catheter 
encrustation by regular daily irrigation with Suby G. However, 
in the model used, the washout reagent was pumped through the
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catheter at a flow rate of lml/min for 30min so that there was 
a constant supply of fresh reagent. This may have allowed more 
encrustation to dissolve than in the study reported here, or 
in the clinical situation, where 100ml of bladder washout 
reagent are normally instilled into the bladder and retained 
for 15min. Although 100ml are instilled, the volume retained 
within the catheter is clearly far less, and may rapidly 
become saturated with dissolved encrustation components, thus 
limiting further dissolution.
Mandelic acid was shown by Stickler et al. (1991), to 
reduce the colony count of several species of micro-organisms 
forming biofilms on silicone surfaces, including P.mirabilis 
and other urease producers. Although there are no previously 
reported studies of the efficacy of mandelic acid in reducing 
catheter encrustation, the results presented here, together 
with those of Stickler et al. suggest that mandelic acid may 
be a particularly useful bladder washout reagent. A 
combination of mandelic/lactic acid may also prove valuable as 
this acidic solution is equally effective against some micro­
organisms growing in biofilm mode (Stickler et al., 1991).
There have been few clinical studies of the effects of 
bladder washouts in reducing encrustation. Ruwaldt (1983) 
reported fewer incidences of catheter "plugging" among ten 
patients receiving Suby G washouts twice daily, however, 
carefully controlled clinical trials are lacking.
One important effect of bladder washouts which cannot be 
estimated by bladder model experiments is the potential damage 
to the urothelium by physical or chemical forces. Donmez et
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al. (1990) demonstrated that acidic solutions caused more 
histological damage to rabbit urothelium than alkaline 
solutions, but that magnesium containing solutions caused less 
injury. The damage caused is likely to be dependent on the 
period of exposure which in these experiments was 5h, 
considerably longer than the 15 min recommended for bladder 
washouts. Although the 1% mandelic acid bladder washout 
reagent marketed by Uro-tainer does not contain magnesium (to 
minimise tissue damage), Robertson and Norton (1990), found 
that 39/40 (97.5%) of patients tolerated it without difficulty 
for 20min in situ. Parsons et al. (1979) also reported damage 
to the rabbit urothelium by acidic solutions, however, 
histological studies indicated that recovery occurred within 
24-48h. Currently available evidence suggests, therefore, that 
Suby G and mandelic acid washouts can be beneficial in 
reducing catheter encrustation, providing that the period 
between instillations is at least 48h, to minimise recurrent 
damage to the urothelium.
Saline solutions are sometimes chosen for bladder 
washouts because they are perceived to cause less potential 
damage than other reagents, but the results presented here 
show that a solution of neutral pH, such as saline, will not 
reduce catheter encrustation. In addition, particles dislodged 
during the washout process may occlude the catheter eyes 
causing blockage. Elliott et al. (1989), proposed that 
increased shedding of urothelial cells was a useful indicator 
of mucosal damage in the clinical situation. All bladder 
washouts tested, including saline irrigations were associated
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with disruption of the urothelium (Elliott et al., 1989), 
suggesting that physical forces play a considerable role in 
urothelial damage. Since saline washouts were ineffective in 
reducing encrustation, and yet may result in urothelial 
damage, their use cannot be recommended.
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KEY POINTS
1. Suby G and mandelic acid bladder washouts are both 
effective in reducing catheter encrustation.
2. Saline bladder washouts DO NOT reduce catheter 
encrustation.
3. Hydrogel-coated catheters appear to develop less 
encrustation than silicone catheters.
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-7 - CONCLUSIONS AJNTD IMPLICATIONS 
F O R  R R A G T I C E
The key objectives of this study, identified in Chapter 3 
and restated below, have been discussed in the preceding 
chapters.
KEY OBJECTIVES
1. to determine whether patients can be classified as 
either "blockers", or "non-blockers" (Kunin et al., 
1987a).
2. to determine the composition of catheter encrustations
3. to determine the factors which contribute to 
encrustation.
4. to determine the potential value of bladder washouts.
A summary of the factors which lead to the cycle of 
events causing recurrent catheter encrustation and blockage, 
is illustrated in Fig.27. In this chapter, ways in which the 
knowledge gained can be used in clinical practice are
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considered, specifically to answer the following questions 
which are frequently raised by practitioners (Chapter 3) :
. Is the occurrence of catheter blockage a continuum or
can patients be classified in one of two discrete
groups ("blockers" or "non-blockers")?
. Why do some patients' catheters block more quickly than
others?
. Can effective care strategies to relieve or reduce 
catheter blockage be formulated?
I. Is the occurrence of catheter blockage a continuum or can 
patients be classified in one of two discrete groups 
("blockers" or "non-blockers")?
Patients can be classified as "blockers" and "non­
blockers", and the justification for this classification has 
been discussed in Chapter 5. When the whole study population 
was considered, the quantity -of encrustation formed was not a 
function of the time the catheter had been in place. 
Nevertheless, the catheters of some "blockers" became blocked 
more quickly than others, and in this respect there was an 
element of a continuum. A second group of patients ("non-
182
FIG. 27 The cycle of events leading to recurrent catheter encrustation and blockage
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blockers") clearly existed however, whose catheters never 
blocked within the six weeks dictated by the study protocol. 
Kunin (1989), in a study of 32 patients whose catheters were 
replaced at intervals of two weeks, proposed a third group of 
"intermediates". Patients were defined as "intermediates" by 
producing catheters with +2 encrustations on more than two 
occasions. Under a similar recatheterisation schedule some of 
the patients classed as "blockers" in the present study may 
have been categorised as "intermediates". Six "non-blockers" 
(25%) also conformed to the "intermediate" category, but it is 
difficult to see any clinical value in this additional 
grouping, unless it can be shown to contribute to patient 
care.
Monitoring the progress and care of all patients is 
fundamental to nursing practice, and an individualised 
programme should form the focus of catheter management. 
However, the classification of catheterised patients into 
broad categories of "blockers" and "non-blockers" is useful in 
identifying those who experience recurrent catheter blockage 
and require a care programme directed towards relief of this 
problem.
II. "Why do some patients catheters block more quickly than 
others?"
Within the category of "blockers", there was considerable 
variation in the length of time catheters remained in situ 
prior to blockage, ranging from 5 - 4 1  days. Certain closely
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related parameters (discussed in Chapter 5) were positively 
correlated with the frequency of recatheterisation:
high mean encrustation score
high pH of first urine
infection with urease producers
encrustation in the form of gritty particles.
However, the factors contributing to the rate of blockage are 
complex and there is no simple answer to the question posed 
above.
The urease-induced increase in pH is likely to depend on 
the number of infecting micro-organisms, and their potency as 
urea-splitters. But catheter-associated infections are usually 
dynamic and polymicrobial. Other micro-organisms may influence 
the growth of urease-producing species and/or contribute to 
the net urinary pH, as may the initial pH of urine from the 
kidneys, and its buffering capacity.
Although no significant relationship between 24h urinary 
composition and Ilblockers,l/,,non-blockers11 was detected, wide 
inter, and intra-individual variations may have masked 
differences which were significant in any one individual. High 
urinary calcium, magnesium and phosphate concentrations might 
be expected to promote encrustation formation, however, the 
actual concentrations measured in urine may be lower due to 
depletion during passage through the catheter.
The distribution of encrustations along the catheter 
length was not related to blockage, although it would be
185
logical to expect accumulation of encrustations close to the 
catheter eye to cause more rapid blockage than an even 
distribution throughout the catheter lumen.
Pattern of "catheter life"
"Is there a characteristic pattern to the frequency with 
which an individual's catheter becomes blocked?".
Clearly, if such a pattern exists, planned catheter 
replacements prior to the likely onset of blockage should form 
an integral part of catheter management. In practice the 
length of time catheters remained in situ prior to removal for 
blockage was variable not only between patients who were 
"blockers", but also, between catheter episodes for the same 
patient. However, in over 60% of "blockers" this difference 
was only five days for at least two catheter episodes.
Patterns were most consistent in patients who were not 
infected with P.mirabilis. Establishment of a planned 
recatheterisation schedule is a key element in patient care, 
and continued records of catheter change frequencies may have 
elucidated clearer individual patterns. Norberg et al.(1983), 
have suggested the need to tarke the median of 3-5 catheter 
"lives" to obtain a reliable parameter.
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Ill. Can effective care strategies to relieve or reduce 
catheter blockage be formulated?
High fluid intake - myth or magic?
Numerous urological and nursing texts exhort nurses to 
encourage their catheterised patients to drink "plenty of 
fluids" in order to:
flush out bacteria
prevent precipitation of "salts" and debris 
maintain a dilute urine 
Although this advice may seem logical it should not be allowed 
to pass unchallenged, particularly as many elderly or immobile 
patients find it difficult or uncomfortable to drink large 
volumes.
Within this study, all patients displayed bacteriuria and 
microbial colonisation of the catheter surface, regardless of 
24h fluid intake or urinary volume. The flushing action of 
micturition may be an effective defence against urinary tract 
infection in the non-catheterised patient, but catheter 
drainage produces a continuous flow of urine without the 
scouring action of periodic voiding. In addition, micro­
organisms are adherent to the catheter surface and persist 
even after extensive washing-procedures (Chapter 5). Although 
risks of upper urinary tract infection and tissue invasion 
undoubtedly exist, systemic symptoms of infection are commonly 
absent in long-term catheterised patients, and there is no 
evidence of increased mortality within this group (Cools and 
Van der Meer,1986; Kunin et al.,1987a).
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Since "blocker" status was not associated with a low 
average daily fluid intake, low 24h urinary volume or high 
urinary osmolality, this study has not provided any evidence 
that "drinking plenty" will reduce mineral precipitation. 
Indeed, 2/18 "blockers" drank only water which had been 
filtered to remove a high proportion of minerals. A further 
7/18 "blockers" were being treated with diuretic medication 
which increased their urinary flow rate, but did not prevent 
their catheter blockage.
Treatment with antibiotics
There is general agreement that antibiotics will not 
prevent infection in long-term catheterised patients 
(Kunin,1987). Catheter encrustation is significantly 
associated with infection by urease-producing micro-organisms, 
many of which are normal inhabitants of the bowel. However, 
patients who suddenly become "blockers", having previously 
been "non-blockers" may have acquired infection with micro­
organisms from an external source. In this situation a course 
of antibiotics coupled with replacement of the colonised 
catheter may prove beneficial. Kunin (1987a) reported one 
patient who converted from being a "blocker" to a "non­
blocker", following such treatment. In the present study, two 
patients classed as "non-blockers" did produce one blocked 
catheter, but following antibiotic therapy, their catheters 
were no longer blocked.
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Bladder washouts
Suby G and mandelic acid washouts both proved effective 
in reducing catheter encrustation. The duration of their 
effect closely followed the urinary pH changes which 
accompanied the washout. Prior to this study there has been 
little published evidence to support the use of bladder 
washouts to reduce encrustation. In the period between the 
preliminary study and the main study, there was a reduction in 
the use of bladder washouts, possibly in response to several 
reports of their potential damaging effects (Elliott et al., 
1989).
Mini-washouts
If the principal aim of the washout procedure is to 
reduce catheter encrustation and blockage, washing the 
catheter itself with a much smaller volume of reagent would 
limit the exposure of the bladder surface to potential damage. 
An 18Ch catheter holds only 4-5ml, therefore a washout with 
10-20ml of reagent would completely fill the catheter but 
would restrict the volume of acidic reagent overflowing into 
the bladder. The small quantity of reagent entering the 
bladder would be rapidly diluted by fresh urine from the 
ureters, thus minimising damage. Furthermore, such "mini- 
washouts" should also reduce exfoliation of urothelial cells 
caused by physical forces associated with current procedures. 
With reduced risk of tissue damage, mini-washouts could be 
used safely and more frequently eg. alternate days, to 
maintain catheter patency.
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A single 100ml bladder washout with saline, at 
recatheterisation, might be of value in flushing out mineral 
deposits which collect within the bladder, or alternatively 
patients could be left without a catheter for one to two days. 
Future experiments using the model of the catheterised bladder 
(Chapter 6) will evaluate the effectiveness of mini-washouts.
Catheter material
The choice of catheter material is important for all 
long-term catheterised patients, with respect to ease of 
insertion and minimising tissue reaction. There was no 
evidence of differential susceptibility to encrustation 
between silicone elastomer-coated and hydrogel-coated 
catheters in clinical use, in the present study. However, the 
population size and study design precluded controls for inter­
individual and intra-individual variations. In a recent 
clinical study by Bull et al.(1991), hydrogel-coated catheters 
remained in situ for significantly longer than silicone 
elastomer-coated catheters. Whilst urinary bypassing was cited 
as the main reason for changes of silicone elastomer-coated 
catheters, a direct relationship with catheter encrustation 
was not established.
Previous in vitro studies were unable to provide evidence 
that any one of three materials; silicone, silicone elastomer- 
coated or hydrogel-coated is significantly more resistant to 
encrustation than the others (Cox et al.,1989c). However, in 
this study, using a model which more closely resembles the in 
vivo situation, less encrustation occurred on hydrogel-coated
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catheters compared to silicone. Therefore, on the basis of 
currently available information, it is concluded that 
hydrogel-coated catheters may be advantageous to "blockers11.
FUTURE RESEARCH
The development of a model of the catheterised bladder 
has provided a useful experimental instrument with which to 
investigate various aspects of catheter encrustation and care 
procedures. The efficacy of Suby G "mini-washouts" in reducing 
encrustation, is of particular interest since potential risks 
associated with acidic bladder washouts may be minimised by 
the use of small volumes. Economic advantages may also exist.
Preliminary observations during the development of the 
model suggested that encrustations formed on silicone were 
less firmly adherent than those formed on hydrogel-coated 
catheters. As a result, a further series of experiments will 
address the effectiveness of washouts on encrustations formed 
on different catheter materials. There is some evidence to 
suggest that less encrustation occurs on conformable catheters 
(Brocklehurst et al.,1988; Cox et al.,1989b), and further 
studies on catheter encrustation will include these catheters.
Although the macroscopic morphology of encrustations was 
not significantly related to-composition, information on the 
relative susceptibility of "gritty particles" and "powdery 
deposits" to dissolution by bladder washout reagents could 
contribute to planning patient care. Simple tests with 
clinical encrustation samples could readily be conducted in 
the laboratory.
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However, in vitro experiments can only present 
implications for practice and clinical studies are critical to 
confirm results. Carefully controlled clinical trials of both 
catheter materials and bladder washout procedures, are 
particularly necessary. These should include an assessment of 
potential damage caused by washouts, based on exfoliation of 
urothelial cells (Elliott et al.,1989). Further studies on the 
reliability with which patterns of "catheter life" can be 
established for individual patients, including an evaluation 
of the proposed assessment form (Appendix F), would also be 
beneficial to planning care.
Finally, collaborative studies with polymer chemists, 
microbiologists and practitioners are essential to maximise 
the potential value of research efforts, in the fields of 
biomaterial development and biofilm control.
RECOMMENDATIONS FOR CARE
The long-term catheterised patient
The decision to catheterise a patient should not be taken 
lightly. Non-invasive measures to control urinary dysfunction, 
should be attempted and evaluated first. Intermittent self- 
catheterisation can be taught to many patients who are 
sufficiently dexterous and self-motivated. Even if indwelling 
catheterisation is the method of choice, it should be reviewed 
and alternatives considered periodically. Once the decision to 
catheterise has been made, it is the responsibility of the
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nurse to ensure that the procedure and subsequent care 
protects the patient from hazards.
Catheter care objectives:
. to minimise catheter-associated complications 
. to enable the patient to reach their potential in terms 
of self-care and independence 
• to provide a cost-effective service
The recommendations presented below are based on the data 
collected, and the conclusions drawn from this study. They are 
directed, therefore, to the management of patients with 
recurrent catheter blockage caused by encrustation:
1. Alternative, non-invasive methods for management of 
urinary dysfunction should be considered, and the 
potential for their use reviewed on a regular basis. 
Intermittent self-catheterisation may also be a practical 
alternative.
2. Planned care - not "crisis care"
Monitoring of "catheter “life" will establish a pattern of 
blockage, which can be used to plan recatheterisations to 
take place before blockage occurs. An example of an 
appropriate chart is provided in Appendix F.
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3. Patients or carers should be provided with the names and 
telephone numbers of key health professionals to contact 
day (or night) in the event of catheter associated 
problems, including blockage.
4. A "catheter replacement kit” containing all equipment 
required for recatheterisation, including TWO spare 
catheters of the correct size and material, should be 
available in the patient's home. This should avoid 
unnecessary, distressing and expensive, transfers to 
hospital simply for catheter replacement. TWO catheters 
are recommended to ensure a second one is available while 
the prescription to replace the first is being processed.
5. Many patients are aware of early signs of impending 
blockage. Patients who suffer from painful retention of 
urine should be taught to recognise these signs and 
contact health professionals early before the situation 
becomes urgent. Patients who suffer from bypassing may be 
taught to remove their own catheters and wear pads while 
awaiting recatheterisation.
6. Mini-washouts* with 20ml Suby G solution, retained for 15 
min, and used on alternate days may reduce the frequency 
of blockage.
i) Although both Suby G and mandelic acid are
effective at reducing encrustation, Suby G has
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the advantage of containing magnesium oxide 
which reduces tissue inflammation.
ii) The benefits of a small volume of washout 
reagent (20ml) have been discussed above. 
However, it is NOT recommended to keep 
solutions once opened for use on subsequent 
occasions.
iii) A period of 48h between washouts should allow 
recovery of the mucous layer lining the bladder 
surface (Parsons et al.,1979).
7. It is NOT necessary to encourage a high fluid intake but 
normal hydration (1000 - 1500 ml/24h) should be 
maintained.
8. Patients should be encouraged to be as mobile as 
possible.
A greater emphasis on care in the community, improved 
quality of care and increased value and efficiency for money 
are cornerstones of recent government white papers, "Working 
for Patients" (DOH,1989) and "Caring for People" (DOH and 
DSS,1989). Until recently the needs of long-term catheterised 
patients at home, and their informal carers, has been largely 
neglected. Indeed, Wilson-Barnett (1990), states that much of 
the nursing research to date has explored issues rather than 
provided direct recommendations for care. The study presented 
here has focused on a common and frequently distressing 
problem experienced by many long-term catheterised patients in 
the community, and has provided research based evidence for 
the recommendations made. It has also highlighted areas of 
practice which are perhaps less critical than previously 
thought eg. encouraging patients to drink large volumes; 
washing urine drainage bags with antiseptic reagents. A 
reduction in catheter encrustation has been demonstrated 
following washouts with Suby G and mandelic acid, and future 
directions for research will include evaluation of "mini- 
washouts" in both laboratory and clinical settings.
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Questionnaire - Preliminary Study
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U S E  O F  LONG-TERM INDWELLING CATH ETERS
I n  T h e  C o m m u n i t y
This questionnaire forms part of a study to investigate the problems of catheter 
blockage in community patients and is a follow-up to the one circulated in 1989. It 
would be appreciated if you would take time to complete one questionnaire per General 
Practice and return it as soon as possible in the envelope provided.
x
j
Thank you. Kathy Getliffe DNS
Nursing Practice Research Unit 
University of Surrey 
Guildford 
Surrey GU2 5XH
0483 300800 extension 2178
I. Practice Details
1. Nam e o f practice ( & telephone number).....................
2. Number of General Practitioners
3. Number of District Nurses attached to practice
4. Total number of patients visited on a regular basis by 
District Nurses
5. Number of patients with long-term indwelling catheters 
(ie in situ for more than 4 weeks)
6. Patient details (Please complete the form on the next page)
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II.  Patient Details: Patient I Patient 2 Patient 3
Age
Sex
Mobility:
bedbound/chairbound 1 
walks with an aid 2 
walks unaided/home 3 
fully mobile 4
How long has the patient been catheterised?
Reason for catheterisation
Type of catheter
Usual interval between catheter changes
Usual reason for change
routine 1 
blocked 2 
leaking (not blocked) 3
Type of blockage (if applicable) 
gritty 1 
powdery 2 
other (please describe) 3
-
Are bladder washouts used?
regularly 1 
only if catheter blocks 2 
not at all 3
-
Type of washout
Frequency of use
Please tick if patient might be suitable 
take part in the study.
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Consent Form 
and
Questionnaire - Main Study
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PATIENT CONSENT FORM
Encrustation and blockage of long-term urinary catheters 
in patients maintained in the community
I confirm that I have read the information sheet and 
that any questions I had about the proposed study have been 
answered to my satisfaction. I understand that my catheter 
is to be changed at intervals of six weeks until three used 
catheters have been collected and that bladder washouts 
will not be used during this time. If the catheter becomes 
blocked before the next scheduled change a new catheter 
will be inserted.
I understand that I will remain in the project until 
three used catheters have been collected and that my normal 
catheter care procedures may be resumed after this time.
I understand that I may withdraw from the project at 
any time by informing the researcher.
I agree to participate in this research.
NAME:
DATE:
220a
Form A/1
Patient name 
Address
Tel.
Date of last catheterisation
1. Age
2. Sex Male M
Female F
3. Reason for catheterisation
Incontinence
Retention
Other .............
1
2
8
4. Medical condition
Prostate enlargement
Multiple sclerosis
Spinal lesion
CVA
Malignant neoplasm
Diabetes
Parkinson's disease
Arthropathy
Other ..........
Date 
Code
GP
DNS
Surgery
Tel.
5. BP. date
6. Current medication 
(excl. laxatives)
7. Mobility
Bed/chairbound 1
Walks with an aid 2
Walks unaided/home 3
Fully mobile 4
CATHETER ENCRUSTATION STUDY 
PATIENT DETAILS
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CATHETER ENCRUSTATION STUDY 
Form A/2 PATIENT DETAILS Code
11. Bowel habits
Easy, reg. - lax. 1
Easy, reg. + lax. 2
Difficulty - lax. 3
Difficulty + lax. 4
8. Diet
General 1
Lacto-vegetarian 2
Vegan 3
Other ........... 8
12. Laxatives 0/1
lactulose
fibogel
senna
normax
other
9. Fluid intake/24 hours
< 1 litre 1
1 - 2  litres 2
> 2 litres 3
10. Alcohol intake/week
< 10 units ...... 1
10 - 20 units .... 2
> 20 units ...... 3
13. Smoking
Never/Stop >10yr 1
Given up <10yr 2
< 20/day 3
20 or more/day 4
HOME SITUATION
14. At home 
Alone 1
15. Main carer 
Self > 1
Spouse 2 * Spouse 2
Spouse + family 3 Relative ..... 3
Relative(s) ..... 4 Social services 4
Residential care 5 Residential care 5
Other .......... 8 Other ......... 8
221
CATHETER ENCRUSTATION STUDY Date
Form B/l CATHETER HISTORY
1. Usual catheter type
Name ..............
Manufacturer ......
2. Catheter material
Silicone elastomer 1
Hydrogel 2
All silicone 3
Other ........... 8
Code
9. Catheter inserted by:
DNS 1
GP 2
Other .. 8
10.Where catheterised
Home 1
GP surgery 2
Other ......... 8
8. Catheterisation antiseptic
None used
Chlorhexidine*
Cetrimide
Saline
Other
1
2
3
4
8
7. Frequency of recath.
< 6 weeks 1
6 - < 12 weeks 2
12 or > 12 weeks.... 3
6. Catheter change policy
Routine change ....
Only if blocks 
Other .............
1
2
8
3. Charriere
4. Balloon size
5. Length M/F
11.Recurrent problems 0/1
Leakage
Retention
Falls out
Other
12.How long catheterised
< 6 months ....
6 mths - < 1 year 
1 year - <  2 years 
> 2 years ......
1
2
3
4
13. First catheterisation
Home
GP surgery
Hospital
Other
1
2
3
8
CATHETER ENCRUSTATION STUDY Date
Form B/2 CATHETER CARE DETAILS Code
1. Bladder washout regime
No washouts 
Only when blocked
< 1 /week ........
1 - 3  /week ......
> 3 /week ........
1
2
3
4
5
2. Bladder washout reagent
0/1
U - Chlorhexidine 
U - Suby G 
U - Saline 
U - Solution R 
U - Mandelic acid 
Sterile saline 
Sterile water 
Tap water 
Other ...........
3. Washout retention
No washout 1
Drained immed. 2
Retained < 10 min 3
Retained > 10 min 4
4. Washout by:
No washouts 1
District nurse 2
Patient 3
Relative 4
Other ....... 8
5. Bladder washout method
No washouts 1
Uro-tainer pack 2
Sterile syringe 3
Other ........ 8
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CATHETER ENCRUSTATION STUDY 
Form B/3 CATHETER BAG DETAILS
1. Drainage bag
1 bag only 1
Leg + night bag/link 2
Leg or night bag 3
Other ............ 8
2. Night bag
Simpla 1
Uriplan 2
Conveen 3
Other . 8
Day/leg bag
Uriplan - short tube 1
Uriplan - long tube 2
Trident - short tube 3
Trident - long tube 4
Conveen 5
Other . 8
3. Bag emptying
< 3 times/day 1
3 - 6  times/day 2
> 6 times/day 3
Code
4. Drainage bag care
Not re-used 1
Wash/water 2
Wash/antisep .... 3
Not washed 4
Other 8
5. How long bag used
< 1 week ...... 1
1 - 2 weeks 2
> 2 weeks ...... 3
6. Hygiene 0/1
Daily meatal cleansing
Daily perineal wash
Recurr. urine leakage
Recurr. faecal incont.
ANTIBIOTICS - during study 
Dates; Antibiotics; Culture
224
CATHETER ENCRUSTATION STUDY
Code
Date
How do you feel about having a catheter?
always seldom
often never
Do you ever feel embarrassed about
having a catheter? --------------------
Do you ever feel worried about the 
catheter working properly?
Do you feel that having a catheter 
is a help to you?
Do you ever feel that you could 
manage with out the catheter?
What is the worst thing about having a catheter?
Are there any good things about having a catheter?
CATHETER ENCRUSTATION STUDY Date
Form D CATHETER-ASSOCIATED PAIN Code
Analogue pain scale
1. Pain associated with catheterisation
Date mm
2. Pain associated with catheter removal
3. Pain associated with catheter in place
4. Pain associated with bladder washout
* * * * * * * * * *
5. Awareness of impending blockage
always
sometimes
never
Can you describe any feelings which you have before 
catheter blocks - before any urine leakage or total 
retention.
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Dietary Analysis
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DIETARY ANALYSIS
Average daily weight (ADW) of dietary components consumed by "blockers" and "non-blockers"
Component "Blockers" 
Mean t SD
"Non-blockers" 
Mean + SD
Protein g 52.81 + 19.55 49.01 + 17.14
Carbohydrate g 185.94 + 51.60 181.10 + 63.43
Fat g 56.85 + 22.19 59.69 + 22.43
Cholesterol mg 207.58 + 131.03 215.37 + 83.33
Fibre g 18.44 + 34.17 7.80 + 3.56
Vitamin A jig 527.24 + 303.25 831.15 + 901.18
Vitamin B6 mg 1.15 + 0.40 1.19 + 0.37
Vitamin B12 jig 3.75 + 2.26 3.99 + 1.89
Vitamin C mg 44.60 + 23.68 47.45 + 28.50
Vitamin D jig 3.41 + 4.26 2.54 + 2.25
Riboflavin mg 1.24 + 0.42 1.42 + 0.44
Thiamine mg 0.83 + 0.33 0.82 + 0.21
Niacin mg 13.24 t 4.41 12.79 + 4.90
Folate jig 139.81 + 63.49 145.50 ± 61.51
Calcium mg 627.58 + 168.72 687.25 + 221.88
Magnesium mg 195.65 + 69.43 177.89 + 62.46
Sodium mg 1900.91 + 818.01 1846.65 + 640.43
Potassium mg 2032.00 + 654.28 2044.00 + 631.20
Iron mg 7.95 + 3.36 7.45 + 2.38
Selenium jig 26.75 + 13.79 25.62 + 14.45
Copper mg 1.27 + 1.05 0.97 + 0.78
Zinc mg 6.38 + 2.43 5.94 + 2.21
Phosphate mg 899.17* + 301.19 884.85 + 254.91
Chlorine mg 2904.33 +1252.82 2823.95 + 982.26
Iodine fig 90.41 + 43.06 82.83 + 32.83
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APPENDIX D
Urinary Compositions
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Drinary composition of all patients providing a liniiui of two catheters.
Patient no. Volume pH Osmolality Calcium Magnesium Phosphate
n=42 ml mosmol/L mM/L mM/L mM/L
1 B 2242 7.00 113 1.90 2.30 6.8
2 B 1460 6.00 118 2.20 1.50 12.9
3 B 2110 8.00 245 2.60 2.10 11.7
4 1930 6.50 335 1.30 1.80 11.8
5 2390 5.50 285 2.20 1.50 10.0
6 B 1970 8.50 409 2.10 0.60 7.2
8 2122 7.00 265 1.90 2.00 8.8
9 490 5.50 562 4.70 4.00 32.6
10 B 845 9.00 557 3.00 1.90 16.6
11 1580 6.00 296 1.40 1.00 7.6
12 B 1660 6.50 321 3.10 2.00 12.5
13 B 1520 8.50 585 4.00 2.60 14.6
14 100 5.50 577 4.40 3.50 25.0
15 2056 6.50 230 3.60 2.40 8.6
16 1950 7.00 205 1.00 1.40 5.7
17 1660 6.50 262 1.80 1.70 4.4
18 B 982 6.50 629 7.86 7.40 21.0
19 840 5.50 437 2.10 1.29 19.7
20 2610 7.00 419 0.86 0.96 9.3
21 B 2035 7.00 237 2.17 1.23 6.2
22 400 6.00 555 4.30 3.85 19.8
23 B 2270 6.50 365 3.56 2.16 7.4
24 B 2630 7.00 141 0.97 0.36 3.4
25 1370 6.00 171 2.24 1.80 14.0
26 1235 6.40 225 3.32 2.85 13.7
28 1275 6.10 325 0.53 1.22 8.8
B - patients classed as "blockers"
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Urinary composition of all patients providing a minimi of two catheters.
Patient no. Volume pH Osmolality Calcium Magnesium Phosphate
n=42 ml mosmol/L mM/L mM/L mM/L
29 1430 5.63 184 2.78 1.65 11.3
30 1310 5.62 204 0.32 1.32 6.6
31 B 1150 8.70 183 1.43 1.40 8.9
32 1800 5.55 194 3.40 1.40 4.8
33 835 8.07 399 0.30 1.20 6.5
34 B 2125 6.01 177 2.20 2.20 7.3
35 1420 5.94 206 0.76 2.31 13.1
36 2340 6.16 186 0.70 2.00 11.3
37 B 2200 7.55 155 1.40 1.10 7.9
38 1480 5.58 329 6.20 2.20 14.5
40 B 1950 5.65 141 3.00 1.90 8.2
41 B 1445 7.78 177 1.35 0.82 10.0
42 2195 5.33 218 1.30 1.68 7.1
44 2360 5.68 382 1.25 0.95 8.2
45 B 660 8.74 234 0.65 0.46 8.0
46 B 1850 8.25 208 0.95 1.09 5.3
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Urinary composition of all patients providing a minimum of two catheters.
Patient no. 
n=42
Oxalate
jimol/L
Urate
mH/L
Ammonia
mH/L
Citrate
mH/L
Creatinine
mH/L
Protein
g/L
I B 123 0.8 034.4 0.06 03.9 0.32
2 B 173 1.4 056.8 1.20 04.2 0.18
3 B 114 0.8 041.6 0.35 04.2 0.20
4 134 0.7 029.2 0.05 04.8 0.10
5 089 0.9 004.8 0.09 03.5 0.10
6 B 197 0.3 092.0 0.62 06.4 0.20
8 096 1.2 021.2 0.13 04.2 0.10
9 247 2.3 028.4 2.50 12.2 0.80
10 B 347 0.6 051.9 1.59 10.8 0.30
11 122 0.6 007.0 0.25 04.5 0.10
12 B 310 1.2 019.3 0.10 04.1 0.10
13 B 341 0.5 038.5 0.15 08.5 0.80
14 324 2.3 064.2 2.80 07.2 0.33
15 255 1.1 039.2 0.70 01.5 0.14
16 099 0.8 039.0 0.70 02.7 0.16
17 113 0.4 071.3 0.20 02.9 0.19
18 B 239 2.3 035.1 4.90 05.1 0.10
19 369 2.4 015.8 0.50 06.5 0.10
20 095 1.3 019.9 1.70 02.8 0.20
21 B 130 0.4 006.8 0.80 02.4 0.10
22 233 4.6 021.2 3.60 14.1 0.20
23 B 097 0.5 336.0 0.00 02.6 0.09
24 B 058 0.3 006.8 0.41 01.3 0.19
25 155 1.6 011.2 1.41 03.0 0.30
26 140 1.8 011.8 1.41 06.6 0.28
28 086 1.1 014.0 0.13 05.5 0.47
29 164 0.9 009.2 0.02 03.5 1.08
30 142 1.3 009.0 0.05 05.5 0.20
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Urinary composition of all patients providing a minimum of two catheters.
Patient no. 
n=42
Oxalate
pol/L
Urate
iM/L
Ammonia
mH/L
Citrate
mH/L
Creatinine
mH/L
Protein
g/L
31 B 257 1.2 102.4 0.01 05.8 0.26
32 131 0.3 021.2 1.10 02.8 0.07
33 164 0.7 069.5 0.30 04.5 ' 0.09
34 B 197 0.3 035.6 0.89 02.0 0.10
35 099 1.4 011.0 0.14 06.5 0.43
36 150 0.9 007.4 0.94 04.0 0.07
37 B 177 0.6 036.7 0.23 02.5 0.11
38 204 0.8 019.8 3.72 09.1 0.09
40 B 121 0.9 006.3 1.06 02.6 0.09
41 B 206 1.4 104.0 0.35 02.2 0.25
42 099 0.8 003.5 0.62 02.1 0.08
44 143 1.1 009.4 0.72 04.2 0.07
45 B 212 1.1 085.6 0.35 04.0 0.15
46 B 110 1.0 " 133.3 0.37 03.4
■-< -. d
„• 0.07
_ _
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Encrustation Composition
Patient Episode Struvite 
mg/ml %
CAP
mg/ml *'
CaOx
mg/ml %
Hass recovery 
mg \
1 1 2.38 82.07 0.52 A 17.93 0.00 0.00 2.90 58.00
1 2 2.15 84.98 0.38 A 15.02 0.00 0.00 2.53 50.60
1 3 2.82 91.56 0.26 A 8.44 0.00 0.00 3.08 61.60
2 1 0.05 1.27 3.03 B 77.10 0.85 21.63 3.93 78.60
2 2 0.54 21.26 2.00 A 78.74 0.00 0.00 2.54 50.80
3 1 1.25 36.34 2.19 A 63.66 0.00 0.00 3.44 68.80
3 2 1.12 37.84 1.84 A 62.16 0.00 0.00 2.96 59.20
3 3 1.36 46.10 1.59 A 53.90 0.00 0.00 2.95 59.00
6 1 1.72 63.94 0.97 A 36.06 0.00 0.00 2.69 53.80
6 2 1.64 60.29 1.08 A 39.71 0.00 0.00 2.72 54.40
6 3 1.65 64.71 0.90 A 35.29 0.00 0.00 2.55 51.00
10 1 1.45 57.54 1.07 A 42.46 0.00 0.00 2.52 50.40
10 2 1.90 72.24 0.73 A 27.76 0.00 0.00 2.63 52.60
11 H/B 3 0.60 18.02 2.24 A 67.27 0.49 14.71 3.33 66.60
12 1 1.72 61.21 1.09 A 38.79 0.00 0.00 2.81 56.20
12 2 1.66 52.20 1.52 A 47.80 0.00 0.00 3.18 63.60
12 3 2.04 66.45 1.03 A 33.55 0.00 0.00 3.07 61.40
13 1 2.66 72.88 0.99 A 27.45 0.00 0.00 3.65 73.00
N/B - non-blocker, blocked catheter CAP - Calcium phosphate
H - non-blocker, non-blocked catheter A - Apatite; B - Brushite
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Encrustation composition
Patient Episode Struvite 
mg/ml \
CAP
mg/ml %
CaOx
mg/ml %
Hass recovery 
mg %
13 2 2.65 99.25 0.02 A 0.75 0.00 0.00 2.67 53.40
18 1 2.38 79.60 0.61 A 20.40 0.00 0.00 2.99 59.80
18 2 2.47 88.21 0.33 A 11.79 0.00 0.00 2.80 56.00
18 3 1.26 44.05 1.60 A 55.95 0.00 0.00 2.86 57.20
19 H 2 0.12 3.40 0.00 0.00 3.41 96.66 3.53 70.60
19 N/B 3 2.44 57.96 1.77 B 42.04 0.00 0.00 4.21 84.20
20 N/B 1 1.45 45.17 1.76 A 54.83 0.00 0.00 3.21 64.20
20 N 3 1.01 33.78 1.98 A 66.22 0.00 0.00 2.99 59.80
21 1 1.45 46.47 1.67 A 53.53 0.00 0.00 3.12 62.40
21 2 1.72 53.42 1.50 A 46.58 0.00 0.00 3.22 64.40
21 3 1.45 48.17 1.56 A 51.83 0.00 0.00 3.01 60.20
23 1 2.67 53.83 2.29 B 46.17 0.00 0.00 4.96 99.20
23 2 1.47 32.38 3.07 B 67.62 0.00 0.00 4.54 90.80
23 3 1.47 33.26 2.95 B 66.74 0.00 0.00 4.42 88.40
24 1 0.73 15.60 3.95 B 84.40 0.00 0.00 4.68 93.60
26 N/B 3 3.55 100.00 0.00 0.00 0.00 0.00 3.55 71.00
27 N 1 2.30 61.50 1.44 B 38.50 0.00 0.00 3.74 74.80
32 N/B 3 0.62 13.05 4.13 B 86.95 0.00 0.00 4.75 95.00
33 N/B 3 3.81 100.00 0.00 0.00 0.00 0.00 3.81 76.20
34 1 2.15 50.12 2.14 B 49.88 0.00 0.00 4.29 85.80
34 2 2.01 40.36 2.97 B 59.64 0.00 0.00 4.98 99.60
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Encrustation composition
Patient Episode Struvite CAP CaOx Mass recovery
mg/ml 1 mg/ml 1 mg/ml * mg 1
34 3 3.08 72.47 1.17 A 27.53 0.00 0.00 4.25 85.00
37 1 1.41 31.13 3.12 B 68.87 0.00 0.00 4.53 90.60
37 2 2.27 48.82 2.38 B 51.18 0.00 0.00 4.65 93.00
38 N 1 0.00 0.00 0.00 0.00 4.22 100.00 4.22 84.40
39 N 1 0.83 18.99 3.54 B 81.01 0.00 0.00 4.37 87.40
40 1 2.12 45.79 2.12 B 45.79 0.39 8.42 4.63 92.60
41 1 2.30 63.89 1.30 B 36.11 0.00 0.00 3.60 72.00
45 1 2.33 60.84 1.50 B 39.16 0.00 0.00 3.83 76.60
46 1 2.91 89.26 0.35 B 10.74 0.00 0.00 3.26 65.20
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APPENDIX F
Indwelling Catheter Assessment Form
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INDWELLING CATHETER ASSESSMENT: 
Establishing a Pattern for Planned Care
Name:........................................................
1st assessment date:................................
Reason for catheterisation
Incontinence
Retention
Other
Previous history of bladder calculi......
Mobility at home
A jS ssment^
Bed/chair bound 
Walks with an aid 
Fully mobile
Catheter material
Assessment 
1. 2.
Hydrogel
Silicone-elastomer
Other
District Nurse:.................................................
Tel:......................................................................
G P :.....................................................................
Tel:......................................................................
2nd assessment date:......................................
History o f  blockage/leakage
Assessment 
1. 2.
None
Occasional (not
every catheter) _________ _______
Frequent
(every c a t h e t e r ) _______________
Bladder washouts
^sessm en^
None
Reagent
Frequency
D m n g ge s y s t m
Assessment 
1. 2.
Closed
Link
Valve/other
Equipment details: (to assist re-ordering)
This form may be used to aid the recognition of a characteristic pattern of "catheter life" for 
patients suffering from recurrent catheter encrustation and blockage.
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ESTABLISHING A PATTERN FOR PLANNED CARE:
Date of  
Catheter 
Change
Reason for 
Change 
Planned/ 
Blocked
No. Days 
Catheter In 
Place
Urine
PH
Encrust.
Visable?
BWO
Reagent
&
Frequency
Next Planned 
Rccath. 
Date
Anti-biotics
given?
EVALUATE CARE PLAN: (after 3 catheter ’lives') 
eg. recatheterisation schedule/BWO schedule.
EVALUATE CARE PLAN:
240
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
